Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3002173	ab-hb	g/l (g/l)	24376	233648	0.00%
3002173	ab-thb	g/l (g/l)	10227	48546	0.00%
3002173	ab-hb	— (—)	1925	9082	100.00%	Distribution not available
3002173	ab-chb	g/l (g/l)	536	1200	0.00%
3002173	ab-hemoglobiini	g/l (—)	480	2002	100.00%	Distribution not available
3002173	ab-hb-vt	g/l (g/l)	138	213	0.00%
3002173	hemoglobiini(totaali),valtimoveri	g/l (—)	117	203	100.00%	Distribution not available
3002173	ab-chb	— (—)	25	28	100.00%	Distribution not available
3002173	ab-hblask	g/l (g/l)	7	27	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Low back pain

4798

20526

1.90

322.83

7.5

8.6

122.75

121.44

g/l

4.16

4633

19800

Hypo-osmolality and hyponatraemia

1489

5289

3.27

321.89

11.4

6.7

116.93

120.26

g/l

7.65

1449

5089

COPD, early/later onset

3610

15731

2.13

321.06

9.4

7.6

124.49

120.34

g/l

23.99

3506

15167

Transplanted organ and tissue status

972

2695

4.48

320.92

22.2

8.1

107.33

124.37

g/l

101.90

950

2584

Venous thromboembolism

3964

20582

2.02

320.26

9.0

7.5

121.16

120.79

g/l

0.50

3837

19838

Viral pneumonia

1132

3449

3.88

319.22

15.8

7.1

121.91

122.72

g/l

0.56

1077

3328

Lower back pain or/and sciatica

6770

28695

1.71

318.43

7.2

8.3

122.79

121.55

g/l

5.06

6544

27645

Abnormal findings on diagnostic imaging of lung

3615

18367

2.09

317.46

9.3

7.6

122.09

120.68

g/l

3.66

3495

17720

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1941

7841

2.70

317.40

8.8

8.4

124.54

122.89

g/l

2.85

1871

7553

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1277

4164

3.47

316.97

9.3

8.8

125.31

123.50

g/l

2.25

1240

4015

All influenza

1879

7570

2.76

312.80

8.4

7.3

122.10

122.47

g/l

0.31

1789

7312

Fall on same level

7498

26063

1.67

312.22

8.9

8.1

120.40

122.79

g/l

17.04

7250

25098

Myocardial infarction, without ST-elevation

3221

15002

2.19

310.91

9.4

7.4

118.86

121.07

g/l

7.18

3107

14460

Alcohol use disorder, ICD-based

3123

15583

2.18

310.49

10.5

8.6

122.21

123.46

g/l

2.40

3037

15017

Spinal stenosis

3824

15849

2.04

308.13

6.9

8.3

120.52

120.57

g/l

0.05

3680

15307

Type 2 diabetes, definitions combined

6237

22285

1.75

307.66

9.4

7.5

122.29

122.05

g/l

0.38

6053

21452

Type 2 diabetes

6782

22814

1.86

307.65

9.8

7.5

121.47

122.18

g/l

1.77

6576

21959

Other disorders of fluid, electrolyte and acid-base balance

2768

9556

3.24

307.65

11.4

7.0

116.83

120.77

g/l

17.88

2694

9196

Nephropathy related operations

1369

4003

4.37

307.65

20.8

7.9

105.56

123.18

g/l

164.50

1340

3860

Bacterial pneumonia (organism specified)

3919

14859

2.69

307.65

11.1

7.2

119.36

121.50

g/l

7.78

3739

14318

Calcific aortic valvular stenosis, operated

2581

11221

2.57

307.65

8.8

7.0

114.45

120.63

g/l

45.07

2498

10793

Valvular heart disease excluding rheumatic fever

4212

11216

3.11

307.65

10.7

7.1

115.45

122.41

g/l

76.52

4097

10779

Implicit bacterial Sepsis

4081

12801

3.46

307.65

14.1

6.5

115.94

122.10

g/l

56.86

3963

12293

Oral corticosteroids

7757

25661

1.94

307.65

8.7

8.0

121.99

121.92

g/l

0.09

7511

24700

Parasetamol

5733

12759

2.43

307.65

8.7

8.5

122.77

123.47

g/l

1.41

5555

12251

Acute renal failure

2079

7231

3.47

307.65

18.4

7.0

110.93

121.99

g/l

93.52

2032

6965

Oxycodone

2902

11876

2.64

307.65

8.7

7.5

115.29

121.97

g/l

52.13

2801

11427

Coronary artery bypass grafting

2384

7873

2.61

307.65

11.8

7.4

114.74

121.30

g/l

41.61

2309

7581

Other pulmonary diagnosis

5511

13931

2.09

307.65

9.4

7.0

122.48

121.65

g/l

1.85

5311

13409

Viral Sepsis

1800

5741

3.71

307.65

13.2

6.5

119.32

122.07

g/l

5.67

1735

5516

Explicit Sepsis

4066

13926

3.22

307.65

12.9

6.6

113.44

122.16

g/l

120.50

3946

13373

Substance abuse

4358

20911

2.15

307.65

10.3

8.4

122.62

123.12

g/l

0.76

4244

20118

Pulmonary heart disease, diseases of pulmonary circulation

2682

11545

2.62

307.65

10.0

7.5

122.04

120.26

g/l

4.02

2605

11124

Other septicaemia

3571

12509

3.26

307.65

13.1

7.0

113.10

122.47

g/l

121.23

3467

12039

COPD/asthma/ILD related infections

7317

19715

1.96

307.65

9.5

7.2

121.18

121.74

g/l

1.32

7053

18992

8023

19698

2.81

307.65

11.1

7.2

120.32

121.74

g/l

6.48

7733

18977

Hypertension

5968

14256

2.56

307.65

10.0

7.7

121.90

123.47

g/l

5.66

5785

13701

COPD differential diagnosis

5471

13938

2.07

307.65

9.4

7.0

122.47

121.63

g/l

1.85

5270

13414

Other arrhythmias

3914

15485

2.05

307.65

7.8

7.2

123.01

122.66

g/l

0.46

3764

14880

Valvular operations

1500

4084

4.51

307.65

14.3

7.1

111.26

122.68

g/l

77.89

1454

3922

Hypothyroidism, levothyroxine purchases

1305

1532

5.20

307.65

9.7

5.9

124.80

127.70

g/l

3.39

1259

1460

Diabetes, insulin treatment (Kela reimbursement)

7043

24855

1.83

307.65

9.6

7.8

120.97

122.22

g/l

4.81

6817

23927

Other heart diseases

4209

6265

5.00

307.65

12.6

6.8

121.38

125.51

g/l

21.01

4078

5996

Cardiovascular diseases

3871

6582

3.42

307.65

10.2

6.7

123.59

125.22

g/l

3.81

3752

6293

Asthma, including avohilmo

7736

27909

1.68

307.65

8.0

8.2

124.04

121.28

g/l

23.62

7472

26894

Renal failure

4024

15601

2.69

307.65

14.2

7.0

110.47

122.22

g/l

213.82

3914

15012

Dorsalgia

6596

21014

1.78

307.65

7.2

8.6

123.32

121.53

g/l

8.85

6367

20267

Insulin, combination of fast acting with intermediate-acting or long-acting

4555

22688

1.99

307.65

10.2

7.8

118.96

122.15

g/l

18.73

4406

21865

Myocardial infarction

4119

13804

2.37

307.65

10.1

7.7

120.19

121.68

g/l

4.14

3985

13326

Other heart diseases, wide

7302

18489

2.66

307.65

10.7

7.4

121.51

123.28

g/l

8.50

7066

17761

Cardiac arrhythmias

4388

9985

3.15

307.65

10.6

6.8

123.21

122.96

g/l

0.29

4234

9562

Care involving use of rehabilitation procedures

4804

22157

2.22

307.65

9.8

7.6

121.06

122.55

g/l

5.04

4538

21401

Pain in limb

5340

21091

1.94

307.65

7.9

8.3

120.90

121.57

g/l

1.43

5181

20340

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

3014

12626

2.30

307.65

7.4

8.0

114.93

122.75

g/l

80.90

2911

12149

STROKE

4626

12650

2.80

307.65

10.1

7.3

121.25

122.75

g/l

4.59

4476

12179

Hypothyroidism (congenital or acquired)

1328

1541

5.25

307.65

9.9

6.0

124.70

127.67

g/l

3.56

1284

1469

Other chronic obstructive pulmonary disease

3588

14192

2.33

307.65

9.4

7.7

124.47

120.04

g/l

26.55

3485

13691

Asthma-related infections

4500

19938

2.42

307.65

8.9

7.8

123.32

120.83

g/l

12.06

4342

19209

Disorders of lipoprotein metabolism and other lipidaemias

6549

20004

2.23

307.65

9.0

7.5

120.88

122.46

g/l

6.98

6337

19278

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

7448

26795

2.14

307.65

9.8

7.7

113.75

123.83

g/l

276.27

7214

25813

Statin medication

4371

12739

2.02

307.65

9.6

7.9

122.51

123.03

g/l

0.78

4233

12220

Pneumonias (Asthma/COPD co-morbidities)

8738

24787

2.68

307.65

11.3

7.2

120.27

122.66

g/l

18.94

8431

23886

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

8023

19698

2.81

307.65

11.1

7.2

120.32

121.74

g/l

6.48

7733

18977

Chronic kidney disease

2431

10836

2.51

307.65

12.4

6.7

108.33

122.05

g/l

189.36

2356

10440

Hypertensive diseases (excluding secondary)

4077

6226

4.20

307.65

10.6

6.8

122.53

125.49

g/l

11.16

3963

5958

Pulmonary embolism

2425

10452

2.62

307.65

9.9

7.5

121.81

120.30

g/l

2.77

2353

10064

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4800

23348

2.06

307.65

9.1

7.7

121.80

120.80

g/l

2.55

4644

22529

Erysipelas

4293

18827

2.27

307.65

9.2

7.3

119.17

123.42

g/l

31.17

4170

18135

Atrial fibrillation and flutter with reimbursement

2447

3518

5.19

307.65

11.4

6.7

123.41

124.59

g/l

1.44

2381

3379

DVT of lower extremities and pulmonary embolism

3215

15797

2.23

307.65

9.1

7.5

121.42

120.61

g/l

1.32

3114

15230

Other bacterial diseases

8597

24207

2.72

307.65

10.7

7.4

116.91

123.61

g/l

138.83

8306

23307

Codeine

6839

18647

2.14

307.65

8.0

7.9

121.98

123.04

g/l

3.44

6608

17909

Codeine or tramadol medication

8098

25614

1.84

307.65

8.0

8.2

121.99

121.89

g/l

0.15

7829

24664

Heart failure,strict

5341

13502

3.35

307.65

11.6

7.1

119.11

122.34

g/l

19.53

5215

12986

All-cause Heart Failure

5589

15940

2.92

307.65

11.1

7.2

118.90

121.33

g/l

12.44

5456

15332

Operations 2 for CAVS

2577

11210

2.56

307.65

8.8

7.0

114.46

120.63

g/l

44.95

2494

10782

Calcific aortic valvular stenosis, including rheumatic fever

2578

11269

2.55

307.65

8.8

7.0

114.47

120.64

g/l

44.96

2495

10839

Mental and behavioural disorders due to alcohol

3833

18959

2.12

307.65

10.2

8.5

122.38

123.32

g/l

1.78

3724

18245

Major coronary heart disease event

5835

19320

2.21

307.65

9.7

7.7

120.20

121.75

g/l

6.01

5651

18650

Calcific aortic valvular stenosis

2581

11221

2.57

307.65

8.8

7.0

114.45

120.63

g/l

45.07

2498

10793

Substance abuse, excluding more controls

4358

17665

2.34

307.65

10.3

8.5

122.62

122.60

g/l

0.02

4244

16983

ILD differential diagnosis

5466

13934

2.07

307.65

9.4

7.0

122.47

121.63

g/l

1.87

5266

13410

Heart failure and bmi 25plus

3158

8994

2.78

307.65

10.9

7.2

119.63

122.96

g/l

12.59

3080

8603

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

6755

18981

2.26

307.65

8.4

8.5

119.66

123.92

g/l

48.75

6532

18268

Other intervertebral disc disorders

5799

20025

1.87

307.65

7.7

8.6

123.13

121.39

g/l

7.32

5538

19312

Hard cardiovascular diseases

6685

19198

2.47

307.65

10.2

7.7

120.45

122.16

g/l

7.89

6468

18514

Any gastric operation

5700

12088

2.51

307.65

9.5

6.6

120.50

125.65

g/l

50.90

5508

11576

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2740

5794

3.21

307.65

9.6

6.5

121.40

124.78

g/l

11.23

2642

5550

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1941

6794

3.14

307.65

8.8

8.2

124.54

122.57

g/l

3.75

1871

6539

Dialysis, with operation codes

1388

4097

4.28

307.65

20.9

7.6

105.59

123.71

g/l

173.08

1359

3944

General symptoms and signs

8185

20519

2.12

307.65

8.7

7.9

121.69

122.88

g/l

4.65

7922

19717

Neoplasms

4881

13238

2.07

307.65

8.6

9.0

122.49

125.04

g/l

12.11

4717

12722

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

8492

24933

2.63

307.65

10.9

7.4

120.12

122.65

g/l

20.71

8188

24038

Angina pectoris

4782

15497

2.29

307.65

8.6

7.7

121.29

121.42

g/l

0.15

4593

14951

Anaemias

1866

1417

9.91

307.65

12.4

6.0

112.12

127.46

g/l

87.33

1813

1354

GASTRO-related operations

5700

12088

2.51

307.65

9.5

6.6

120.50

125.65

g/l

50.90

5508

11576

COPD/asthma related infections

7317

19715

1.96

307.65

9.5

7.2

121.18

121.74

g/l

1.32

7053

18992

4384

20673

2.10

307.65

10.7

8.3

121.81

123.25

g/l

3.98

4261

19893

First line medication for Crohn's disease

7960

23596

1.94

307.65

9.0

7.9

121.01

122.67

g/l

8.66

7700

22697

Ischemic heart diseases

6413

18608

2.37

307.65

9.7

7.9

121.02

121.81

g/l

1.97

6214

17945

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

6750

18983

2.26

307.65

8.4

8.5

119.65

123.91

g/l

49.02

6527

18270

Diabetes, varying definitions

7064

23508

1.89

307.65

10.1

7.5

121.33

122.25

g/l

2.78

6843

22623

Benign neoplasm: Colon

3413

12742

2.23

307.65

8.0

8.1

118.77

123.22

g/l

28.47

3314

12260

Other diseases of pleura

3740

15881

2.32

307.65

11.5

7.4

122.04

120.77

g/l

2.91

3638

15310

Diabetes medication

6994

24485

1.83

307.65

9.6

7.7

121.06

122.26

g/l

4.42

6771

23568

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4498

21247

2.32

307.65

10.8

7.4

116.80

121.71

g/l

47.49

4346

20482

Asthma, unspecified (mode)

4146

12685

2.83

307.65

8.3

6.9

123.18

121.10

g/l

7.52

4009

12218

Coronary atherosclerosis

5715

16742

2.44

307.65

9.5

7.9

119.99

121.66

g/l

6.53

5531

16151

Pulmonary heart disease

2425

10513

2.60

307.65

9.9

7.5

121.81

120.36

g/l

2.61

2353

10125

Mental and behavioural disorders due to psychoactive substance use

4459

21283

2.13

307.65

10.2

8.4

122.62

123.09

g/l

0.70

4343

20478

Diseases of arteries, arterioles and capillaries (FINNGEN)

2526

3422

6.18

307.65

12.0

6.8

116.11

124.94

g/l

58.51

2449

3284

Dentinal caries

1915

7221

2.98

307.65

13.1

8.1

115.21

123.45

g/l

48.60

1854

6965

Symptoms and signs involving cognition, perception, emotional state and behaviour

6595

26846

1.81

307.65

7.7

8.3

122.22

121.61

g/l

1.52

6399

25867

Endocrine, nutritional and metabolic diseases

5308

13606

2.08

307.65

9.9

7.2

122.92

123.13

g/l

0.25

5141

13049

Malignant neoplasm, wide definition for exclusion

6751

18988

2.26

307.65

8.4

8.5

119.65

123.92

g/l

48.97

6528

18275

Non-rheumatic valve diseases

4174

11148

3.09

307.65

10.4

7.1

115.48

122.37

g/l

74.61

4059

10713

Diabetes mellitus

7098

23523

1.90

307.65

10.0

7.5

121.35

122.25

g/l

2.73

6874

22639

Implicit Sepsis

6916

20700

2.93

307.65

12.4

6.7

119.02

122.76

g/l

34.40

6724

19923

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4960

22297

2.44

307.65

10.8

7.3

116.81

121.94

g/l

56.01

4792

21493

Complications of medical and surgical care

6178

25572

2.54

307.65

10.4

7.4

117.26

122.08

g/l

60.83

5971

24664

Cerebrovascular diseases (FINNGEN)

2915

4506

5.35

307.65

11.1

6.5

122.06

124.90

g/l

8.17

2833

4322

Other CVD (FINNGEN)

935

1530

5.67

307.65

9.1

6.3

118.21

122.85

g/l

7.34

909

1452

Cerebrovascular diseases

5718

21887

2.02

307.65

9.2

7.8

120.70

121.27

g/l

1.22

5551

21094

COPD, hospital admissions

3596

15640

2.14

307.65

9.4

7.6

124.52

120.33

g/l

24.28

3492

15081

Asthma

5907

13819

2.46

307.65

8.4

7.0

124.17

121.63

g/l

13.89

5708

13301

Peripheral artery disease

3544

14195

2.22

307.65

9.7

7.0

115.43

121.59

g/l

56.94

3432

13664

Hypertensive diseases

5977

14260

2.56

307.65

10.1

7.7

121.90

123.48

g/l

5.67

5794

13705

Bacterial infection, other or unspecified

4478

17055

2.65

307.65

10.8

7.0

113.94

122.74

g/l

142.95

4318

16424

Condition for Implicit Sepsis (Organ dysfunction codes)

7547

22187

2.74

307.65

12.3

6.8

119.89

122.87

g/l

23.98

7329

21349

Certain infectious and parasitic diseases

6829

18948

1.89

307.65

9.4

7.3

120.00

123.56

g/l

32.09

6593

18213

Malignant neoplasm

6516

20288

2.03

307.65

8.4

119.21

123.53

g/l

50.33

6288

19559

Heart failure and antihypertensive medication

2860

3853

6.01

307.65

13.9

7.1

119.60

123.69

g/l

13.57

2796

3686

Diseases of arteries, arterioles and capillaries

5625

20121

2.30

307.65

10.6

7.3

116.64

122.10

g/l

66.80

5455

19392

Opioids

7027

18829

2.07

307.65

8.7

7.9

121.16

123.07

g/l

10.00

6792

18085

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

7118

24468

2.11

307.65

11.3

7.4

117.79

122.89

g/l

72.16

6871

23605

Malaise and fatigue

3874

13822

2.56

307.65

8.3

7.6

119.45

121.50

g/l

7.13

3779

13287

Depression medications

1633

1644

5.30

307.65

9.5

5.8

125.63

128.15

g/l

3.02

1582

1564

Pneumonia, organism unspecified

7667

23240

2.62

307.65

10.6

7.2

119.95

122.59

g/l

20.47

7420

22410

Asthma (only as main-diagnosis)

5067

13819

2.36

307.65

7.9

7.0

124.12

121.63

g/l

12.19

4894

13301

Hypothyroidism and >3 levothyroxin purchases

1305

1532

5.20

307.65

9.7

5.9

124.80

127.70

g/l

3.39

1259

1460

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

6719

22829

1.90

307.65

9.7

7.6

121.02

122.27

g/l

4.57

6510

21968

3001

13878

2.31

307.65

8.6

8.1

124.23

121.22

g/l

11.80

2901

13384

Hernia of abdominal wall, postoperative

1418

4457

3.62

307.65

10.6

6.7

119.72

125.40

g/l

17.66

1382

4264

Tramadol

6553

17781

2.58

307.65

8.9

8.0

121.00

122.91

g/l

9.59

6381

17081

Asthma (only as main-diagnosis), excluding more controls

4932

12317

2.55

307.65

8.0

6.7

124.25

121.97

g/l

9.91

4765

11834

Convulsions, not elsewhere classified

1741

6505

2.91

307.65

9.0

8.3

122.10

123.27

g/l

1.41

1697

6240

Bacterial Sepsis

4547

14221

3.32

307.65

13.7

6.5

115.93

122.27

g/l

67.19

4412

13669

Alcohol use disorder, Swedish definition

4211

19973

2.12

307.65

10.9

8.3

121.67

123.30

g/l

4.81

4093

19226

Dyspnoea

7882

25265

2.64

307.65

8.3

8.0

123.61

120.85

g/l

23.33

7694

24291

Mental and behavioural disorders due to alcohol, excluding acute intoxication

3404

17007

2.17

307.65

10.5

8.6

122.16

123.50

g/l

2.89

3307

16392

Other diseases of intestines

7069

23858

1.80

307.65

9.1

8.1

120.61

122.94

g/l

15.54

6847

22944

Cardiovascular diseases (excluding rheumatic etc)

4580

7481

3.83

307.65

10.3

6.7

122.93

125.40

g/l

9.18

4445

7154

4551

21106

2.08

307.65

10.7

8.3

121.92

123.17

g/l

3.24

4424

20310

Abnormalities of breathing

7335

17976

2.62

307.65

8.4

8.2

124.61

120.94

g/l

34.46

7130

17264

Fever of other and unknown origin

4254

16723

2.57

307.65

9.7

7.8

116.33

122.27

g/l

60.80

4136

16081

All pneumoniae

8789

24807

2.69

307.65

11.3

7.2

120.28

122.64

g/l

18.49

8472

23918

Atrial fibrillation and flutter

2830

4325

4.88

307.65

12.0

6.6

122.66

125.32

g/l

6.38

2743

4149

Septicaemia

3971

13770

3.21

307.65

12.8

7.0

113.42

122.47

g/l

125.58

3849

13253

Pain in throat and chest

6366

17545

2.38

307.65

7.6

8.2

124.34

120.93

g/l

27.62

6139

16852

Paralytic ileus and intestinal obstruction

2099

8711

2.70

307.65

10.1

7.4

117.44

121.47

g/l

15.03

2033

8382

Bacterial pneumoniae

3756

12568

3.00

307.65

11.2

6.8

119.52

122.02

g/l

9.83

3579

12119

Implicit viral Sepsis

1798

5731

3.71

307.65

13.2

6.5

119.31

122.09

g/l

5.75

1733

5506

Influenza and pneumonia

9072

24491

2.67

307.65

11.0

7.3

120.61

122.62

g/l

13.88

8736

23618

Asthma, hospital admission 2, infections

4500

19938

2.42

307.65

8.9

7.8

123.32

120.83

g/l

12.06

4342

19209

Colorectal cancer, excluding all cancers (controls excluding all cancers)

2290

9115

2.76

307.65

8.2

7.6

115.61

122.18

g/l

48.60

2235

8776

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2357

4548

2.73

307.65

9.0

8.1

123.93

123.18

g/l

0.77

2276

4328

Non-ischemic cardiomyopathy

2498

7541

3.11

307.65

11.0

6.9

119.42

120.94

g/l

2.65

2442

7244

Symptoms and signs involving the circulatory and respiratory systems

7077

18037

2.07

307.65

8.3

8.2

124.01

121.00

g/l

22.95

6841

17323

Covid-19 confirmed case

2824

9226

3.62

307.65

12.6

7.7

120.65

121.43

g/l

1.06

2767

8871

Bleeding

6677

23938

2.20

307.65

10.5

7.6

118.10

122.45

g/l

47.20

6490

23057

Codes for special purposes

3430

14414

2.62

307.65

11.8

7.7

121.18

121.89

g/l

1.14

3367

13887

Excluding asthma or asthma-COPD overlap

5525

13931

2.09

307.65

9.4

7.0

122.41

121.65

g/l

1.62

5323

13409

Intestinal stricture

2474

11071

2.51

307.65

10.3

7.5

116.82

121.04

g/l

19.83

2406

10668

Non-invasive ventilation

4548

3561

19.40

307.65

9.9

6.2

120.29

122.19

g/l

4.46

4168

3441

Asthma, hospital admissions 3, pneumonia

3200

12235

2.97

307.65

9.7

7.4

122.02

120.08

g/l

5.48

3091

11769

Asthma (mode)

5520

13934

2.32

307.65

8.2

7.0

123.73

121.63

g/l

9.56

5328

13410

Any event in cancer register

6385

20779

1.93

307.65

8.3

119.87

123.27

g/l

31.40

6148

20042

Complications of procedures, not elsewhere classified

6536

25583

2.41

307.65

10.4

7.5

117.28

122.72

g/l

78.92

6338

24645

Complications of surgical and medical care, not elsewhere classified

8200

26480

2.42

307.65

10.1

7.5

117.35

122.89

g/l

98.64

7947

25498

Any reimbursement code in KELA

3571

6192

3.06

307.65

9.4

7.4

123.60

125.33

g/l

4.03

3456

5945

Asthma-related pneumonia or sepsis

3200

12235

2.97

307.65

9.7

7.4

122.02

120.08

g/l

5.48

3091

11769

Asthma, unspecified (mode), excluding more controls

4059

11317

3.09

307.65

8.4

6.7

123.30

121.44

g/l

5.90

3925

10881

Poisoning by drugs, medicaments and biological substances

1839

6445

3.20

307.65

8.7

8.6

125.10

123.10

g/l

3.68

1785

6212

Intracranial trauma

3848

13231

2.31

307.65

8.7

7.9

122.09

120.79

g/l

3.07

3734

12723

Poisoning by medicine

1685

5724

3.31

307.65

8.9

8.7

125.14

123.17

g/l

3.29

1635

5512

Myocardial infarction, strict

3756

13128

2.30

307.65

9.8

7.7

120.00

121.70

g/l

4.90

3632

12668

Provisional assignment of new diseases of uncertain etiology

3427

14395

2.62

307.65

11.8

7.7

121.18

121.88

g/l

1.12

3364

13868

Coronary revascularization (ANGIO or CABG)

3777

12383

2.35

307.65

9.9

7.6

117.43

121.61

g/l

25.92

3654

11944

Hypertension, essential

6054

14022

2.68

307.65

9.6

7.7

121.94

123.45

g/l

5.32

5865

13480

Heart failure and coronary heart disease

2801

9399

2.51

307.65

10.6

6.9

117.62

120.48

g/l

9.32

2733

9060

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1019

1872

4.69

307.65

12.2

7.9

123.88

120.44

g/l

4.31

988

1800

Dental caries

2125

8200

2.88

307.65

13.1

8.1

115.21

123.51

g/l

55.10

2058

7908

Infections, IBD-co-morbidities

1292

2519

4.18

307.65

11.8

7.9

116.10

121.03

g/l

11.04

1253

2429

Hypothyroidism, drug reimbursement

737

966

5.86

307.65

9.6

6.4

123.33

126.53

g/l

2.65

702

920

Bacterial pneumonia, not elsewhere classified

3601

11881

3.05

307.65

11.2

6.7

119.55

121.87

g/l

8.15

3431

11458

ILD medications

7876

24911

1.82

307.65

9.3

7.8

121.12

122.37

g/l

5.18

7623

23964

Asthma-related pneumonia

3193

12210

2.97

307.65

9.7

7.4

122.00

120.09

g/l

5.31

3084

11745

ILD medications: prednisolone, methylprednisolone, prednisone

7815

24669

1.89

307.65

9.1

7.8

121.21

122.32

g/l

4.19

7581

23734

Metabolic disorders

7990

21788

2.49

307.65

9.9

7.7

120.25

122.61

g/l

16.71

7729

20971

Inflammatory bowel disease treatment related agents

7945

26125

1.81

307.65

8.6

8.0

121.93

122.01

g/l

0.12

7696

25147

Diseases of oesophagus, stomach and duodenum

7082

26280

1.71

307.65

9.3

7.9

120.02

122.49

g/l

17.26

6854

25308

Examination and observation for other reasons

4455

13096

2.21

307.65

9.0

7.9

119.58

122.69

g/l

17.11

4397

12594

Insulin medication

4548

19418

2.16

307.65

10.2

7.7

118.97

122.31

g/l

19.99

4399

18705

Sequelae of external causes of morbidity and mortality

2066

8545

2.75

307.65

10.5

7.7

115.65

121.35

g/l

28.30

2000

8239

Chronic lower respiratory diseases

8366

26085

1.82

307.65

8.5

8.1

124.30

121.18

g/l

30.51

8086

25134

COPD

3750

14637

2.35

307.65

9.5

7.7

124.51

120.12

g/l

27.05

3636

14121

Paroxysmal tachycardia

1405

3480

3.73

307.65

10.5

6.6

123.30

124.26

g/l

0.83

1368

3324

Heart failure, strict

5705

16206

2.93

307.65

11.3

7.2

118.98

121.39

g/l

12.40

5570

15593

Asthma/COPD (KELA code 203)

6374

25998

1.81

307.65

7.8

8.1

124.44

121.16

g/l

27.84

6151

25054

Asthma (diagnoses ohter than nonallergic)

6108

28025

1.98

307.65

8.2

8.0

123.52

121.10

g/l

15.38

5905

27011

Antihypertensive medication - note that there are other indications

3622

7640

2.74

307.65

9.5

7.0

123.64

124.49

g/l

1.30

3494

7313

Pure hypercholesterolaemia

5921

18823

2.30

307.65

8.4

7.5

120.85

122.20

g/l

4.84

5715

18146

Other medical care

3119

14502

2.31

307.65

7.6

7.0

115.73

121.63

g/l

46.08

2997

13982

Type 2 diabetes, wide definition

6311

20370

2.19

307.65

9.6

7.4

120.06

121.97

g/l

9.16

6113

19628

Presence of cardiac and vascular implants and grafts

4054

14211

2.42

307.65

11.1

7.3

117.69

121.97

g/l

30.03

3906

13717

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

3790

12395

2.69

307.65

9.0

8.0

115.40

122.76

g/l

89.68

3689

11937

Other chronic obstructive pulmonary disease, including avohilmo

4202

18199

2.10

307.65

9.3

7.7

124.33

120.49

g/l

24.31

4083

17551

Acute tubulo-interstitial nephritis

4369

19582

2.13

307.65

8.7

6.9

116.47

122.19

g/l

62.69

4250

18841

Ischaemic heart disease, wide definition

6361

18395

2.38

307.65

9.7

7.9

120.99

121.82

g/l

2.13

6161

17739

Persons encountering health services for specific procedures and health care

8511

25166

2.25

307.65

10.2

7.6

119.18

123.04

g/l

47.45

8167

24301

Benign neoplasm of colon, rectum, anus and anal canal

3874

13469

2.22

307.65

8.0

8.2

119.06

123.48

g/l

31.44

3763

12971

Insulin, intermediate and long-acting

4213

21246

2.11

307.65

10.1

7.8

119.07

122.31

g/l

17.76

4076

20468

Calcific aortic valvular stenosis, diagnosis (helper)

2577

11210

2.56

307.65

8.8

7.0

114.46

120.63

g/l

44.95

2494

10782

Heart failure, not strict

7803

18541

3.37

307.65

11.8

7.3

118.60

122.84

g/l

46.92

7591

17845

Asthma, excluding more controls

5704

12317

2.65

307.65

8.4

6.7

124.27

121.97

g/l

10.94

5512

11834

Early onset COPD, excluding more controls

1785

6121

3.34

307.65

11.0

7.2

126.50

121.83

g/l

14.32

1732

5890

COPD (mode)

2836

8129

3.17

307.65

9.7

6.8

124.44

120.80

g/l

13.66

2754

7836

Spondylopathies

5656

19180

1.90

307.65

7.0

8.6

121.73

121.23

g/l

0.97

5451

18509

Major coronary heart disease event excluding revascularizations

5259

18327

2.17

307.65

9.6

7.7

121.30

121.73

g/l

0.71

5089

17697

Renal tubulo-interstitial diseases

7166

24538

2.45

307.65

11.3

7.3

114.73

122.99

g/l

188.32

6976

23630

Other soft tissue disorders, not elsewhere classified

6100

21720

1.82

307.65

7.9

8.4

121.61

121.76

g/l

0.20

5905

20940

Pacemaker

2698

12538

2.34

306.05

10.7

7.0

118.35

120.27

g/l

4.94

2593

12056

Haemorrhage from respiratory passages

2525

10772

2.37

305.68

9.9

7.8

119.68

119.90

g/l

0.19

2443

10343

Other neurological diseases

5057

23485

1.84

305.56

7.8

7.9

121.49

120.94

g/l

1.08

4889

22653

Other nutritional deficiencies

4052

21539

1.95

305.45

9.9

8.2

124.26

121.56

g/l

12.19

3947

20745

Hypertensive heart and/or renal disease

1972

6227

2.73

304.25

8.8

6.9

118.86

121.52

g/l

5.65

1936

5993

Type 2 diabetes, strict (exclude DM1)

6253

22449

1.74

303.54

9.4

7.6

122.30

121.99

g/l

0.50

6066

21610

Suicide or other Intentional self-harm

1776

7054

2.78

303.41

9.0

8.5

124.62

123.11

g/l

2.24

1721

6799

Headache

3909

17418

1.97

301.96

7.6

7.9

124.24

122.47

g/l

6.17

3782

16736

Psychiatric diseases

7256

22480

1.68

301.45

8.4

8.1

122.54

121.60

g/l

2.99

7026

21629

Symptoms and signs involving the digestive system and abdomen

6857

20961

1.71

300.57

8.7

8.2

122.14

122.35

g/l

0.33

6637

20124

COPD related to multimorbidity

3138

13316

2.19

299.70

9.5

7.4

123.95

120.19

g/l

17.40

3049

12829

Emergency coronary revascularization (for ACS)

4267

16921

1.97

299.42

9.5

7.6

117.69

121.66

g/l

27.37

4123

16335

Atherosclerosis, excluding cerebral and coronary sclerosis

3268

13324

2.15

297.31

9.4

6.9

115.45

121.43

g/l

50.05

3166

12822

Type 2 diabetes, definitions combined, including avohilmo

6217

22217

1.73

296.63

9.3

7.6

122.45

121.99

g/l

0.88

6029

21384

Polyarthropathies

4581

17043

1.89

295.35

9.1

8.7

118.80

122.05

g/l

19.32

4436

16440

Neurological diseases, wide definition

1869

3475

2.84

294.53

9.5

8.1

124.97

121.50

g/l

7.90

1804

3335

Other respiratory disorders and diseases

1765

7180

2.82

294.44

13.9

7.2

125.55

120.07

g/l

19.22

1713

6916

Other diseases of the respiratory system

1765

7180

2.82

294.44

13.9

7.2

125.55

120.07

g/l

19.22

1713

6916

Other (not insulin) diabetes medications

6342

23397

1.71

288.74

9.1

7.7

121.67

122.06

g/l

0.70

6144

22527

Aplastic and other anaemias

3315

16454

2.08

286.13

9.6

7.3

107.47

122.04

g/l

298.02

3226

15830

Any mental disorder

7378

23252

1.65

286.12

8.4

8.1

122.51

121.57

g/l

3.03

7140

22381

Other dorsopathies, not elsewhere classified

6516

21064

1.70

283.85

7.4

8.6

123.41

121.54

g/l

9.35

6267

20315

Respiratory insufficiency

808

2133

4.65

283.61

13.9

6.3

130.88

119.54

g/l

34.24

788

2057

Diseases of the digestive system

3299

17285

2.06

282.66

9.9

7.5

114.78

121.83

g/l

63.35

3216

16634

Obesity

3829

20779

1.93

282.63

9.9

8.1

124.54

121.55

g/l

14.19

3731

20012

Obesity and other hyperalimentation

3844

20876

1.93

282.35

9.9

8.1

124.53

121.54

g/l

14.27

3746

20107

Stroke, including SAH

4564

19339

1.87

282.21

9.4

7.8

120.69

120.98

g/l

0.39

4430

18635

Concussion

2993

12973

2.10

279.02

7.7

7.9

123.19

120.77

g/l

7.66

2903

12477

Abdominal and pelvic pain

6731

20953

1.68

278.43

8.6

8.1

122.80

122.35

g/l

0.88

6521

20116

Asthma, hospital admissions , main diagnosis only

5250

28156

1.75

278.39

7.8

8.1

123.88

121.23

g/l

16.12

5071

27136

Nerve, nerve root and plexus disorders

6930

27555

1.65

277.52

7.7

8.3

122.38

121.56

g/l

2.49

6641

26599

COPD, hospital admission 2, with asthma infections

2582

10644

2.30

276.69

9.9

7.3

124.48

120.27

g/l

17.66

2504

10243

Peripheral arterial reconstruction

1573

6283

2.95

276.50

10.9

7.0

113.12

120.47

g/l

38.58

1523

6055

Later onset COPD, excluding more controls

1707

5349

2.83

275.36

8.1

6.0

122.72

119.36

g/l

7.90

1664

5132

Personality disorders, excluding more controls

1592

6247

2.75

274.89

8.3

8.4

124.51

123.19

g/l

1.67

1542

6011

Conduction disorders

2013

7290

2.51

270.42

9.2

6.7

120.37

121.99

g/l

2.74

1949

6985

Injuries to the head

6951

28869

1.63

270.35

8.7

8.1

121.48

121.94

g/l

1.01

6746

27789

Benign neoplasms

4456

14123

1.86

269.70

8.3

8.9

123.15

124.77

g/l

5.00

4309

13577

Hypertensive Heart Disease

1746

5871

2.70

267.55

9.0

6.9

119.86

121.39

g/l

2.01

1718

5648

Sequelae with surgical and medical care as external cause

1636

6737

2.78

265.81

10.5

7.6

114.72

121.05

g/l

28.73

1586

6492

Insulin, fast-acting

2584

12720

2.20

265.78

10.5

7.8

117.61

122.67

g/l

26.27

2489

12258

Glucagon-like peptide-1 (GLP-1) analogues

3969

18396

1.91

264.99

8.9

7.6

119.51

121.29

g/l

5.60

3829

17737

Obesity related asthma

2331

11071

2.30

264.71

8.9

8.1

125.64

121.18

g/l

17.98

2270

10661

Hernia

6068

25619

1.68

264.24

8.7

8.1

121.06

121.94

g/l

2.45

5891

24640

Episodal and paroxysmal disorders

7059

22980

1.63

263.83

8.2

8.1

124.15

120.69

g/l

32.65

6828

22085

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

1315

4768

3.07

262.34

5.7

6.4

115.98

119.23

g/l

8.55

1280

4568

Epilepsy

2209

10269

2.33

260.92

8.5

8.0

122.86

120.76

g/l

4.95

2142

9877

Nausea and vomiting

1858

7918

2.52

260.81

9.4

7.2

118.61

120.47

g/l

3.21

1803

7613

Other diseases of the digestive system

2453

11987

2.25

260.72

10.1

7.5

113.57

121.83

g/l

62.28

2399

11544

GI-bleeding

2464

12060

2.25

260.59

10.1

7.5

113.65

121.81

g/l

61.13

2411

11616

Sciatica+with lumbago

3302

16795

1.98

260.42

7.0

8.7

123.47

121.21

g/l

7.94

3200

16208

Disorders of gallbladder, biliary tract and pancreas

6432

26231

1.65

259.58

9.1

7.9

120.21

121.79

g/l

7.24

6237

25287

Cardiac arrest

567

997

5.81

258.54

16.2

7.1

119.14

124.42

g/l

5.99

555

945

Neurological diseases

5421

16281

1.74

257.04

8.4

8.2

123.67

120.73

g/l

18.00

5228

15670

Other and unspecified anaemias

3014

15362

2.06

256.12

9.3

7.2

107.33

121.95

g/l

274.32

2939

14788

Other anaemias

3036

15485

2.05

255.22

9.4

7.2

107.33

121.95

g/l

276.97

2960

14908

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

1082

3705

3.49

254.26

7.6

119.10

122.54

g/l

6.77

1059

3559

AV-block

1329

4514

3.00

252.74

9.6

6.4

119.38

121.90

g/l

4.03

1282

4322

COPD-related respiratory insufficiency

1133

4015

3.41

252.12

12.9

7.3

125.85

119.84

g/l

15.19

1103

3867

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

1401

5496

2.93

251.63

7.8

8.0

115.25

122.61

g/l

35.23

1354

5286

Biguanides

6177

23984

1.66

251.48

8.9

7.9

121.81

121.76

g/l

0.06

5976

23096

Unstable angina pectoris

2894

12475

2.10

250.24

8.0

7.3

122.11

121.11

g/l

1.68

2778

12022

Non-allergic asthma (mode), excluding more controls

1304

4826

2.93

249.28

8.1

6.3

124.87

120.88

g/l

9.05

1262

4629

Cardiomyopathy

1327

5057

2.95

248.99

13.9

7.1

123.29

123.18

g/l

0.06

1305

4854

L04AD Calcineurin inhibitors

949

3045

3.72

248.06

19.8

9.0

108.91

124.00

g/l

80.86

922

2935

Other special examinations and investigations of persons without complaint or reported diagnosis

4555

13253

1.82

247.60

8.5

7.9

122.27

122.65

g/l

0.50

4355

12741

Syncope and collapse

2955

13732

2.03

245.99

7.9

7.6

121.86

121.70

g/l

0.15

2865

13210

Diverticular disease of intestine

4827

19205

1.76

245.40

8.0

7.9

119.73

122.13

g/l

12.19

4707

18492

Oedema, not elsewhere classified

2112

9867

2.31

245.15

9.1

7.4

118.88

121.25

g/l

5.60

2048

9485

Colectomy operation

1451

5904

2.85

243.54

10.9

7.5

113.88

121.04

g/l

34.84

1419

5676

Other antidepressants

6791

22808

1.61

242.03

8.3

8.1

122.72

121.71

g/l

3.26

6584

21943

Mood disorders, excluding more controls

5850

22313

1.66

240.76

8.5

8.1

122.93

121.65

g/l

4.43

5670

21470

Alcohol abuse, main dg, excluding more controls

1159

4204

3.11

238.94

9.2

8.8

124.96

123.60

g/l

1.21

1136

4053

Insulin, fast-acting or short human

2598

13316

2.11

238.46

10.6

8.0

117.58

122.51

g/l

25.27

2503

12836

Abnormal findings on examination of blood, without diagnosis

3351

17470

1.94

237.62

8.3

120.05

122.18

g/l

7.00

3216

16884

Use of hypnotics and sedatives

6852

25850

1.59

236.12

8.3

121.21

122.21

g/l

3.32

6616

24918

Early onset COPD

1785

8037

2.49

235.62

11.0

8.5

126.50

121.31

g/l

18.15

1732

7741

Secondary hypertension

554

1239

5.07

232.45

12.1

6.8

111.96

125.26

g/l

33.95

536

1179

Lumbar disc prolapse

4075

18951

1.80

231.72

8.0

8.8

123.47

121.49

g/l

7.08

3897

18283

COPD, hospital admissions 3, with asthma pneumonia sepsis

2167

8924

2.29

231.23

10.0

7.3

123.81

119.82

g/l

13.87

2100

8583

Care involving dialysis

780

2344

4.12

229.19

16.7

7.9

103.19

123.49

g/l

134.63

762

2270

Gastrointestinal diseases

3536

9615

1.91

228.57

9.1

7.3

121.94

124.67

g/l

10.09

3397

9215

Diarrhoea and gastroenteritis of presumed infectious origin

4336

23667

1.74

227.65

9.2

7.8

121.11

122.29

g/l

3.08

4213

22780

Other or unspecified ileus, impaction or obstruction

1457

6081

2.69

227.35

9.5

7.4

117.28

121.42

g/l

11.10

1414

5844

Autoimmune diseases excluding thyroid diseases

6681

24191

1.59

227.18

9.3

8.0

119.73

122.83

g/l

25.27

6454

23300

Diseases of the respiratory system

4058

11571

1.83

226.83

8.5

7.0

121.91

120.76

g/l

2.61

3909

11148

Stroke, excluding SAH

4182

18462

1.79

226.81

9.1

7.7

120.50

120.88

g/l

0.55

4054

17800

Benign neoplasm of colon, rectum, anus and anal canal

4210

22818

1.77

226.58

7.9

7.8

119.01

121.11

g/l

9.18

4091

21991

Osteopathies and chondropathies

3544

19244

1.85

226.16

8.5

7.7

118.05

121.33

g/l

17.62

3423

18560

7092

24732

1.57

225.49

8.4

7.8

122.42

121.05

g/l

5.81

6855

23825

Nutritional anaemias

3222

17565

1.90

222.93

9.7

7.1

111.62

121.29

g/l

129.37

3133

16913

Iron deficiency anaemia

2759

14623

2.01

222.32

9.9

7.2

111.09

121.18

g/l

119.71

2687

14063

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

945

3240

3.50

221.93

7.5

7.6

119.73

122.35

g/l

3.69

925

3118

Intestinal infectious diseases

5749

28798

1.62

221.72

9.1

7.9

120.67

122.03

g/l

5.00

5580

27722

ILD medications: immunosuppressive drugs

3743

20928

1.80

221.68

11.2

8.0

116.74

122.36

g/l

49.96

3628

20147

Dizziness and giddiness

4722

23649

1.70

220.75

7.3

8.0

121.92

121.05

g/l

2.15

4576

22796

Pain (limb, back, neck, head abdominally)

4795

14477

1.72

219.21

8.3

8.6

122.57

121.80

g/l

1.50

4638

13893

Autoimmune diseases excluding thyroid diseases, strict definition

6464

23532

1.59

218.40

9.1

8.0

119.73

122.82

g/l

24.36

6248

22664

Infections of the skin and subcutaneous tissue

3550

20544

1.81

214.85

9.8

8.4

120.38

122.91

g/l

9.56

3459

19789

Pain, not elsewhere classified

1684

7616

2.38

213.06

8.3

7.7

121.47

121.83

g/l

0.30

1639

7308

Dorsopathies

6357

21125

1.59

212.99

7.6

8.6

123.11

121.55

g/l

6.60

6124

20376

General examination and investigation of persons without complaint and reported diagnosis

4215

13220

1.77

212.93

8.8

7.9

122.80

122.66

g/l

0.15

4090

12710

Non-allergic asthma (mode)

1304

5222

2.69

212.85

8.1

6.5

124.87

120.46

g/l

10.98

1262

5019

Schizophrenia or delusion, excluding more controls

1869

8735

2.27

212.55

7.7

8.3

123.99

122.67

g/l

1.86

1795

8397

Ulcer of lower limb, not elsewhere classified

1201

4787

2.93

211.21

11.9

7.7

111.16

121.12

g/l

50.80

1181

4614

Other disorders of urethra and urinary system

4247

19253

1.73

210.42

7.9

7.6

119.22

120.98

g/l

6.69

4104

18520

Other postsurgical states

624

1715

4.54

209.18

8.1

7.8

119.65

122.62

g/l

2.70

615

1645

Misadventures to patients during surgical and medical care

1099

4179

3.01

209.14

11.8

7.2

115.66

122.10

g/l

20.69

1064

4022

Obesity due to excess calories

2753

14998

1.95

207.86

9.8

8.1

124.34

121.62

g/l

8.90

2679

14429

Other disorders of skin and subcutaneous tissue

4342

24564

1.70

207.43

8.7

7.7

117.46

121.42

g/l

30.27

4207

23678

Substance use, excluding alcohol

1305

5372

2.66

206.45

10.2

8.8

124.59

123.93

g/l

0.51

1278

5173

Vocal cord dysfunction

808

2362

3.45

204.99

10.8

6.1

121.57

122.19

g/l

0.35

770

2261

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

1425

6184

2.59

204.52

8.2

7.5

114.62

122.08

g/l

38.10

1391

5946

Focal epilepsy

1530

6823

2.48

204.01

8.4

8.0

123.46

121.67

g/l

2.83

1483

6571

COPD, hospital admissions 1, only main diagnosis

2602

11954

2.02

202.91

9.4

7.4

125.82

120.17

g/l

31.72

2531

11515

Alcohol dependence

1983

9817

2.20

202.53

9.9

8.7

122.64

123.21

g/l

0.51

1938

9469

Other acute lower respiratory infections

3359

18654

1.81

201.18

8.7

7.9

123.28

121.46

g/l

5.25

3260

17960

Falls/tendency to fall

6776

22679

1.54

200.53

8.9

8.1

120.84

122.78

g/l

10.36

6539

21844

ILD, hospital admission 2, with pulmonary infections

830

2794

3.53

200.28

12.4

6.9

122.29

120.76

g/l

1.18

805

2697

Symptoms and signs involving the urinary system

4929

24339

1.64

198.71

8.3

8.0

120.05

121.67

g/l

6.23

4777

23476

Gout

2063

9477

2.17

198.59

10.1

8.3

117.39

121.78

g/l

15.78

2009

9151

Other functional intestinal disorders

2802

14797

1.91

198.17

7.6

7.3

120.03

121.43

g/l

3.13

2696

14233

Bronchitis

6475

28618

1.54

195.53

8.5

7.9

123.14

121.34

g/l

9.22

6279

27554

Anxiety disorders, excluding more controls

4769

19963

1.64

193.33

8.6

8.1

123.27

121.71

g/l

5.48

4613

19206

Kidney transplant status

544

1445

4.85

193.31

13.2

10.0

105.26

124.43

g/l

77.37

534

1397

Direct fill therapy

1014

3848

2.99

192.80

12.9

8.8

116.31

123.08

g/l

18.31

976

3710

Coronary angioplasty

2601

10853

1.98

192.65

7.7

7.6

120.14

121.33

g/l

2.01

2512

10464

Personality disorders

1592

7389

2.31

188.55

8.3

8.8

124.51

123.37

g/l

1.37

1542

7120

Focal epilepsy, strict definition

1416

6330

2.48

188.14

8.5

8.0

123.56

121.71

g/l

2.80

1375

6098

Diseases of pulp and periapical tissues

2288

12165

2.01

187.43

11.9

8.0

117.97

123.05

g/l

24.38

2217

11737

Aneurysms, operations, SAH

1258

5386

2.63

186.33

10.0

7.7

122.28

120.39

g/l

2.69

1220

5171

Type 1 diabetes

1611

7573

2.28

184.60

11.1

7.6

116.39

123.35

g/l

29.58

1546

7273

Unspecified mental disorder

2476

13542

1.93

184.10

7.7

8.5

124.13

122.61

g/l

3.03

2378

13049

Volume depletion

755

2515

3.49

183.61

10.8

6.7

116.44

120.62

g/l

5.62

741

2421

Disorders of adult personality and behaviour

1637

7772

2.25

182.67

8.2

8.8

124.66

123.52

g/l

1.41

1577

7488

Focal epilepsy, mode (most common among epilepsy diagnosis)

1341

5940

2.50

182.07

8.4

8.0

123.66

121.66

g/l

3.07

1303

5719

External causes of morbidity and mortality

4038

12241

1.71

181.12

8.6

7.5

121.15

123.15

g/l

6.87

3901

11790

Hypokalaemia

885

3251

3.11

179.84

11.6

7.1

118.76

121.03

g/l

2.27

859

3129

Soft tissue disorders

6273

21960

1.53

179.82

7.7

8.4

122.42

121.84

g/l

1.24

6042

21168

Other disorders of teeth and supporting structures

1519

7111

2.34

179.70

10.5

7.7

117.21

122.43

g/l

17.50

1475

6862

Benzodiazepine use

6066

29313

1.52

179.48

8.0

8.1

121.93

121.76

g/l

0.26

5899

28211

Benign neoplasms

5983

22381

1.54

179.47

8.0

8.5

122.28

122.57

g/l

0.47

5790

21549

Mood [affective] disorders

6099

27196

1.52

179.00

8.6

8.2

123.03

121.78

g/l

4.50

5913

26188

Mood disorders

6115

27248

1.52

178.80

8.6

8.2

123.04

121.77

g/l

4.72

5928

26238

Alcohol abuse, main dg

1159

4872

2.66

177.79

9.2

9.3

124.96

123.78

g/l

1.00

1136

4702

Benign neoplasm: Colon

3496

20965

1.74

177.38

8.0

7.8

118.70

120.90

g/l

8.50

3397

20211

Chronic periapical parodontitis

1483

6919

2.35

177.14

13.3

8.0

115.82

122.96

g/l

29.83

1434

6671

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

995

3928

2.91

176.84

8.3

7.9

117.47

122.68

g/l

14.64

972

3775

Peripheral artery operations in Hilmo

1049

4239

2.82

176.84

12.0

7.1

111.25

121.11

g/l

45.21

1026

4081

L04AA Selective immunosuppressants

1443

6657

2.37

176.75

14.4

8.4

112.98

122.37

g/l

53.22

1407

6399

ILD, hospital admissions 3, with pneumonia sepsis

722

2420

3.58

176.33

12.4

6.7

121.62

120.09

g/l

1.06

699

2334

Intracranial injury

3516

20738

1.72

176.09

8.6

7.8

121.55

121.75

g/l

0.21

3419

19960

Other and unspecified iron deficiency

2087

11023

2.04

175.45

9.5

7.1

111.16

121.15

g/l

94.51

2039

10607

Abnormalities of heart beat

2019

10398

2.04

174.97

7.9

7.5

123.13

119.55

g/l

11.48

1961

9972

Type 1 diabetes, wide definition, subgroup 1

1301

5753

2.44

173.43

10.6

7.6

116.37

123.95

g/l

28.21

1250

5518

Ischaemic Stroke, excluding all haemorrhages

3780

17752

1.71

173.09

8.3

7.7

120.30

120.76

g/l

0.65

3664

17107

Obesity, other/unspecified

1946

10067

2.06

172.11

9.9

8.1

124.47

121.60

g/l

7.14

1907

9687

Finngen Rheumatological endpoints

5780

22134

1.54

172.04

8.2

8.4

121.58

122.69

g/l

3.43

5545

21341

Problems related to lifestyle

789

2780

3.21

171.86

9.5

8.2

124.75

g/l

0.00

766

2663

Lung cancer and mesothelioma

1342

5140

2.45

171.57

8.3

6.5

120.75

120.31

g/l

0.35

1304

4944

Depression

5549

25689

1.54

170.83

8.7

8.3

123.18

121.90

g/l

4.40

5380

24735

Malignant neoplasm of digestive organs

2637

14937

1.87

169.37

8.8

7.4

115.33

120.93

g/l

41.95

2550

14387

Kela-code for severe mental illness

2243

12247

1.94

168.17

7.3

8.6

124.18

122.70

g/l

2.68

2155

11802

Viral hepatitis, IBD co-morbidity

379

818

5.24

167.97

11.4

7.9

121.26

124.34

g/l

1.65

370

787

Other respiratory diseases principally affecting the interstitium

1364

6342

2.42

167.37

12.5

7.4

122.41

120.09

g/l

3.46

1318

6108

Constipation

5339

25737

1.54

166.33

8.1

8.0

119.35

121.52

g/l

11.85

5163

24833

Specific personality disorders

1363

6256

2.34

166.09

8.2

8.8

124.35

123.20

g/l

1.24

1316

6034

Acute alcohol intoxication

1749

8887

2.13

165.23

8.8

8.4

124.11

123.01

g/l

1.26

1711

8567

Glomerular diseases

1330

6145

2.41

164.36

12.4

8.3

109.55

122.66

g/l

90.87

1298

5922

Deforming dorsopathies

1735

8792

2.11

163.56

7.1

8.2

120.06

120.57

g/l

0.51

1671

8473

Continuous positive airway pressure

944

3136

2.77

162.93

13.2

6.5

120.91

122.84

g/l

1.86

936

3029

Diaphragmatic hernia

2341

13180

1.90

161.36

8.2

7.4

118.80

120.66

g/l

4.42

2278

12665

Artificial opening status

525

1547

4.28

160.19

15.4

8.1

113.85

121.97

g/l

16.80

514

1482

Other reaction to severe stress, and adjustment disorders

1923

10134

1.99

159.14

9.0

8.3

122.43

122.42

g/l

0.01

1868

9741

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

1365

6464

2.34

158.12

8.1

7.6

115.88

122.36

g/l

28.60

1327

6220

Diseases of the skin and subcutaneous tissue

6302

21843

1.49

158.11

8.9

7.9

121.13

122.60

g/l

5.94

6108

21000

Cardiomyopathies, Primary/intrinsic

887

3473

2.87

157.97

16.3

7.3

123.02

123.04

g/l

0.01

869

3332

Exposure to unspecified factor

5654

30212

1.50

157.79

9.6

7.9

119.93

122.22

g/l

13.40

5480

29097

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

796

2985

3.12

157.68

11.0

8.3

116.65

121.59

g/l

8.20

765

2872

Other symptoms and signs involving cognitive functions and awareness

2858

16003

1.78

157.57

7.0

7.7

121.43

120.57

g/l

1.42

2770

15405

Cutaneous abscess, furuncle and carbuncle

1601

8008

2.15

157.33

10.6

8.4

118.51

123.11

g/l

13.54

1558

7711

Spondylosis

3303

17471

1.70

156.90

6.7

8.6

122.20

120.96

g/l

2.85

3212

16873

Acute alcohol intoxication, ICD10

1358

6435

2.31

155.64

9.2

9.1

124.67

123.49

g/l

1.16

1331

6210

Other diseases of urinary system

6107

23827

1.49

154.98

8.2

8.0

119.82

121.97

g/l

12.69

5896

22956

Shoulder lesions

4845

19739

1.56

154.90

7.1

8.4

122.77

121.59

g/l

3.36

4662

19044

Transient ischemic attack

3406

17637

1.69

154.57

7.5

120.83

120.51

g/l

0.39

3292

16984

Factors influencing health status and contact with health services

2091

5461

2.01

154.01

9.0

7.2

122.94

125.64

g/l

5.80

2019

5246

Aortic aneurysm

1676

8485

2.13

153.90

12.4

7.3

118.09

122.44

g/l

13.66

1625

8174

Cardiomyopathy (excluding other)

907

3647

2.78

152.88

16.1

7.2

123.07

123.42

g/l

0.18

889

3499

Chronic periodontitis

1120

4985

2.51

151.84

13.9

8.2

112.71

122.67

g/l

46.05

1089

4807

Glomerular disorders in diseases classified elsewhere

920

3772

2.80

151.42

14.0

8.5

106.43

122.73

g/l

101.20

901

3633

Osteoporosis

1683

8309

2.10

150.96

7.7

6.6

116.97

119.08

g/l

4.24

1627

7997

Anxiety (asthma-related co-morbidities)

3011

14329

1.72

150.09

8.9

8.3

123.77

122.59

g/l

2.30

2921

13789

Other headache syndromes

2324

13265

1.84

149.15

7.7

7.8

124.14

119.84

g/l

19.70

2251

12748

Missing teeth due to accident, extraction or parodontitis

898

3668

2.78

148.17

10.4

7.8

116.41

121.89

g/l

11.88

870

3531

Schizophrenia or delusion

1869

10036

1.97

147.71

7.7

8.7

123.99

122.98

g/l

1.24

1795

9679

Injuries to the abdomen, lower back, lumbar spine and pelvis

2395

13790

1.83

147.46

8.9

7.6

118.55

121.42

g/l

9.35

2323

13268

Type 1 diabetes, wide definition

1336

6372

2.24

147.44

10.6

7.6

116.48

123.54

g/l

25.53

1282

6119

Used for control exclusion in common control thyroid runs

6381

22719

1.46

147.37

8.9

8.0

121.42

122.80

g/l

5.26

6161

21878

Allergic asthma (mode), excluding more controls

1161

5110

2.34

146.68

8.1

6.5

124.57

122.10

g/l

3.57

1117

4899

Need for other prophylactic measures

518

1595

3.99

146.50

14.5

9.2

117.88

122.41

g/l

5.55

508

1539

Schizophrenia, schizotypal and delusional disorders

1873

10094

1.97

146.35

7.7

8.7

124.01

122.93

g/l

1.38

1798

9735

Extracorporeal dialysis

568

1863

3.77

145.83

18.4

9.1

103.40

123.04

g/l

96.18

553

1797

Complications of internal orthopaedic prosthetic devices, implants and grafts

1518

7708

2.15

145.33

8.0

6.7

115.72

121.13

g/l

21.04

1472

7410

Disorders of lens

4298

17893

1.58

144.86

8.6

8.5

119.20

122.08

g/l

14.99

4147

17281

Injuries to the thorax

2820

17197

1.73

144.31

9.3

8.0

121.20

121.99

g/l

1.17

2730

16588

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

495

1463

3.85

144.28

9.7

9.5

125.24

126.47

g/l

0.58

485

1413

Emotionally unstable personality disorder

704

2542

3.02

143.86

7.3

8.6

124.02

123.73

g/l

0.14

685

2451

Gout, FINNGEN

2063

11632

1.92

143.63

10.1

7.7

117.39

121.96

g/l

17.62

2009

11214

Chronic pancreatitis

963

4130

2.65

143.51

13.3

8.2

116.30

122.88

g/l

17.49

938

3977

Other external causes of accidental injury

5018

16926

1.53

143.07

8.6

7.8

120.98

122.48

g/l

5.01

4842

16288

ILD, hospital admissions

1132

5221

2.45

142.43

11.5

7.4

123.78

120.21

g/l

6.35

1095

5029

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

518

1599

3.75

142.34

7.7

8.8

125.61

122.79

g/l

2.38

505

1543

Acute bronchitis

2470

14264

1.79

142.26

8.2

7.6

123.43

120.87

g/l

7.56

2405

13735

Malignant neoplasm of urinary organs

838

3412

2.87

141.73

7.7

7.8

119.31

121.03

g/l

1.71

818

3276

Autoimmune diseases

6664

24276

1.44

141.45

9.0

8.0

120.77

122.83

g/l

11.59

6440

23379

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

495

1502

3.88

140.74

6.5

6.9

113.24

119.79

g/l

13.22

481

1433

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

450

1315

4.41

140.25

7.0

8.0

120.53

122.80

g/l

1.52

439

1269

Endovascular or surgical operations to intracerebral aneurysms

563

1868

3.61

140.01

9.3

8.6

123.11

121.47

g/l

1.15

553

1787

Other interstitial pulmonary diseases

1140

5312

2.42

139.70

11.4

7.4

123.80

120.16

g/l

6.59

1103

5118

Hernia of abdominal wall

2850

17592

1.71

139.50

9.3

8.1

122.13

121.93

g/l

0.19

2768

16979

Interstitial lung disease

1140

5318

2.42

139.31

11.4

7.4

123.80

120.14

g/l

6.64

1103

5123

Interstitial lung disease endpoints

1140

5318

2.42

139.31

11.4

7.4

123.80

120.14

g/l

6.64

1103

5123

Disorders of thyroid, IBD co-morbidities

915

2680

2.62

138.49

9.0

7.3

122.84

120.41

g/l

2.59

882

2577

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

653

2348

3.18

138.09

8.8

7.4

120.94

122.72

g/l

1.29

633

2258

Injuries to the hip and thigh

2898

16423

1.70

137.46

8.2

7.4

116.01

121.39

g/l

37.18

2811

15808

Accidents

4980

16926

1.52

136.78

8.5

7.8

120.98

122.48

g/l

4.99

4804

16288

Gastroduodenal ulcer

1820

9977

1.96

136.29

9.8

7.2

114.77

121.26

g/l

30.54

1764

9606

Anxiety disorders

4932

24036

1.50

136.21

8.6

8.4

123.29

121.96

g/l

4.34

4772

23131

Amputation

806

3270

2.84

135.87

12.6

7.7

109.83

121.32

g/l

46.12

789

3148

Diseases of liver

2130

12261

1.85

135.86

11.9

8.1

116.23

122.25

g/l

29.16

2058

11813

Neurotic, stress-related and somatoform disorders

4862

23741

1.50

135.08

8.6

8.4

123.32

121.98

g/l

4.32

4703

22853

Symptoms and signs involving the nervous and musculoskeletal systems

3365

21721

1.62

134.47

8.1

7.9

123.18

121.02

g/l

7.86

3249

20950

Other CVD

1357

6836

2.19

133.78

8.6

7.1

117.61

119.97

g/l

4.10

1312

6588

Persons encountering health services for examination and investigation

4047

13253

1.58

132.99

9.0

7.9

122.33

122.65

g/l

0.38

3897

12741

Pain in joint

3248

13545

1.64

132.77

7.9

8.8

122.17

121.84

g/l

0.38

3149

13002

Malignant neoplasm of kidney, except renal pelvis

770

3115

2.90

132.21

7.4

8.0

119.96

120.94

g/l

0.70

753

2988

Explicit bacterial Sepsis

741

2905

2.87

131.99

12.4

6.7

114.97

122.82

g/l

19.75

718

2786

Dialysis

396

1103

4.53

131.18

14.6

8.5

102.59

124.53

g/l

71.59

389

1063

Other complications of surgical and medical care, not elsewhere classified

678

2551

2.99

130.90

11.9

7.4

119.39

122.62

g/l

3.80

667

2441

Cough

2193

12238

1.80

130.87

7.8

7.9

122.07

119.88

g/l

5.37

2139

11754

Unspecified acute lower respiratory infection

1026

4666

2.42

130.64

11.0

8.4

122.34

122.64

g/l

0.16

987

4497

Hyperlipidaemia, other/unspecified

2391

13559

1.77

130.42

8.3

7.3

120.18

121.49

g/l

2.32

2323

13075

Congenital malformations, deformations and chromosomal abnormalities

3059

18596

1.63

129.12

9.4

8.3

121.50

122.68

g/l

2.36

2953

17903

Other/unspecified dorsalgia

2131

12314

1.81

129.06

7.7

8.2

121.73

120.64

g/l

1.64

2061

11873

Ventral hernia

1554

8267

2.03

128.88

10.2

7.6

120.79

121.22

g/l

0.34

1515

7945

Invasive ventilation

606

2193

3.25

128.81

19.3

8.3

115.00

121.89

g/l

11.80

586

2104

Gout, idiopatic and unspecified

1728

9568

1.97

128.64

10.3

7.9

117.93

121.67

g/l

10.15

1689

9229

Viral pneumonia (unknown virus, not influenza)

531

1777

3.48

128.53

23.0

8.7

122.61

123.63

g/l

0.46

518

1714

Allergic asthma (mode)

1161

5399

2.21

128.08

8.1

6.7

124.57

121.83

g/l

4.30

1117

5188

ILD, hospital admissions 1, main diag only

1013

4670

2.46

127.98

11.3

7.4

124.13

120.25

g/l

6.58

981

4494

Cerebral aneurysm, nonruptured

669

2555

3.02

127.21

8.6

8.3

122.84

121.18

g/l

1.33

649

2451

Streptococcal septicaemia

650

2445

3.06

127.04

11.8

7.4

114.41

122.94

g/l

20.49

628

2342

Medical observation and evaluation for suspected diseases and conditions

3938

13250

1.57

126.78

9.0

7.9

122.12

122.65

g/l

0.76

3829

12738

Cardiodefibrillation

2471

15144

1.75

126.12

10.8

7.7

122.74

120.99

g/l

3.67

2411

14596

Genitourinary diseases

3720

12107

1.59

125.97

10.2

8.3

122.34

125.33

g/l

12.20

3579

11671

Injury, poisoning and certain other consequences of external causes

3125

9741

1.66

125.81

8.5

7.4

121.65

122.97

g/l

2.65

3025

9360

Unspecified fall

2840

17802

1.66

124.69

9.5

7.7

120.30

121.44

g/l

2.14

2757

17154

Benign neoplasm of other and ill-defined parts of digestive system

1080

5115

2.31

124.13

9.0

7.5

118.24

122.15

g/l

7.96

1048

4913

Intestinal adhesions without obstruction

661

2542

3.00

124.09

10.7

7.3

119.45

121.37

g/l

1.47

645

2432

832

3524

2.58

123.96

12.8

7.7

118.09

122.47

g/l

8.00

809

3380

Other and unspecified drugs and medicaments

630

2366

3.06

123.54

8.8

8.6

120.93

121.67

g/l

0.38

611

2282

Traumatic subdural haemorrhage

914

3988

2.49

123.46

9.8

7.0

118.66

119.45

g/l

0.53

892

3821

Abnormal serum enzyme levels

2080

12121

1.83

123.09

7.8

8.8

121.42

122.67

g/l

1.89

1978

11724

Fungal Sepsis

355

958

4.68

122.93

18.9

7.0

112.88

121.85

g/l

10.46

347

913

Hyperkalaemia

459

1459

3.76

122.25

11.6

7.0

111.43

120.99

g/l

18.77

453

1401

Sleep disorders (combined)

5721

26990

1.43

121.88

8.5

8.2

125.80

121.02

g/l

50.85

5572

25966

Colorectal cancer

1604

8811

1.98

121.79

8.2

7.7

115.66

120.61

g/l

21.14

1556

8481

Postprocedural musculoskeletal disorders, not elsewhere classified

586

2155

3.24

121.78

8.4

8.0

116.59

120.92

g/l

5.53

545

2076

All anxiety disorders

3045

15651

1.62

121.36

8.9

8.5

123.74

122.61

g/l

2.19

2955

15075

Persons encountering health services in other circumstances, wide

7107

27301

1.38

121.18

9.6

7.7

120.39

122.38

g/l

11.98

6929

26220

Unspecified kidney failure

761

3177

2.73

120.50

11.6

6.7

109.55

121.62

g/l

49.21

745

3058

Retention of urine

2252

11450

1.77

119.80

8.0

7.9

119.42

121.72

g/l

5.95

2195

11020

Rotator cuff syndrome

3747

18677

1.55

119.72

7.0

8.4

122.91

121.48

g/l

3.82

3614

18029

Visual disturbances

2681

16891

1.66

119.56

8.5

7.8

121.88

121.04

g/l

1.35

2570

16298

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

420

1279

3.90

119.31

8.9

8.0

127.62

123.73

g/l

3.48

405

1234

Parodontitis or operation codes

5274

27804

1.44

119.09

9.2

8.1

120.72

122.00

g/l

4.24

5087

26807

Undetermined asthma, excluding more controls

715

2870

2.69

118.33

8.5

6.2

122.93

121.42

g/l

1.08

696

2748

Parodontitis

5265

27803

1.44

118.31

9.1

8.1

120.74

121.99

g/l

4.05

5078

26807

Cholelithiasis, broad definition with cholecystitis

5001

24268

1.46

118.25

7.9

7.7

121.05

121.27

g/l

0.31

4847

23385

Chronic periodontitis, including avohilmo

5245

27800

1.44

117.98

9.2

8.1

120.75

122.00

g/l

4.05

5059

26804

Other and unspecified nonorganic psychotic disorders

1061

5050

2.24

117.94

8.6

9.0

123.99

124.13

g/l

0.07

1012

4865

Senile cataract

3915

16408

1.54

117.83

8.5

119.19

121.68

g/l

10.61

3770

15838

Enterocolitis due to Clostridium difficile

786

3358

2.63

117.33

11.1

7.4

113.40

120.53

g/l

17.93

759

3234

Other diseases of pericardium

374

1071

4.21

117.20

13.5

7.8

115.34

123.09

g/l

9.31

364

1029

Gastric ulcer

1257

6444

2.13

117.12

9.7

7.2

114.50

120.86

g/l

20.87

1226

6216

Implicit fungal Sepsis

328

870

4.79

116.56

18.8

7.1

113.19

121.54

g/l

8.44

320

829

Vascular disorders of the intestines

559

2046

3.20

116.15

12.8

7.0

111.87

120.66

g/l

18.79

537

1960

Fracture of femur

1705

8771

1.90

115.64

8.1

6.7

112.21

120.37

g/l

53.20

1657

8430

Other specific joint derangements/joint disorders

3933

17880

1.52

115.36

7.8

8.8

122.63

122.40

g/l

0.28

3801

17236

Other arthrosis

3199

14971

1.59

114.56

7.7

8.7

121.96

121.92

g/l

0.03

3086

14457

Visual disturbances and blindness

2861

18484

1.62

114.30

8.5

7.8

121.61

120.93

g/l

1.03

2745

17837

Other anxiety disorders

2161

11458

1.73

114.04

9.2

8.2

123.55

122.67

g/l

1.14

2103

11018

Other bacterial intestinal infections

1156

5797

2.16

113.84

10.5

7.5

116.10

120.77

g/l

11.36

1119

5570

Gonarthrosis [arthrosis of knee](FG)

4637

19120

1.48

113.44

7.0

8.4

122.14

122.26

g/l

0.13

4456

18449

ILD-related respiratory insufficiency

352

1018

4.64

113.08

16.7

8.1

122.62

120.46

g/l

0.99

338

985

Unspecified haematuria

2647

14410

1.66

112.50

8.9

8.1

118.86

121.91

g/l

11.46

2567

13896

Nontraumatic intracranial haemmorrhage

1335

7079

2.04

112.17

11.6

7.3

121.28

120.07

g/l

1.33

1299

6811

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1393

7489

2.01

112.16

6.2

8.0

114.34

122.69

g/l

44.52

1346

7209

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

972

4433

2.30

111.54

12.7

8.7

116.59

123.22

g/l

18.32

942

4268

Clear cell adenocarcinoma of kidney

450

1525

3.75

111.11

7.0

8.7

120.53

121.77

g/l

0.66

439

1469

Disorders of other endocrine glands

2372

14516

1.68

110.60

8.5

7.7

121.13

120.75

g/l

0.38

2300

13974

Depression or dysthymia

4116

15816

1.50

109.74

8.3

8.4

123.05

121.56

g/l

4.13

3991

15200

Diabetic nephropathy, excluding more controls

1050

4292

2.28

109.39

12.2

9.3

109.81

123.89

g/l

78.96

1021

4148

Mycoses

1576

8851

1.90

109.36

10.2

8.0

119.26

121.53

g/l

3.87

1525

8529

Sub-endpoint used in defining T1D endpoints

1740

9849

1.83

109.10

10.7

8.0

116.35

122.40

g/l

25.35

1670

9489

Cervicobrachial syndrome

1278

6703

2.03

109.01

5.6

8.7

125.28

120.82

g/l

12.10

1241

6458

malignant neoplasm of female genital organs

941

4459

2.32

108.82

5.9

6.5

115.96

118.19

g/l

3.33

911

4303

Emphysema

572

2193

3.02

108.48

9.6

7.7

128.33

120.29

g/l

13.70

544

2111

Myocarditis

290

720

4.51

107.61

14.1

7.7

126.19

126.25

g/l

0.01

280

688

Gonarthrosis

3980

15683

1.51

107.42

7.0

8.6

122.43

121.85

g/l

0.93

3822

15133

Sequelae of cerebrovascular disease

2207

11942

1.72

107.10

8.3

7.3

120.19

120.31

g/l

0.09

2140

11471

Other cataract

2648

13118

1.64

106.96

7.8

8.2

118.74

121.36

g/l

8.37

2572

12632

Coxarthrosis

3121

13983

1.58

106.14

7.2

8.5

119.68

121.36

g/l

4.50

3007

13509

Colorectal adenocarcinoma

1365

7455

2.00

106.07

8.1

7.6

115.88

120.42

g/l

15.14

1327

7178

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

1528

7151

1.92

105.78

8.7

7.8

120.33

122.45

g/l

3.89

1481

6886

Acute pancreatitis

1276

6797

2.03

105.70

12.1

8.2

119.01

122.12

g/l

5.38

1235

6536

Spondylolisthesis/Spondylolysis

1124

5725

2.12

105.58

6.6

8.5

120.69

120.53

g/l

0.10

1084

5510

Benign neoplasm: Colon, unspecified

1426

7823

1.95

105.51

8.2

7.8

118.47

122.53

g/l

11.26

1378

7532

Deposits [accretions] on teeth

510

1789

3.12

104.90

15.0

8.5

113.07

123.93

g/l

22.42

493

1725

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

624

2522

2.78

104.77

4.5

6.2

118.90

119.00

g/l

0.04

611

2416

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1018

5065

2.23

104.67

12.9

8.5

112.05

122.47

g/l

39.22

989

4890

Hypotension

1122

5771

2.13

104.39

8.3

7.0

118.21

119.90

g/l

2.00

1090

5562

Fracture of rib(s), sternum and thoracic spine

1853

11056

1.78

104.26

9.7

8.1

120.87

121.79

g/l

1.11

1799

10662

Mental and behavioural disorders due to opioids

284

720

4.61

104.24

12.1

9.9

122.57

125.97

g/l

1.69

276

691

Extreme obesity with alveolar hypoventilation

375

1175

3.95

103.83

10.9

8.9

132.28

121.35

g/l

15.35

370

1126

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

513

1891

3.08

103.59

8.7

7.8

126.39

122.89

g/l

3.58

495

1822

Other disorders of the musculoskeletal system and connective tissue

974

4773

2.24

103.42

8.0

8.1

119.64

121.23

g/l

1.56

923

4598

Undetermined asthma

715

3056

2.52

103.37

8.5

6.5

122.93

120.99

g/l

1.59

696

2937

Ascites

554

2139

2.98

103.36

11.3

7.4

108.63

121.16

g/l

39.37

539

2053

Amiodarone users

784

3565

2.52

103.26

16.2

8.0

122.39

121.11

g/l

0.89

767

3434

Injuries to the knee and lower leg

6673

28798

1.36

102.80

8.7

8.0

121.83

121.81

g/l

0.03

6451

27746

Coxarthrosis [arthrosis of hip](FG)

3336

16336

1.54

102.05

7.2

8.1

119.46

121.58

g/l

7.42

3218

15775

Arthrosis

4276

16507

1.47

101.38

7.4

8.7

122.56

122.12

g/l

0.66

4101

15922

Diseases of the musculoskeletal system and connective tissue

2993

9734

1.58

101.16

7.9

9.2

123.11

122.41

g/l

0.94

2880

9381

Cholelithiasis

4720

23866

1.43

100.93

7.7

121.11

121.17

g/l

0.07

4572

22992

Injuries to the shoulder and upper arm

4733

28770

1.42

100.72

8.0

8.2

121.15

122.01

g/l

2.04

4573

27729

Benign neoplasm of meninges

624

2571

2.70

100.11

7.2

7.6

121.37

121.11

g/l

0.13

607

2467

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

1016

4794

2.18

100.10

8.7

7.3

120.76

122.34

g/l

1.81

989

4610

Delirium, not induced by alcohol and other psychoactive substances

801

3690

2.42

100.02

12.3

7.3

117.45

120.12

g/l

3.09

786

3551

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

5551

26745

1.39

99.82

8.4

8.1

120.67

121.93

g/l

4.27

5364

25781

Bipolar affective disorders

978

4805

2.16

99.72

7.6

8.5

123.76

122.73

g/l

0.80

945

4621

Gout, unspecified

1378

7704

1.95

99.57

10.4

7.8

117.90

121.67

g/l

8.55

1349

7420

Disorders of choroid and retina

4727

24954

1.42

99.25

8.7

7.9

118.42

121.78

g/l

23.56

4573

24072

Endocarditis

303

843

4.36

99.24

18.4

7.7

110.58

123.26

g/l

17.95

298

808

Diseases of the eye and adnexa

4555

16175

1.44

99.11

9.1

8.6

122.96

123.33

g/l

0.53

4390

15586

Other diseases of intestine

824

3855

2.36

98.61

14.4

7.7

116.12

121.61

g/l

11.37

805

3699

Acute upper respiratory infections of multiple and unspecified sites

3970

20928

1.46

97.92

8.8

8.1

123.70

121.66

g/l

7.52

3859

20159

Other retinal disorders

3739

21044

1.48

97.57

8.6

7.7

117.43

121.35

g/l

25.82

3623

20281

Parodontitis and operation codes

4863

27641

1.41

97.54

9.2

8.1

120.71

122.00

g/l

4.10

4682

26666

Benign neoplasm of other and unspecified endocrine glands

752

3397

2.42

97.24

8.0

123.78

123.17

g/l

0.33

724

3261

Gout, strict definition

1240

6779

2.01

96.86

10.3

8.0

116.71

121.41

g/l

11.56

1220

6522

Other and unspecified nerve root and plexus disorders, also in other diseases

1119

5866

2.05

96.62

7.0

8.7

125.30

122.16

g/l

5.43

1038

5659

Diseases of oral cavity, salivary glands and jaws

5395

20330

1.40

96.52

8.5

7.6

120.61

122.24

g/l

6.48

5196

19597

Other gastritis (incl. Duodenitis)

1430

8142

1.88

95.09

9.0

7.5

118.37

121.35

g/l

6.10

1396

7844

Diagnoses used for exclusion with ILD

1579

9251

1.82

94.81

11.4

7.8

121.32

121.11

g/l

0.14

1512

8922

Bacterial intestinal infections, IBD co-morbidities

1139

6075

2.02

93.83

10.5

7.4

115.69

120.77

g/l

13.50

1101

5848

Benign neoplasm: Sigmoid colon

1068

5584

2.07

93.67

7.9

7.8

119.57

122.68

g/l

5.30

1042

5371

Open wound of head

2950

19699

1.53

93.38

8.7

8.1

120.93

122.45

g/l

3.53

2856

18951

Benign neoplasm: Cerebral meninges

566

2308

2.74

92.95

7.2

7.7

121.26

121.28

g/l

0.01

550

2206

Fracture of lumbar spine and pelvis

1325

7423

1.91

92.93

8.6

7.0

115.67

120.45

g/l

14.76

1288

7145

Autoimmune diseases related-to ILD

4604

29630

1.40

92.69

8.8

8.0

120.40

121.99

g/l

5.93

4461

28545

Congenital malformations of the circulatory system

825

3802

2.27

92.62

14.2

8.7

119.41

123.23

g/l

5.68

803

3666

Left ventricular outflow tract obstruction (LVOTO), broad definition

692

3111

2.48

91.74

15.5

9.7

115.64

124.39

g/l

21.89

677

3007

Abdominal aortic aneurysm (AAA)

743

3406

2.39

91.52

12.0

6.4

117.89

121.32

g/l

4.35

720

3292

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

688

3092

2.49

91.50

8.3

7.6

117.40

122.28

g/l

9.11

665

2970

Symptoms and signs concerning food and fluid intake

633

2729

2.54

90.86

8.7

7.6

118.10

121.70

g/l

4.12

610

2622

Superficial injury of head

1279

7118

1.91

90.75

7.8

7.5

121.20

121.80

g/l

0.47

1252

6838

Acute pancreatitis (for exclusion)

1276

7136

1.92

90.74

12.1

8.3

119.01

122.03

g/l

5.13

1235

6882

Cystitis

4550

20226

1.41

89.64

8.0

7.6

119.18

121.10

g/l

8.58

4424

19449

Idiopathic pulmonary fibrosis

592

2537

2.69

89.56

11.7

7.4

126.21

120.02

g/l

9.32

570

2437

Adjustment and management of implanted device

1211

6704

1.95

89.43

12.5

6.9

120.06

121.26

g/l

1.24

1193

6481

Cellulitis

1259

7030

1.91

88.97

9.7

8.3

118.93

122.50

g/l

7.16

1230

6775

Fracture of lower leg, including ankle

3015

20643

1.51

88.91

9.6

7.9

120.16

121.65

g/l

3.46

2910

19886

ILD medications: azathioprine

836

4059

2.20

88.81

11.5

8.1

117.02

122.99

g/l

13.92

819

3896

Pleural effusion

1014

5327

2.08

88.49

10.4

7.2

116.08

120.10

g/l

8.50

988

5128

Dermatitis

3308

23161

1.48

88.45

8.5

7.9

120.27

121.39

g/l

2.35

3213

22321

Disorders of eyelid, lacrimal system and orbit

4674

27060

1.39

88.16

7.1

8.1

121.42

121.11

g/l

0.47

4500

26110

Arthropathies

4963

18559

1.39

87.84

7.6

8.7

122.47

122.40

g/l

0.08

4781

17890

Benign neoplasm: Rectum, anus and anal canal

1138

6199

1.97

87.75

7.6

7.7

119.32

122.72

g/l

6.86

1098

5972

Carpal tunnel syndrome

3285

20729

1.48

87.43

7.1

8.1

122.41

120.95

g/l

3.80

3141

20023

All influenza (not pneumonia)

846

4154

2.18

87.20

9.0

7.5

122.05

123.65

g/l

1.34

810

4012

Later onset COPD

1850

9018

1.72

87.11

7.8

6.6

122.53

119.29

g/l

8.55

1798

8681

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

764

3653

2.31

86.72

7.8

6.9

114.36

121.65

g/l

20.05

744

3511

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

1318

6230

1.89

86.69

8.4

7.5

120.66

122.27

g/l

2.20

1279

6001

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1672

10165

1.73

86.33

8.5

8.1

121.27

122.19

g/l

1.00

1600

9806

Migraine

2123

11502

1.62

86.08

7.2

7.9

124.72

120.19

g/l

21.12

2053

11043

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

658

2979

2.46

85.94

8.2

7.4

117.83

122.39

g/l

7.71

637

2862

Sleep apnoea

5158

26260

1.37

85.26

8.7

8.3

126.27

121.10

g/l

53.61

5024

25280

Azathioprine

836

4126

2.17

85.03

11.5

8.3

117.02

122.61

g/l

12.36

819

3964

Aortic valve malfunction, age under 60 years

648

2932

2.47

84.89

14.9

9.6

115.65

124.45

g/l

20.94

633

2835

Other joint disorders

4733

18526

1.39

84.52

7.2

8.7

123.36

122.38

g/l

2.32

4552

17858

Decubitus ulcer and pressure area

450

1739

3.00

84.30

13.4

7.7

112.20

120.86

g/l

14.29

444

1670

Assault

711

3309

2.30

84.19

10.4

9.4

124.00

126.10

g/l

1.72

695

3187

Symptoms and signs involving the skin and subcutaneous tissue

3654

26132

1.43

84.01

7.7

8.0

121.85

121.29

g/l

0.90

3540

25190

Benign neoplasm: Rectum

1021

5458

2.02

83.82

7.7

7.9

119.67

122.71

g/l

5.06

985

5261

Subarachnoid haemorrhage

709

3338

2.35

83.77

11.7

7.6

121.82

120.91

g/l

0.57

689

3204

Selective serotonin reuptake inhibitors

5731

22862

1.35

83.75

8.1

8.2

122.71

121.73

g/l

2.78

5539

21996

Mental and behavioural disorders due to sedatives or hypnotics

449

1721

2.92

83.61

10.5

9.3

124.87

124.33

g/l

0.21

438

1665

Amputation of toe

547

2333

2.70

83.60

11.8

8.1

110.43

121.56

g/l

28.46

535

2244

Iron deficiency anaemia secondary to blood loss (chronic)

1000

5317

2.03

83.44

11.0

7.1

109.40

121.19

g/l

54.30

971

5116

Unspecified misadventure during surgical and medical care

421

1587

3.11

83.10

13.3

8.7

115.64

121.46

g/l

7.12

408

1531

Non-selective monoamine reuptake inhibitors

2183

13831

1.60

82.69

7.5

7.7

120.88

120.45

g/l

0.45

2115

13304

Dysphagia

1379

8072

1.81

82.55

8.8

7.4

120.06

121.06

g/l

1.04

1344

7762

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1376

8062

1.81

82.44

9.0

8.5

126.48

122.67

g/l

8.75

1336

7757

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

233

620

4.70

82.22

6.5

6.0

111.48

119.07

g/l

8.89

227

595

Cholecystectomy

3851

24742

1.42

81.74

8.4

7.7

121.23

120.54

g/l

1.31

3737

23836

Schizophrenia

926

4822

2.05

81.16

7.7

9.4

123.64

123.67

g/l

0.02

885

4653

Acute peritonitis

479

1946

2.81

80.63

15.2

8.5

109.22

121.79

g/l

29.97

472

1873

Exclusions for E4_PCOS_BROAD

931

4870

2.04

80.39

9.4

8.4

123.66

122.24

g/l

1.22

899

4693

Congenital malformations of heart and great arteries

729

3384

2.25

80.26

14.0

8.9

117.99

123.62

g/l

9.95

706

3265

Chronic ulcer of skin, not elsewhere classified

508

2128

2.73

80.20

9.3

8.2

113.58

121.21

g/l

13.49

493

2047

Pain in thoracic spine

830

4175

2.12

80.14

6.8

8.6

125.56

121.20

g/l

7.07

805

4014

Gingivitis and periodontal diseases

5195

20167

1.36

80.07

8.6

7.6

121.11

122.25

g/l

3.36

5006

19441

Transport accidents

2331

13721

1.55

79.44

8.6

8.0

122.24

123.01

g/l

0.96

2226

13198

Diabetic retinopathy, excluding more controls

1599

5425

1.78

79.29

11.7

9.0

115.63

123.58

g/l

37.80

1542

5247

Chronic viral hepatitis

343

1170

3.29

79.25

10.8

10.3

122.32

125.78

g/l

1.97

334

1130

Thoracic aortic aneurysm

907

4780

2.08

79.09

13.5

7.9

118.09

123.04

g/l

9.85

877

4606

Insulin, fast-acting (human)

802

4003

2.13

78.93

11.3

7.9

114.89

124.06

g/l

25.24

772

3847

Diseases of peritoneum

675

3191

2.33

78.88

12.5

8.0

112.79

121.52

g/l

21.40

656

3068

Phobic anxiety disorders

596

2646

2.38

78.10

9.7

8.2

124.65

124.12

g/l

0.23

572

2552

Other symptoms and signs involving the circulatory and respiratory systems

422

1621

2.90

78.07

7.4

8.0

125.03

120.84

g/l

3.50

399

1548

Toxic effects of substances chiefly nonmedicinal as to source

678

3210

2.29

77.88

8.5

8.6

126.27

123.37

g/l

3.03

662

3093

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

263

783

4.03

77.88

6.6

6.3

111.71

118.46

g/l

8.08

258

749

severe traumatic brain injury, does not include concussion

1356

8063

1.79

77.60

10.7

7.6

118.89

121.16

g/l

3.65

1320

7772

Enlarged lymph nodes

859

4421

2.07

77.56

8.6

8.1

119.87

122.26

g/l

2.54

822

4240

Acute sinusitis

2571

16342

1.51

77.56

8.3

123.54

122.06

g/l

2.89

2480

15736

Elevated blood glucose level

552

2423

2.54

77.41

10.0

8.4

121.13

122.66

g/l

0.87

544

2329

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

524

2254

2.61

77.22

11.2

7.7

115.46

121.10

g/l

8.60

510

2167

Post-traumatic stress disorder

370

1324

2.99

76.50

7.7

8.1

125.40

122.18

g/l

2.27

352

1274

Sleep apnoea, including avohilmo

5355

26614

1.34

76.15

8.5

8.2

126.25

121.04

g/l

56.73

5216

25613

Other disorders of kidney and ureter

828

4280

2.12

76.12

11.2

7.8

115.41

121.35

g/l

12.98

800

4125

Benign neoplasm of other and ill-defined parts of digestive system

1080

6077

1.91

75.59

9.0

7.6

118.24

120.51

g/l

3.18

1048

5847

Primary_lymphoid and hematopoietic malignant neoplasms

1296

7648

1.79

75.42

9.9

7.8

111.43

122.75

g/l

65.05

1248

7360

Sequelae of other external causes

382

1435

3.04

74.87

10.9

8.8

116.15

121.14

g/l

4.19

368

1379

Alcohol-induced chronic pancreatitis

494

2113

2.67

74.73

15.0

9.0

119.07

124.28

g/l

5.56

481

2041

Total colectomy operation

326

1131

3.37

74.73

13.3

8.9

116.03

122.59

g/l

6.33

318

1090

Total colectomy

326

1131

3.37

74.73

13.3

8.9

116.03

122.59

g/l

6.33

318

1090

Nonorganic sleeping disorders, excluding more controls

849

4396

2.03

74.57

8.5

8.1

122.97

122.14

g/l

0.55

826

4226

Acute upper respiratory infections

5713

27684

1.32

74.45

8.5

7.9

122.65

121.14

g/l

5.98

5527

26674

Panic disorder

673

3203

2.21

74.39

10.9

8.0

124.31

123.12

g/l

0.77

648

3080

Viral and other specified intestinal infections

945

4943

1.94

74.01

8.6

8.3

122.43

123.42

g/l

0.69

911

4754

Schizoaffective disorder

469

1945

2.65

73.80

7.0

9.2

125.53

124.06

g/l

0.79

451

1878

Gonarthrosis,primary

5189

25030

1.34

73.29

7.1

8.3

121.67

121.25

g/l

0.74

4990

24177

Noninfective enteritis and colitis

2404

16404

1.51

73.14

9.2

8.1

119.73

122.07

g/l

6.60

2333

15809

Other pulmonary heart/vessel disease

364

1363

3.13

72.86

15.5

8.2

124.83

119.60

g/l

4.05

357

1312

Vascular diseases of the intestine

310

1064

3.46

72.86

16.1

7.5

114.29

120.57

g/l

5.96

299

1025

Candidiasis

753

3803

2.13

72.65

13.1

8.0

116.55

121.30

g/l

8.19

728

3656

Other pleural conditions

686

3377

2.24

72.42

9.9

7.2

116.31

120.17

g/l

5.20

670

3245

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1182

6754

1.80

72.18

8.9

8.0

123.46

122.48

g/l

0.84

1139

6503

Other metabolic disorders

657

3154

2.22

71.91

8.8

7.2

120.03

121.54

g/l

1.05

628

3034

Benign neoplasm: Transverse colon

624

2973

2.32

71.84

7.9

7.7

120.22

122.22

g/l

1.52

609

2857

Fracture of shoulder and upper arm

1931

12680

1.59

71.75

8.7

7.9

117.67

121.21

g/l

11.85

1876

12219

Non-small cell lung cancer

1016

5712

1.92

71.47

8.7

7.3

120.76

119.90

g/l

0.75

989

5515

Abnormalities of gait and mobility

769

3965

2.13

71.38

8.9

7.6

119.70

120.82

g/l

0.81

742

3816

Brain meningioma, excluding all cancers (controls excluding all cancers)

344

1257

3.12

71.04

6.9

7.4

121.37

120.67

g/l

0.29

339

1206

Lung diseases due to external agents

882

4752

2.01

70.96

12.1

7.4

120.12

120.68

g/l

0.32

847

4579

Abnormal findings on diagnostic imaging of other body structures

756

3871

2.12

70.75

7.8

7.5

120.45

120.61

g/l

0.07

733

3717

Status epilepticus

284

938

3.54

70.73

15.4

8.1

121.52

121.11

g/l

0.11

268

904

Use of disulfiram, acamprosate or naltrexone

575

2663

2.38

70.71

9.9

10.0

125.90

124.99

g/l

0.45

564

2568

Other diseases of pancreas

526

2367

2.50

70.37

11.5

7.9

115.95

121.98

g/l

8.84

511

2271

Migraine with aura

1005

5583

1.87

70.32

7.6

7.5

124.52

120.12

g/l

10.08

973

5353

Other viral hepatitis

382

1472

2.87

70.07

11.5

10.1

120.95

125.59

g/l

3.56

373

1425

Secondary right heart disease

335

1228

3.22

70.05

15.2

8.0

124.97

119.75

g/l

3.65

328

1178

Exposure to other specified factors

3763

26191

1.38

69.89

8.9

8.4

121.20

122.54

g/l

3.57

3660

25225

Fibrosis and cirrhosis of liver

518

2328

2.51

69.62

12.0

8.1

111.19

121.62

g/l

21.20

499

2247

Acidosis

195

522

4.82

69.04

14.7

8.0

114.68

121.64

g/l

4.28

187

504

Behavioural syndromes associated with physiological disturbances and physical factors

1436

8863

1.68

68.65

7.9

8.3

122.88

122.12

g/l

0.69

1407

8521

Suppurative and necrotic conditions of lower respiratory tract

416

1715

2.80

68.43

14.4

8.6

115.79

122.60

g/l

8.75

404

1648

Other and unspecified dermatitis

2645

18646

1.47

68.29

8.5

7.8

120.14

121.27

g/l

2.03

2578

17962

Recurrent or chronic depression

1889

8877

1.58

68.22

8.7

124.03

122.13

g/l

3.50

1838

8534

Short Achilles tendon (acquired)

222

649

4.06

67.37

6.9

8.2

125.09

121.68

g/l

1.61

203

622

In situ neoplasms

1684

10354

1.61

67.34

7.2

7.0

117.43

121.71

g/l

16.21

1626

9944

Other diseases of biliary tract

564

2654

2.35

67.03

11.0

7.5

114.68

120.67

g/l

8.93

550

2552

Persons encountering health services for other counselling and medical advice, not elsewhere classified

6032

27116

1.29

66.52

9.9

7.8

119.41

122.41

g/l

23.46

5901

26049

Gastro-oesophageal reflux disease

3594

23648

1.38

66.28

8.4

7.8

121.48

122.22

g/l

1.32

3467

22796

Other noninfective gastroenteritis and colitis

1283

7797

1.72

66.19

9.6

7.7

118.40

121.22

g/l

5.29

1243

7504

Certain disorders involving the immune mechanism

1073

6246

1.82

66.02

11.7

8.1

120.11

122.07

g/l

2.16

1023

6015

Postprocedural endocrine and metabolic disorders, not elsewhere classified

601

2883

2.23

65.98

8.2

7.2

119.88

121.09

g/l

0.72

576

2775

Other and unspecified effects of external causes

1302

7939

1.71

65.94

9.1

8.3

123.85

122.07

g/l

2.31

1265

7632

Other specified and unspecified personality disorders

506

2274

2.40

65.82

9.2

9.0

123.89

124.02

g/l

0.05

496

2197

Rheumatoid arthritis

1735

10298

1.59

65.21

7.9

8.2

118.08

120.72

g/l

6.27

1668

9939

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

765

4056

2.04

64.36

8.7

7.2

117.01

122.91

g/l

13.16

746

3907

Disorders of mineral metabolism

487

2189

2.44

64.19

9.5

7.4

115.21

121.81

g/l

8.54

478

2107

Exclusions for E4_PCOS_CONSORTIUM

3327

15224

1.40

64.16

7.7

120.36

120.51

g/l

0.16

3216

14656

Polyneuropathies and other disorders of the peripheral nervous system

1295

8008

1.72

64.08

10.1

8.1

117.94

121.18

g/l

6.61

1266

7712

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1665

10856

1.60

64.02

8.5

7.8

123.13

120.72

g/l

4.74

1600

10478

Other diseases of anus and rectum

1578

10164

1.62

63.90

8.2

7.3

118.45

121.44

g/l

7.14

1529

9778

Neuromuscular dysfunction of bladder

580

2806

2.27

63.84

8.7

8.3

120.78

122.09

g/l

0.79

554

2696

Other aneurysm

394

1633

2.75

63.64

11.7

7.7

117.59

122.02

g/l

3.83

382

1577

Malignant neoplasm of brain

265

898

3.48

63.59

10.0

8.9

127.48

122.36

g/l

3.80

253

867

Other disorders of ear

5047

26190

1.31

63.57

7.4

8.3

121.85

121.49

g/l

0.59

4854

25308

Malignant neoplasm of colon

937

5337

1.90

63.43

8.0

7.2

114.38

120.20

g/l

16.88

910

5137

Type of accident

1476

9395

1.64

63.27

8.2

8.0

120.80

122.07

g/l

1.50

1414

9058

Benign neoplasm of meninges

624

3120

2.19

63.06

7.2

7.8

121.37

119.46

g/l

1.93

607

3000

Haemorrhage, not elsewhere classified

277

966

3.33

62.85

12.3

7.4

114.61

120.50

g/l

4.09

269

920

Disorder of lipoprotein metabolism, unspecified

814

4447

1.97

62.65

9.9

7.4

118.79

121.00

g/l

2.22

798

4279

Diseases of the myoneural junction and muscle

734

3897

2.04

62.02

11.3

8.1

121.28

121.62

g/l

0.16

708

3747

Cervical disc disorders

1954

13276

1.53

61.69

7.4

8.7

124.50

121.19

g/l

9.94

1892

12816

Other disorders of glucose regulation and pancreatic internal secretion

515

2406

2.34

61.65

11.0

8.3

116.86

122.16

g/l

6.91

503

2309

Postprocedural disorders of digestive system, not elsewhere classified

263

908

3.45

61.42

10.8

8.9

115.03

120.92

g/l

4.40

257

880

Other systemic involvement of connective tissue (FG)

1317

8165

1.67

61.10

7.6

7.4

118.07

120.11

g/l

3.47

1274

7877

Diseases of pulp and periapical tissues, including avohilmo

5955

24561

1.28

60.90

8.4

7.9

121.66

121.61

g/l

0.06

5745

23669

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

823

4547

1.94

60.82

7.5

8.3

115.41

123.05

g/l

20.20

789

4368

Viral pneumonia (known virus, not influenza)

206

621

4.09

60.70

10.1

8.4

121.04

120.82

g/l

0.05

197

604

Arterial embolism and thrombosis

400

1698

2.64

60.68

12.8

6.7

114.51

121.63

g/l

9.24

385

1637

Soft tissue disorders related to use, overuse and pressure

1433

9155

1.64

60.64

7.7

8.3

121.65

121.24

g/l

0.32

1389

8823

Cirrhosis of liver, NAS

380

1595

2.77

60.59

12.4

8.8

110.43

121.99

g/l

19.15

371

1537

Benign neoplasm: Adrenal gland

439

1943

2.51

60.47

8.1

7.7

122.50

122.23

g/l

0.09

428

1865

Other arthritis (FG)

1582

10326

1.59

60.39

8.9

8.3

120.14

121.89

g/l

2.73

1534

9972

Dental pulpitis 4

5961

24617

1.28

60.29

8.4

7.9

121.69

121.61

g/l

0.09

5752

23723

Systemic connective tissue disorders

1820

12274

1.54

59.84

8.6

7.2

117.53

120.03

g/l

6.51

1762

11823

Dental pulpitis 1

5956

24622

1.28

59.81

8.4

7.9

121.69

121.61

g/l

0.10

5747

23728

Other and unspecified polyneuropathies, also in other diseases

1142

6971

1.75

59.72

9.6

8.1

117.77

121.02

g/l

6.07

1122

6703

Other embolism and thrombosis

773

4220

1.97

59.55

10.6

8.1

117.82

121.16

g/l

4.44

751

4066

Disturbances of skin sensation

1312

8239

1.66

59.23

7.5

8.3

124.87

121.75

g/l

6.46

1267

7937

Oesophageal varices

320

1251

3.00

59.20

12.8

8.6

107.39

122.52

g/l

24.52

315

1201

Benign neoplasm of other and unspecified endocrine glands

752

4089

1.98

58.92

8.0

8.1

123.78

121.48

g/l

2.31

724

3930

Disorders of calcium metabolism

378

1582

2.65

58.91

9.1

7.1

114.02

120.56

g/l

6.76

371

1521

Diabetic nephropathy

1060

6327

1.80

58.87

12.2

9.3

109.86

122.22

g/l

66.23

1031

6114

Toxic effect of carbon monoxide

170

462

4.67

58.76

4.2

9.4

129.18

121.54

g/l

4.07

165

446

Pneumonitis due to solids and liquids

524

2520

2.29

58.74

15.1

7.5

117.21

121.21

g/l

4.12

502

2426

Artrosis, including avohilmo

4706

20039

1.32

58.70

7.2

8.9

123.10

121.88

g/l

3.49

4528

19315

Benign neoplasm: Caecum

595

3001

2.17

58.70

8.7

7.5

116.67

122.01

g/l

9.06

580

2885

Coagulation defects, purpura and other haemorrhagic conditions

1013

5993

1.79

58.57

10.8

7.8

116.44

121.58

g/l

11.47

984

5777

Abnormal involuntary movements

755

4111

1.97

58.53

7.1

7.9

123.52

121.52

g/l

1.77

738

3963

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

412

1808

2.55

58.18

9.6

6.7

116.81

121.86

g/l

5.12

400

1739

Temporomandibular joint disorders

712

3775

1.97

58.09

6.9

7.9

122.27

120.62

g/l

1.34

688

3606

Benign neoplasm: Cerebral meninges

566

2820

2.20

57.87

7.2

7.6

121.26

119.46

g/l

1.65

550

2710

Combinations of oral blood glucose lowering drugs

1612

10727

1.58

57.49

9.4

8.1

122.10

122.18

g/l

0.05

1565

10348

Colon adenocarcinoma

764

4226

1.97

57.37

7.8

7.2

114.36

120.19

g/l

13.70

744

4064

L04AX Other immunosuppressants

2754

20132

1.41

57.29

9.5

8.1

118.61

121.94

g/l

14.54

2664

19415

Second line medication for Crohn's disease

2810

20615

1.40

57.11

9.4

8.2

118.61

121.98

g/l

15.16

2719

19876

Left ventricular outflow tract obstruction, narrow definition

326

1296

2.84

57.08

17.9

9.9

113.36

124.94

g/l

18.94

321

1251

Speech and linguistic disorders, excluding more controls

321

1161

2.75

57.02

9.4

9.0

123.47

122.80

g/l

0.21

308

1114

Chronic periodontitis, complicated

611

3150

2.13

57.01

14.8

8.5

112.25

122.68

g/l

27.97

598

3033

Abnormal spermatozoa

148

4880

0.28

56.88

6.0

9.0

120.96

122.14

g/l

0.28

139

4696

Serous carcinoma of ovary

263

949

3.27

56.73

6.6

6.8

111.71

118.41

g/l

8.61

258

919

Benign neoplasm: Ascending colon

717

3888

1.99

56.67

7.7

7.5

118.05

122.15

g/l

5.91

701

3728

Right hemicolectomy

420

1891

2.51

56.45

12.5

7.7

111.64

120.51

g/l

15.36

406

1817

Disorders of synovium and tendon

2648

17320

1.41

56.33

7.5

8.4

122.28

121.52

g/l

1.10

2551

16695

Benign neoplasm: Stomach

537

2642

2.21

56.22

8.3

7.5

117.26

121.93

g/l

6.17

522

2534

Idiopathic gout

616

3212

2.13

56.13

9.6

8.2

118.24

122.01

g/l

3.78

602

3092

Dental operations

3862

15051

1.35

55.94

8.2

7.8

120.78

122.05

g/l

3.10

3715

14538

Pyothorax

323

1305

2.87

55.75

15.7

8.8

115.15

122.51

g/l

8.02

314

1251

Asthma and allergy, excluding more controls

487

2250

2.22

55.64

7.9

6.2

125.68

122.77

g/l

2.53

472

2161

Appendectomy

3147

22702

1.37

55.22

8.7

8.3

122.07

122.32

g/l

0.27

3049

21868

Benign neoplasm: Colon, unspecified

1426

9339

1.61

55.21

8.2

7.8

118.47

120.59

g/l

3.63

1378

8990

Cholecystitis

821

4672

1.88

55.03

8.9

7.3

118.57

120.62

g/l

1.99

801

4491

Disorders of parathyroid gland

1141

6993

1.70

55.01

7.3

6.8

117.69

119.25

g/l

1.75

1103

6719

Cerebral palsy and other paralytic syndromes

642

3381

2.04

55.00

9.9

8.2

122.32

122.04

g/l

0.13

619

3255

Other diseases of blood and blood-forming organs, wide

1177

7367

1.68

54.84

10.4

7.9

116.91

121.44

g/l

8.97

1141

7103

Conductive and sensorineural hearing loss

4420

23934

1.31

54.77

7.0

8.1

121.81

121.21

g/l

1.12

4242

23140

Alcohol withdrawal state with delirium

484

2335

2.31

54.53

11.3

9.1

120.86

123.82

g/l

2.13

473

2252

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

646

3460

2.05

53.99

8.5

7.8

117.22

120.78

g/l

5.13

624

3330

Tobacco use

333

1373

2.72

53.91

9.2

9.5

123.81

123.13

g/l

0.21

322

1326

Unspecified privation

622

3272

2.05

53.75

11.5

8.2

117.85

122.50

g/l

6.26

612

3147

Ulcer of oesophagus

490

2391

2.28

53.50

8.4

7.9

118.74

121.98

g/l

2.80

477

2302

Disorders resulting from impaired renal tubular function

271

1026

3.10

53.39

14.2

9.9

107.57

121.79

g/l

25.78

266

996

Malignant neoplasm of eye, brain and central nervous system

303

1205

2.86

53.39

9.5

9.3

127.08

122.04

g/l

4.36

290

1164

Sequelae of injuries, of poisoning and of other consequences of external causes

1223

7761

1.65

53.33

10.8

8.5

120.72

122.97

g/l

3.11

1158

7487

DVT of lower extremities

1084

6703

1.71

53.29

7.9

120.60

120.93

g/l

0.20

1048

6466

Myocardial infarction, with ST-elevation

1096

6815

1.71

53.18

9.4

7.8

120.73

120.99

g/l

0.15

1060

6565

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

415

1894

2.42

53.18

8.9

7.5

115.75

121.63

g/l

7.44

407

1823

Mixed and other personality disorders

420

1909

2.37

53.18

7.3

9.4

124.99

124.76

g/l

0.08

407

1844

Other and unspecified local infections of skin and subcutaneous tissue

549

2782

2.14

52.99

10.9

8.4

119.51

122.67

g/l

2.76

536

2673

Hydronephrosis

644

3442

2.01

52.98

8.6

7.1

111.84

122.82

g/l

35.53

621

3308

Organic, including symptomatic, mental disorders

2786

14860

1.40

52.95

7.4

7.3

119.96

120.08

g/l

0.11

2706

14315

Hypoglycaemia, other or unspecified

411

1872

2.41

52.57

11.3

8.7

115.98

122.51

g/l

8.22

400

1798

Cervicalgia

1041

6369

1.71

52.55

6.6

8.2

124.03

120.39

g/l

6.85

1005

6139

Seropositive rheumatoid arthritis

1319

8520

1.61

52.50

7.8

117.24

120.32

g/l

6.65

1268

8223

Viral hepatitis

410

1861

2.39

52.46

11.4

9.7

121.07

125.07

g/l

3.09

400

1803

Procreative management

1395

7645

1.59

52.44

9.4

123.23

123.87

g/l

0.51

1316

7378

Glomerulonephritis

600

3152

2.06

52.34

10.9

8.5

113.90

122.57

g/l

17.96

578

3040

Umbilical hernia

1444

9571

1.58

52.04

8.8

8.5

123.48

123.22

g/l

0.16

1403

9220

Intracerebral haemorrhage

744

4186

1.90

52.02

12.3

7.0

121.17

120.08

g/l

0.72

722

4024

Inguinal hernia

3333

17032

1.35

51.81

8.3

8.5

122.60

123.43

g/l

1.37

3223

16390

Pneumothorax

453

2165

2.30

51.74

12.5

8.0

123.11

121.83

g/l

0.61

441

2082

Other mental disorders due to brain damage and dysfunction and to physical disease

688

3799

1.96

51.72

6.7

7.3

120.96

120.20

g/l

0.45

669

3658

Osteomyelitis

414

1917

2.40

51.48

11.3

8.7

111.41

122.41

g/l

20.89

401

1848

Alcoholic liver disease

631

3411

2.02

51.00

13.5

8.7

111.57

122.94

g/l

29.07

614

3298

Benign neoplasm: Sigmoid colon

1068

6674

1.70

50.97

7.9

7.8

119.57

120.67

g/l

1.01

1042

6420

Stomatitis and related lesions

456

2184

2.25

50.81

10.0

7.7

119.10

123.40

g/l

4.12

435

2111

Nonischemic cardiomyopathy

363

1600

2.53

50.70

17.5

8.4

123.81

123.69

g/l

0.03

354

1533

Psychotic depression

339

1436

2.55

50.61

8.9

7.9

124.03

121.79

g/l

1.08

324

1381

Asthma and allergy

487

2339

2.13

50.36

7.9

6.5

125.68

122.48

g/l

2.98

472

2257

Other local infections of skin and subcutaneous tissue

572

2996

2.06

50.11

10.8

8.3

119.66

122.65

g/l

2.64

559

2877

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

2724

13763

1.39

50.03

7.0

8.0

119.89

122.72

g/l

10.33

2631

13245

Viral infections characterized by skin and mucous membrane lesions

2051

14617

1.45

49.77

9.0

8.2

120.19

122.23

g/l

4.39

1988

14098

Adenocarcinoma and papilloma adenocarcinoma of rectum

613

3316

2.02

49.70

8.3

7.8

117.68

120.70

g/l

3.67

594

3195

Other blood glucose lowering drugs, excl. Insulins

968

5932

1.73

49.60

8.6

7.4

121.34

120.85

g/l

0.29

932

5692

Congenital malformations of aortic and mitral valves

277

1092

2.88

49.56

18.3

10.0

113.29

124.58

g/l

15.97

272

1055

Other degenerative diseases of the nervous system

1374

6823

1.58

49.55

5.6

6.9

120.91

119.44

g/l

1.86

1325

6548

Fracture of skull and facial bones

1075

6737

1.67

49.30

11.1

8.3

121.85

123.33

g/l

1.48

1052

6474

Cytomegalovirus infection, IBD co-morbidity

181

573

3.82

49.18

15.9

10.6

108.30

121.98

g/l

14.47

171

553

Pneumonia due to other infectious organisms, not elsewhere classified

216

751

3.29

49.04

11.7

8.3

115.49

121.17

g/l

2.98

210

722

Cholangitis (primary sclerosing, PSC)

380

1730

2.42

48.98

11.7

7.9

112.76

121.91

g/l

14.03

370

1661

Reimbursement for rheumatic diseases

2883

21693

1.36

48.95

8.6

7.8

118.87

121.19

g/l

8.00

2787

20930

Sleep disorders

990

6084

1.70

48.90

8.2

8.4

123.23

122.46

g/l

0.54

967

5855

Somatoform disorder

780

4511

1.81

48.58

7.6

7.9

123.65

121.51

g/l

2.22

749

4341

Attention to artificial openings

276

1101

2.87

48.52

12.2

7.8

115.73

122.88

g/l

6.99

270

1073

Assault by bodily force

382

1733

2.36

48.51

10.4

9.2

124.64

126.07

g/l

0.60

374

1675

Noninfectious colitis NAS

712

4024

1.87

48.50

8.9

7.6

118.33

121.71

g/l

4.45

694

3879

Injuries to unspecified part of trunk, limb or body region

552

2889

2.06

48.47

10.4

8.3

117.56

122.15

g/l

5.74

544

2777

Other symptoms and signs involving the nervous and musculoskeletal systems

2040

14608

1.44

48.30

7.8

7.9

124.68

121.18

g/l

12.05

1958

14087

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

492

2485

2.16

48.25

8.5

6.8

114.29

121.47

g/l

13.78

476

2392

Acute and transient psychotic disorders

605

3255

1.97

48.19

7.6

9.2

123.54

123.41

g/l

0.05

577

3143

Paracetamol of NSAID medication

923

2702

1.77

48.08

8.5

9.2

122.65

121.63

g/l

0.66

888

2588

Sensorineural hearing loss

4181

23119

1.30

47.91

6.8

8.1

121.72

121.04

g/l

1.30

4015

22353

Parodontitis or/and operation codes

3304

14994

1.34

47.88

9.4

8.1

120.94

121.99

g/l

2.08

3178

14433

Polyarthrosis

1039

6244

1.67

47.65

5.4

7.7

119.60

119.38

g/l

0.13

1014

6031

Migraine without aura

717

4045

1.83

47.62

7.5

7.7

125.84

120.71

g/l

9.90

701

3886

Other and unspecified mood [affective] disorders

320

1351

2.52

47.61

8.8

124.64

123.50

g/l

0.43

312

1300

Other and unspecified myopathies

523

2720

2.10

47.41

11.9

7.9

119.95

121.48

g/l

0.88

505

2615

Cytomegaloviral disease

181

585

3.69

47.36

15.9

10.7

108.30

121.99

g/l

14.65

171

566

Disorders of continuity of bone

501

2552

2.11

47.33

8.6

117.64

122.72

g/l

6.55

477

2460

Other viral diseases

1281

8385

1.57

47.31

10.9

8.6

120.07

123.32

g/l

6.20

1235

8092

Other specified/unspecified arthritis

1323

8766

1.57

47.22

9.1

8.5

120.29

121.62

g/l

1.52

1283

8464

Benign neoplasm of brain and other parts of central nervous system

359

1616

2.43

47.19

8.7

7.8

124.51

123.02

g/l

0.73

353

1553

Coxarthrosis, primary

3280

21989

1.33

46.88

7.0

7.8

119.23

120.63

g/l

3.70

3164

21207

Brain meningioma

334

1476

2.55

46.82

6.9

8.2

121.03

119.44

g/l

0.90

329

1424

Injuries to the neck

1075

6819

1.64

46.70

8.7

8.3

122.02

122.61

g/l

0.40

1043

6566

Pneumonia due to Streptococcus pneumoniae

267

1060

2.80

46.62

9.6

8.1

120.84

122.45

g/l

0.55

254

1024

Hydrocephalus

473

2390

2.16

46.57

8.0

7.6

124.01

120.08

g/l

4.06

461

2296

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

482

2452

2.15

46.53

7.5

6.9

110.67

121.49

g/l

24.24

466

2355

Open wound of lower leg

764

4461

1.81

46.52

10.6

8.1

118.45

121.79

g/l

4.29

746

4301

Extrapyramidal and movement disorders

1943

13930

1.45

46.46

6.2

7.7

122.07

120.51

g/l

2.82

1876

13431

Osteoporosis with pathological fracture (FG)

402

1915

2.31

46.38

8.3

6.1

114.26

118.63

g/l

4.80

386

1839

Other and unspecified injuries of head

366

1679

2.39

46.17

8.1

8.7

122.80

122.57

g/l

0.07

361

1613

Fall on same level involving ice and snow

2806

21276

1.35

46.01

8.4

7.9

121.26

121.36

g/l

0.09

2712

20506

Benign neoplasm: Rectum, anus and anal canal

1138

7391

1.63

45.91

7.6

7.8

119.32

120.64

g/l

1.44

1098

7110

Pericarditis

225

826

3.05

45.86

9.9

8.1

121.75

123.64

g/l

0.57

220

791

Other/unspecified cytomegaloviral diseases

156

471

4.04

45.83

16.5

11.3

107.68

122.07

g/l

13.49

148

456

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

371

1718

2.37

45.79

10.5

6.8

112.85

122.00

g/l

15.04

360

1658

Dental caries 1

4471

18156

1.28

45.77

8.1

7.8

120.94

121.52

g/l

1.00

4312

17474

Dental caries, including avohilmo

4463

18139

1.28

45.43

8.1

7.8

120.98

121.52

g/l

0.89

4304

17457

Other diseases of liver

904

5555

1.71

45.40

10.4

8.2

118.73

121.98

g/l

4.36

877

5355

Kyphosis

124

324

4.84

45.25

8.0

6.8

118.81

121.17

g/l

0.62

118

315

Hyperparathyroidism

986

6126

1.68

45.22

7.1

6.9

117.78

119.33

g/l

1.53

954

5888

Myalgia

1045

6630

1.64

45.18

8.5

8.2

123.59

121.06

g/l

3.63

1003

6392

Scoliosis

406

1940

2.22

45.10

8.0

7.7

116.94

120.65

g/l

3.39

390

1871

Diplopia

714

4142

1.84

44.91

9.1

7.9

122.21

121.30

g/l

0.60

691

3989

Benign neoplasm: Rectum

1021

6511

1.66

44.84

7.7

7.9

119.67

120.65

g/l

0.84

985

6278

Benign neoplasm: Transverse colon

624

3510

1.94

44.68

7.9

7.8

120.22

120.72

g/l

0.24

609

3377

Other disorders of lacrimal gland

1636

11447

1.48

44.51

7.0

7.7

121.30

120.23

g/l

1.38

1576

11027

Insomnia

736

4297

1.80

44.36

8.4

123.12

122.85

g/l

0.13

718

4141

Paralytic ileus

267

1094

2.76

44.25

13.0

7.5

116.90

122.10

g/l

3.57

260

1044

Shock, not elsewhere classified

222

5.85

44.21

41.6

7.5

110.16

119.34

g/l

3.30

213

Nonorganic sleeping disorders

849

5153

1.72

44.08

8.5

8.3

122.97

122.77

g/l

0.10

826

4965

Vascular syndromes of brain in cerebrovascular disorders

322

1444

2.52

43.90

7.1

7.6

119.86

119.91

g/l

0.01

311

1388

Malignant neoplasm of rectum

595

3315

1.95

43.84

8.3

7.7

117.39

120.79

g/l

4.44

575

3188

Disorders of lacrimal system

2019

14689

1.42

43.73

6.9

7.7

121.00

120.02

g/l

1.40

1940

14145

Disorders of skin appendages

2166

15905

1.40

43.61

8.8

8.2

121.42

122.12

g/l

0.83

2092

15318

Family history of malignant neoplasm

468

2386

2.07

43.54

7.5

7.2

120.98

122.54

g/l

1.01

436

2297

Dental caries 3

4650

19089

1.27

43.34

8.0

7.9

121.02

121.48

g/l

0.75

4485

18387

Disorders of ocular muscles, binocular movement, accommodation and refraction

2101

15249

1.40

43.23

9.6

8.0

122.82

121.89

g/l

1.24

2032

14701

Melanocytic naevi

1186

7813

1.57

43.15

7.4

8.0

120.69

123.25

g/l

3.96

1137

7506

Lesion of ulnar nerve

746

4425

1.78

43.06

9.7

9.0

123.78

122.22

g/l

1.20

722

4268

Hyperkinetic disorders, excluding more controls

288

1168

2.48

43.04

8.5

9.2

128.59

125.02

g/l

2.15

279

1124

Other diseases of lip and oral mucosa

839

5129

1.72

43.01

9.1

7.6

118.98

121.68

g/l

3.40

813

4952

Cerebral cysts

309

1357

2.48

42.96

12.3

9.4

123.54

123.43

g/l

0.03

298

1300

Chronic gastritis

1501

10427

1.50

42.85

8.7

7.1

117.24

120.50

g/l

7.88

1461

10045

Type 1 diabetes, definitions combined

414

2018

2.14

42.82

10.5

8.0

121.27

126.13

g/l

4.36

391

1935

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

555

3030

1.96

42.82

11.2

7.6

115.49

123.04

g/l

14.19

539

2918

Familial hypercholesterolemia

861

5322

1.71

42.54

8.1

7.2

119.71

120.94

g/l

0.96

850

5123

Dental caries 3 and operation codes

5046

21026

1.25

42.49

8.3

7.9

121.06

121.73

g/l

1.36

4864

20270

Fentanyl

550

3000

1.95

42.17

9.4

6.7

114.27

121.17

g/l

11.99

523

2881

Familial hypercholesterolemia, with ischemic heart disease

554

3048

1.96

42.14

9.0

7.1

119.76

120.36

g/l

0.28

547

2923

Type 1 diabetes, strict (exclude DM2)

410

2004

2.14

42.11

10.5

8.8

121.15

126.18

g/l

4.58

387

1924

Superficial injury of thorax

783

4730

1.75

42.10

8.9

8.1

122.36

122.17

g/l

0.08

757

4554

Malignant neoplasm of corpus uteri

475

2493

2.08

42.05

4.4

6.2

118.73

117.67

g/l

0.63

464

2398

Strabismus

1226

8183

1.55

41.90

9.9

8.1

122.61

121.77

g/l

0.69

1185

7879

Dental caries 1 and operation codes

4875

20270

1.26

41.87

8.2

7.9

121.09

121.74

g/l

1.29

4703

19533

Functional dyspepsia

1281

8655

1.53

41.76

8.5

7.3

123.20

121.16

g/l

2.99

1235

8332

Fall on and from stairs and steps

1262

8513

1.54

41.75

8.5

7.9

119.60

121.50

g/l

2.65

1215

8207

Injury of intra-abdominal organs

176

599

3.38

41.63

14.8

9.4

117.90

123.60

g/l

2.72

168

575

Persistent mood disorders

934

5894

1.65

41.57

8.1

7.9

121.28

121.26

g/l

0.01

914

5662

Subjective visual disturbances

1169

7768

1.57

41.52

8.2

7.7

121.34

121.11

g/l

0.15

1127

7483

Dental pulpitis 2

3999

16246

1.28

41.46

8.0

7.7

121.11

121.38

g/l

0.33

3868

15632

Other viral diseases, not elsewhere classified

849

5230

1.69

41.20

10.7

8.6

120.95

123.02

g/l

2.02

825

5047

Dissociative [conversion] disorders

198

717

3.01

40.81

6.5

7.7

126.27

121.63

g/l

2.57

191

691

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

2428

12497

1.37

40.74

6.8

7.8

119.65

122.40

g/l

8.80

2347

12026

Dermatitis and eczema

5592

30338

1.23

40.73

8.6

8.1

121.15

121.99

g/l

2.22

5427

29214

Dental pulpitis 4, only avohilmo

5906

25569

1.22

40.49

7.9

8.1

122.39

121.37

g/l

3.13

5710

24641

Radiculopathy

867

5427

1.67

40.35

6.2

8.1

122.74

120.10

g/l

3.31

844

5235

Primary_lymphoid and hematopoietic malignant neoplasms

1296

8875

1.53

40.25

9.9

7.8

111.43

121.43

g/l

52.95

1248

8550

Charcot foot

128

367

4.14

40.22

14.3

9.6

111.59

123.30

g/l

6.78

123

348

Recurring oral aphthae, including avohilmo

678

3996

1.79

40.01

8.1

8.0

119.27

121.40

g/l

1.88

645

3846

Injuries to the elbow and forearm

3308

23553

1.29

39.75

8.3

8.0

119.70

121.57

g/l

6.05

3197

22717

Other benign neoplasms of skin

1643

11517

1.44

39.36

6.8

7.6

120.77

122.48

g/l

2.65

1582

11060

Dentofacial anomalies [including malocclusion]

1148

7581

1.54

39.03

8.3

7.8

122.54

122.61

g/l

0.04

1103

7301

Dermatophytosis

715

4320

1.76

38.93

7.0

8.2

121.87

121.93

g/l

0.02

688

4165

Superficial injury of lower leg

1115

7426

1.55

38.85

8.5

7.9

121.47

121.67

g/l

0.11

1082

7157

Oxicams

1447

5673

1.50

38.83

6.5

8.8

122.90

119.82

g/l

6.13

1407

5450

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

217

849

2.81

38.80

13.6

10.0

112.45

126.26

g/l

14.69

203

818

Injuries to the ankle and foot

3128

22362

1.30

38.65

8.5

122.65

122.64

g/l

0.01

3032

21536

Dental pulpitis 2, only avohilmo

4064

16672

1.27

38.63

8.0

7.8

121.21

121.26

g/l

0.05

3931

16042

Other systemic involvement of connective tissue

1338

9267

1.50

38.62

7.5

7.2

118.19

120.07

g/l

3.10

1295

8915

Phlebitis and thrombophlebitis (not including DVT)

1142

7676

1.55

38.62

8.1

8.0

121.86

121.15

g/l

0.55

1106

7400

Mental and behavioural disorders due to cannabinoids

152

489

3.40

38.57

10.7

127.66

129.54

g/l

0.47

147

464

Focal brain injury

363

1774

2.19

38.47

11.5

7.8

119.44

120.46

g/l

0.40

354

1697

Dental pulpitis 1, only avohilmo

5898

25663

1.22

38.44

8.0

8.1

122.37

121.36

g/l

3.06

5702

24734

Primary gonarthrosis, bilateral

2698

18254

1.33

38.32

6.7

7.9

120.51

120.36

g/l

0.15

2589

17626

Type 1 diabetes, strict definition, subgroup 1

279

1214

2.40

38.24

10.2

7.4

123.70

128.05

g/l

2.51

263

1164

Disorders of muscles

524

2907

1.91

38.12

9.6

8.8

122.51

122.23

g/l

0.11

508

2797

Parkinson's disease, excluding more controls

703

4131

1.75

37.92

5.4

7.1

121.77

118.98

g/l

3.01

672

3969

Diseases of the ear and mastoid process

6119

25904

1.21

37.88

7.5

8.5

122.98

121.85

g/l

3.84

5896

25007

Purpura and other haemorrhagic conditions

690

4152

1.76

37.86

9.9

7.9

114.12

121.74

g/l

16.85

671

3999

Acute posthaemorrhagic anaemia

235

977

2.70

37.72

10.2

8.4

106.20

121.75

g/l

22.53

226

939

Other symptoms and signs involving general sensations and perceptions

240

1005

2.66

37.68

8.1

8.2

121.34

120.52

g/l

0.25

232

963

Artificial joint operation, meniscal resection

4925

27031

1.23

37.67

7.2

8.3

121.70

121.63

g/l

0.08

4759

26063

Amputation of foot

202

793

3.03

37.66

11.4

9.4

108.18

121.02

g/l

16.87

195

757

Injury of unspecified body region

414

2146

2.08

37.62

10.6

8.4

117.93

121.82

g/l

3.40

409

2060

Mental disorders, not otherwise specified

377

1878

2.13

37.55

9.5

9.0

124.45

123.35

g/l

0.45

363

1814

Vitreous haemorrhage

567

3252

1.87

37.52

11.0

8.0

113.67

121.79

g/l

15.27

549

3129

Other other unspecified disorders of the circulatory system

247

1062

2.63

37.03

9.9

8.8

114.33

121.22

g/l

5.91

234

1024

Neuralgia and neuritis, unspecified

293

1343

2.38

37.03

8.7

9.2

122.35

122.42

g/l

0.02

280

1286

Follow-up examination after treatment for malignant neoplasms

568

3263

1.85

36.90

8.2

7.0

118.24

120.05

g/l

1.36

539

3145

Hypertensive Renal Disease

216

871

2.75

36.59

8.7

7.3

111.79

119.86

g/l

6.03

206

836

Benign neoplasm: Caecum

595

3499

1.83

36.47

8.7

7.7

116.67

120.61

g/l

5.43

580

3371

Trochanteric bursitis

663

3980

1.75

36.47

6.6

7.6

120.42

119.76

g/l

0.38

645

3829

Benign neoplasm: Adrenal gland

439

2358

2.03

36.46

8.1

8.2

122.50

121.04

g/l

0.72

428

2271

Event of undetermined intent

328

1580

2.24

36.31

8.7

9.6

122.62

124.62

g/l

0.91

316

1526

Follow-up examination after treatment for conditions other than malignant neoplasms

2079

10129

1.37

36.15

8.5

7.7

119.41

121.76

g/l

6.09

2034

9744

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

1680

7893

1.42

36.05

6.1

7.2

118.03

120.72

g/l

7.57

1627

7566

Carcinoma in situ of other and unspecified digestive organs

180

678

3.11

36.02

10.5

7.4

114.06

122.16

g/l

6.11

171

658

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

1680

7895

1.42

35.99

6.1

7.2

118.03

120.72

g/l

7.57

1627

7568

Social phobias

316

1490

2.22

35.99

9.5

8.5

125.17

124.91

g/l

0.07

300

1438

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

2315

12143

1.35

35.64

6.8

7.7

119.74

122.26

g/l

7.23

2237

11685

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

599

3164

1.77

35.48

9.1

9.3

126.69

124.63

g/l

1.56

578

3047

Hepatic failure, not elsewhere classified

238

1030

2.60

35.17

22.9

9.5

110.37

121.16

g/l

10.54

231

998

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

2342

12299

1.34

35.07

6.8

7.8

119.83

122.27

g/l

6.85

2260

11833

Gonarthrosis, primary, with knee surgery

3003

19426

1.30

35.04

6.6

7.9

120.05

120.35

g/l

0.36

2904

18758

Other diseases of arteries and capillaries

485

2713

1.91

34.70

10.0

7.4

115.30

121.87

g/l

9.02

467

2612

Visual field defects

476

2657

1.92

34.54

9.3

8.1

121.46

120.91

g/l

0.23

453

2555

Benign neoplasm: Pituitary gland, craniopharyngeal duct

263

1187

2.40

34.37

8.1

8.4

126.39

124.00

g/l

1.17

248

1142

Zoster [herpes zoster]

911

5997

1.59

34.35

8.6

7.4

117.71

120.30

g/l

3.38

884

5776

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

389

2037

2.06

34.20

7.1

7.5

119.15

119.66

g/l

0.18

374

1956

Sulfonylureas

1995

11991

1.37

34.06

8.4

7.0

116.87

120.51

g/l

12.14

1933

11537

Oesophagitis

329

1635

2.20

34.04

11.0

8.1

118.57

122.20

g/l

2.48

319

1578

Other extrapyramidal and movement disorders in other diseases

1125

7743

1.51

34.01

6.4

7.7

121.94

120.61

g/l

1.40

1089

7472

Cardiac murmurs and other cardiac sounds

389

1999

2.01

33.99

8.6

7.7

115.85

120.56

g/l

4.44

371

1919

Traumatic subarachnoid haemorrhage

216

904

2.65

33.95

14.6

7.9

117.63

119.84

g/l

0.76

210

865

Benign neoplasm: Descending colon

365

1884

2.11

33.94

7.7

7.1

117.94

122.25

g/l

3.59

352

1813

Malignant neoplasm of ovary

269

1241

2.40

33.92

8.3

6.8

112.84

118.58

g/l

6.58

258

1201

Injury of other and unspecified intrathoracic organs

374

1950

2.08

33.73

13.0

8.8

116.56

123.08

g/l

7.33

360

1872

Other condition

664

4071

1.71

33.69

9.5

8.4

121.43

122.89

g/l

1.02

649

3924

Leisure time condition

850

5532

1.60

33.45

7.3

8.0

120.49

121.85

g/l

1.10

801

5334

Acute gastritis

434

2376

1.96

33.42

7.7

119.43

121.53

g/l

1.23

426

2287

Infective dermatitis

608

3664

1.75

33.28

8.0

121.32

122.11

g/l

0.38

585

3528

Agranulocytosis

566

3352

1.79

33.17

9.9

8.3

112.10

121.49

g/l

22.29

546

3230

Benign neoplasm: Stomach

537

3145

1.83

33.13

8.3

7.7

117.26

120.41

g/l

3.22

522

3028

Other symptoms and signs involving the digestive system and abdomen

730

4589

1.65

33.08

7.5

7.1

116.68

120.35

g/l

5.72

709

4413

Other disorders involving the immune mechanism, not elsewhere classified

201

829

2.73

32.93

11.1

9.9

112.05

123.15

g/l

9.72

195

799

Arterial embolism and thrombosis of lower extremity artery

232

1020

2.54

32.93

12.4

6.7

113.92

121.51

g/l

6.41

223

979

Diseases of salivary glands

911

6037

1.57

32.79

9.2

7.6

120.58

121.90

g/l

1.18

884

5823

Mental and behavioural disorders due to tobacco

450

2507

1.92

32.76

10.2

8.7

124.61

123.06

g/l

0.80

441

2410

Other diseases of hard tissues of teeth

3074

18268

1.28

32.71

9.1

8.0

120.79

122.70

g/l

5.44

2975

17629

Fracture of neck

353

1829

2.11

32.69

11.9

8.2

117.54

122.12

g/l

3.94

345

1760

Dental caries 1, only avohilmo

4477

18888

1.23

32.58

7.8

8.1

121.10

121.21

g/l

0.12

4319

18188

Smoking dependency

450

2512

1.92

32.55

10.2

8.7

124.61

123.08

g/l

0.78

441

2417

Other sleep disorders

549

3236

1.79

32.43

6.8

8.2

125.49

121.10

g/l

4.86

533

3111

Fall involving bed

207

877

2.70

32.36

8.4

6.9

114.66

119.34

g/l

2.82

194

843

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

378

1991

2.01

32.35

7.9

8.1

122.48

122.36

g/l

0.04

362

1905

Parkinson's disease, strict definition, excluding more controls

639

3852

1.71

32.11

5.5

7.0

121.61

119.04

g/l

2.45

610

3699

Type 1 diabetes, strict definition

291

1386

2.18

32.02

10.4

7.8

123.44

127.68

g/l

2.50

274

1327

Other or ill-defined heart diseases

260

1198

2.32

32.00

11.2

8.0

122.15

124.24

g/l

0.79

252

1150

Superficial injury of hip and thigh

720

4564

1.65

31.86

7.2

117.93

121.70

g/l

4.99

700

4390

Behavioural disorders, excluding more controls

250

4.08

31.75

9.7

8.3

128.24

127.85

g/l

0.06

240

Duodenal ulcer

622

3822

1.72

31.74

10.4

7.3

114.87

121.39

g/l

10.65

600

3686

Other disorders of eyelid

2258

16928

1.32

31.70

7.0

7.5

120.91

119.79

g/l

1.86

2178

16309

Dental operations, only avohilmo

3968

16617

1.24

31.69

8.0

8.1

121.32

121.47

g/l

0.16

3830

16026

Speech and linguistic disorders

324

1550

2.09

31.67

11.1

9.4

123.38

124.23

g/l

0.29

310

1499

Failure and rejection of transplanted organs and tissues

105

312

4.06

31.61

13.9

8.2

104.22

124.24

g/l

19.51

300

Artificial joint re-operation

410

2260

1.98

31.58

7.2

7.3

117.21

120.05

g/l

2.21

398

2174

Sulfasalazine

1331

9540

1.43

31.52

8.1

7.9

118.76

121.58

g/l

5.67

1286

9175

Ovarian cyst

1542

6446

1.41

31.51

7.0

7.4

119.81

118.22

g/l

2.56

1495

6214

Cervicocranial syndrome

508

2951

1.81

31.49

5.9

8.2

125.11

120.75

g/l

5.08

495

2835

Other problems related to primary support group, including family circumstances

430

2305

1.89

31.44

11.0

8.5

121.07

122.96

g/l

1.04

418

2228

Use of biperiden

312

1566

2.17

31.41

6.9

9.3

121.23

122.95

g/l

0.78

300

1515

Fibromyalgia

357

1857

2.02

31.39

8.2

7.8

121.63

120.69

g/l

0.39

348

1786

Migraine with aura and triptan purchases

543

3199

1.76

31.37

6.8

8.2

125.45

121.33

g/l

5.25

528

3081

Pneumonia derived septicemia

205

871

2.61

31.26

10.8

9.0

116.58

122.02

g/l

3.16

194

839

Adverse effects, not elsewhere classified

827

5426

1.58

31.05

9.1

8.1

123.59

121.80

g/l

1.64

798

5216

Benign neoplasm: Small intestine

236

1072

2.45

31.05

8.0

6.8

116.57

121.33

g/l

2.91

226

1034

Disorders of psychological development

403

2013

1.92

30.96

8.8

9.6

125.14

124.40

g/l

0.28

385

1940

Benign neoplasm: Ascending colon

717

4601

1.65

30.95

7.7

7.6

118.05

120.41

g/l

2.36

701

4438

Other congenital malformations of the digestive system

225

987

2.45

30.94

9.5

118.16

121.78

g/l

1.68

219

953

Rheumatoid arthritis, including avohilmo

1855

14064

1.35

30.90

7.7

7.6

118.44

120.23

g/l

3.46

1786

13547

Open wound of ankle and foot

504

2944

1.81

30.88

9.5

8.9

117.73

123.28

g/l

6.81

491

2830

Congenital malformations of cardiac septa

311

1505

2.13

30.73

13.2

9.4

122.80

123.09

g/l

0.08

298

1451

Dental caries 3, only avohilmo

4642

19769

1.22

30.63

7.7

8.1

121.39

121.22

g/l

0.21

4478

19053

Congenital malformations of the urinary system

296

1468

2.17

30.43

8.9

9.4

113.08

122.86

g/l

13.49

287

1414

Bronchiectasis

434

2454

1.90

30.29

7.5

7.2

121.00

119.07

g/l

1.21

413

2371

Other fall from one level to another

1035

7151

1.50

30.24

9.5

8.6

121.59

122.81

g/l

1.09

991

6903

Other arterial embolism and thrombosis

188

784

2.69

30.11

14.3

6.8

115.53

121.16

g/l

3.04

182

753

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

243

1130

2.37

30.03

8.8

7.9

117.55

122.61

g/l

3.71

237

1092

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

185

767

2.71

30.01

10.7

10.1

111.32

123.03

g/l

10.12

179

738

Generalized anxiety disorder

542

3230

1.73

29.97

7.9

124.26

122.88

g/l

0.84

531

3116

Volvulus

177

720

2.78

29.94

9.9

7.2

115.19

121.52

g/l

3.45

171

683

Tubulo-interstitial nephritis, not specified as acute or chronic

356

1891

2.00

29.89

8.0

6.8

117.54

121.50

g/l

3.47

347

1814

Hypopituitarism

346

1823

2.03

29.82

9.6

127.67

124.82

g/l

1.43

335

1759

Other/unspecified seropositive rheumatoid arthritis

1308

9461

1.43

29.81

7.8

7.5

117.26

120.11

g/l

5.81

1257

9120

Necrotizing fasciitis

122

7.12

29.81

17.5

13.6

110.22

121.00

g/l

2.71

116

Alcohol-induced acute pancreatitis

245

1154

2.38

29.79

16.4

9.3

117.51

124.86

g/l

5.25

239

1108

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1286

9279

1.43

29.77

7.9

7.6

117.22

120.10

g/l

5.83

1236

8944

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

192

815

2.66

29.70

6.0

7.3

118.65

122.49

g/l

1.60

182

790

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

439

2505

1.88

29.67

8.1

7.3

112.44

119.88

g/l

12.84

423

2420

Other disorders of skin and subcutaneous tissue, not elsewhere classified

721

4663

1.62

29.50

9.0

7.6

114.71

121.40

g/l

15.17

696

4485

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

653

4132

1.66

29.41

10.1

7.7

113.13

122.64

g/l

23.89

624

3960

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

279

1382

2.22

29.40

7.5

6.6

114.29

121.75

g/l

7.45

272

1332

Disorders of oesophagus in diseases classified elsewhere

149

566

3.06

29.35

11.5

8.3

112.25

121.22

g/l

5.59

143

545

Seropositive rheumatoid arthritis, wide

1319

9579

1.42

29.35

7.8

7.5

117.24

120.13

g/l

6.02

1268

9232

Heartburn

478

2786

1.80

29.32

7.4

7.7

124.74

121.98

g/l

2.05

463

2671

Emotional disorders starting during childhood or adolecense, excluding more controls

127

418

3.10

29.16

9.3

8.9

125.44

123.91

g/l

0.34

122

402

Other disorders of nervous system

363

1967

1.99

29.14

7.6

8.4

121.55

122.42

g/l

0.33

352

1890

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

189

804

2.65

29.14

9.1

7.2

115.81

121.31

g/l

3.52

180

779

Fracture of foot, except ankle

1034

7193

1.48

29.04

8.6

120.82

122.46

g/l

1.71

998

6927

Symptoms and signs involving speech and voice

1542

11491

1.38

28.99

9.0

7.6

121.91

120.55

g/l

2.00

1503

11059

Meniscus derangement

2867

15724

1.27

28.98

7.2

8.8

123.41

122.17

g/l

2.53

2774

15168

Other and unspecified abdominal hernia

248

1183

2.31

28.88

9.1

8.4

120.43

120.83

g/l

0.11

238

1131

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2527

19666

1.28

28.84

9.7

8.5

123.81

121.88

g/l

4.76

2422

18955

Benign neoplasm of brain and other parts of central nervous system

359

1946

1.99

28.78

8.7

124.51

121.22

g/l

2.54

353

1871

Maltreatment syndromes

223

1007

2.35

28.73

9.3

10.4

124.75

124.66

g/l

0.02

218

967

Toxic effect of ethanol

224

1021

2.38

28.70

10.7

9.9

126.45

124.36

g/l

0.73

215

985

Other diseases of upper respiratory tract

5934

26472

1.18

28.70

8.4

8.1

122.95

121.16

g/l

8.41

5739

25517

Dipeptidyl peptidase 4 (DPP-4) inhibitors

640

4072

1.66

28.57

9.3

7.6

119.83

121.31

g/l

1.06

620

3903

Osteonecrosis

327

1728

2.05

28.50

11.3

8.5

114.49

121.80

g/l

9.29

319

1662

Non-follicular lymphoma, hilmo, excluding all cancers

474

2792

1.80

28.49

10.6

7.4

111.78

122.24

g/l

21.36

455

2691

Polycystic ovarian syndrome, consortium definition

2826

13623

1.27

28.29

7.5

6.9

120.61

118.79

g/l

5.47

2711

13134

Coxarthrosis, primary, with hip surgery

2440

18395

1.29

28.26

6.8

7.6

118.60

120.29

g/l

4.10

2360

17732

Sarcoidosis

673

4332

1.63

28.20

10.9

8.3

123.08

121.98

g/l

0.64

639

4169

Benign lipomatous neoplasm

1245

9004

1.42

28.10

7.4

7.9

123.50

123.09

g/l

0.30

1195

8669

Inflammatory bowel disease

1433

10597

1.39

28.08

9.3

8.5

120.91

122.67

g/l

2.50

1391

10205

Primary coxarthrosis, bilateral

1485

11093

1.39

27.97

7.1

7.5

119.81

119.99

g/l

0.13

1425

10695

Methotrexate

681

4391

1.61

27.92

9.0

7.5

116.45

120.75

g/l

6.99

662

4217

Dissection of aorta

208

939

2.47

27.91

21.1

6.9

113.85

122.72

g/l

7.27

202

902

Benign neoplasm of urinary organs

245

1174

2.27

27.90

6.9

7.0

122.43

121.60

g/l

0.26

235

1135

Abnormal findings on antenatal screening of mother

234

1085

2.23

27.69

4.2

7.6

124.71

121.29

g/l

1.76

221

1041

Malignant neoplasm of bladder

423

2441

1.86

27.67

9.5

7.4

115.07

120.70

g/l

8.00

414

2352

Dental caries 2 and operation codes, only avohilmo

2299

18045

0.78

27.61

8.1

8.5

122.52

121.72

g/l

1.07

2229

17357

Use of pramipexole

1084

7711

1.46

27.54

7.4

7.6

121.50

120.32

g/l

1.15

1043

7436

Asthma and opportunity respiratory infection

270

1354

2.19

27.54

8.6

7.6

121.15

119.38

g/l

0.74

259

1299

Other strabismus

909

6218

1.50

27.44

10.2

8.1

123.66

122.17

g/l

1.31

878

5981

Ulcerative colitis, NAS

641

4095

1.63

27.40

9.5

8.5

120.91

123.24

g/l

1.97

618

3951

Benign neoplasm: Kidney

194

856

2.51

27.31

6.7

122.01

121.16

g/l

0.24

187

826

Ulcerative colitis

1120

7999

1.44

27.26

8.9

8.3

121.03

122.78

g/l

2.03

1083

7699

Other maltreatment syndromes

170

703

2.64

27.23

8.9

9.9

124.51

125.46

g/l

0.22

164

679

Hypothyroidism, strict autoimmune

3524

19226

1.23

27.03

7.9

7.6

120.72

121.69

g/l

2.04

3408

18512

Other diseases of oesophagus

518

3170

1.73

26.93

8.5

7.5

119.06

121.63

g/l

1.91

503

3053

Secondary parkinsonism, excluding more controls

154

616

2.78

26.78

5.5

8.1

124.12

119.53

g/l

1.75

149

592

Abscess of anal and rectal regions

416

2398

1.83

26.72

9.7

8.5

121.90

124.98

g/l

2.10

403

2306

Oter anti-inflammatory and antirheumatic agents, non-steroids

1332

5380

1.41

26.50

7.1

8.7

120.61

119.60

g/l

0.97

1299

5170

Alzheimer’s disease (Atypical or mixed), excluding more controls

406

2011

1.85

26.22

3.8

6.2

118.87

117.28

g/l

0.82

391

1931

Dental pulpitis 3

323

1209

1.97

26.16

7.7

9.3

124.46

124.54

g/l

0.02

310

1163

Congenital malformations and deformations of the musculoskeletal system

337

1817

1.93

26.13

9.4

124.87

123.06

g/l

0.87

329

1748

Melanocytic naevi of trunk

479

2881

1.73

26.11

7.8

8.0

119.32

123.92

g/l

4.98

462

2775

Diabetic retinopathy

1932

9486

1.33

26.10

10.9

9.1

115.71

121.91

g/l

30.77

1868

9182

Recurring oral aphthae

252

1253

2.18

26.05

9.6

8.7

116.96

120.63

g/l

2.02

238

1212

Childhood asthma (age<16), excluding more controls

347

1477

1.90

25.98

10.6

6.9

124.47

126.08

g/l

0.67

333

1419

Other misadventures during surgical and medical care

143

565

2.90

25.95

10.8

8.1

115.55

120.44

g/l

1.88

137

547

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

1685

7826

1.35

25.88

7.6

9.1

121.42

125.35

g/l

11.52

1608

7567

Benign neoplasm: Duodenum

162

680

2.71

25.87

9.2

6.9

116.88

121.72

g/l

2.11

156

654

In situ neoplasms

1684

12935

1.34

25.68

7.2

7.1

117.43

119.69

g/l

5.21

1626

12462

Early complications of trauma

237

1159

2.23

25.68

9.2

9.4

120.28

122.91

g/l

0.97

229

1111

!Aliquae complicationes praecoces traumatis

237

1159

2.23

25.68

9.2

9.4

120.28

122.91

g/l

0.97

229

1111

Other necrotizing vasculopathies (FG)

321

1745

1.98

25.50

10.0

8.1

116.20

120.75

g/l

3.63

311

1688

Other and unspecified visual disturbances

457

2748

1.76

25.38

7.7

8.3

120.80

121.51

g/l

0.32

436

2639

Postmenopausal osteoporosis with pathological fracture

325

1785

1.97

25.30

7.6

5.8

113.60

117.07

g/l

2.82

312

1720

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1601

10641

1.34

25.29

6.7

7.7

120.31

119.77

g/l

0.52

1534

10249

Agoraphobia

132

497

2.84

25.23

15.7

8.7

126.06

123.59

g/l

0.61

124

477

Brachial plexus disorders

391

2247

1.82

25.17

5.1

9.0

126.42

122.82

g/l

2.62

371

2163

Type1 diabetes, definitions combined, early onset

230

1100

2.17

25.09

11.8

10.0

121.75

126.65

g/l

2.45

216

1059

Cyst of kidney

385

2231

1.86

25.04

9.6

8.2

120.29

121.30

g/l

0.43

369

2152

Carcinoma in situ of other and unspecified digestive organs

180

809

2.56

25.03

10.5

8.9

114.06

120.24

g/l

4.02

171

785

Immunodeficiencies

248

1243

2.15

24.98

14.9

8.9

117.63

121.20

g/l

1.81

236

1199

Unspecified jaundice

276

1437

2.07

24.96

11.0

7.7

114.24

121.50

g/l

6.94

264

1377

Lesion of lateral popliteal nerve

276

1442

2.07

24.86

11.8

9.4

118.26

122.06

g/l

2.08

264

1384

178

4.76

24.84

6.4

7.7

120.84

121.03

g/l

0.03

171

Other noninfective disorders of lymphatic vessels and lymph nodes

199

922

2.36

24.82

9.0

8.1

121.13

121.29

g/l

0.03

193

894

Retinal vascular occlusion

645

4247

1.60

24.79

7.5

7.1

118.32

120.26

g/l

1.60

621

4090

Pneumococcal septicemia

193

885

2.40

24.79

10.7

9.6

116.92

121.70

g/l

2.45

182

850

Disorders of sclera, cornea, iris and ciliary body

2510

20295

1.26

24.79

8.2

8.1

121.13

121.92

g/l

1.13

2431

19560

Persons encountering health services in other circumstances

1661

12762

1.33

24.75

7.8

7.7

121.94

122.19

g/l

0.19

1616

12262

Alzheimer disease, excluding more controls

876

4032

1.50

24.68

4.5

6.5

120.34

118.23

g/l

2.30

844

3873

Corns and callosities

364

2078

1.87

24.62

8.0

8.6

119.25

121.88

g/l

1.47

354

1993

Degeneration of macula and posterior pole

2412

16019

1.27

24.59

6.6

7.2

117.89

120.15

g/l

6.81

2345

15435

Childhood asthma (age<16)

347

1506

1.87

24.52

10.6

7.4

124.47

125.78

g/l

0.51

333

1449

Disorders of the thyroid gland

4717

26313

1.19

24.52

8.1

8.0

121.39

121.35

g/l

0.05

4549

25380

Other symptoms and signs involving the urinary system

538

3405

1.67

24.48

8.6

8.3

119.95

122.32

g/l

1.87

507

3277

Irregular menses

1644

10204

1.33

24.39

7.7

7.3

121.85

119.51

g/l

5.32

1575

9838

Glaucoma suspect

1760

13713

1.32

24.31

6.3

7.6

120.80

120.00

g/l

0.91

1670

13223

Retinal vascular disorders

652

4320

1.59

24.30

7.5

7.1

118.19

120.32

g/l

1.87

628

4161

Presence of other functional implants

2814

16277

1.25

24.28

6.8

7.1

118.18

121.26

g/l

12.47

2713

15704

Orchitis and epididymitis

508

3180

1.69

24.22

10.9

9.5

122.75

123.73

g/l

0.44

492

3073

Causalgia

105

363

3.27

24.22

7.3

11.2

126.61

121.83

g/l

1.44

353

5-aminosalicylic acid

900

6319

1.46

24.05

9.4

8.3

120.92

122.73

g/l

1.84

870

6076

Diseases of male genital organs

2934

12116

1.25

23.97

9.0

9.8

125.17

124.87

g/l

0.29

2810

11728

Other necrotizing vasculopathies

381

2224

1.83

23.97

10.1

8.0

115.68

120.66

g/l

4.96

368

2142

Superficial injury of abdomen, lower back and pelvis

651

4301

1.57

23.91

8.1

7.9

122.25

122.62

g/l

0.17

625

4141

Inflammatory diseases of the central nervous system

405

2398

1.78

23.82

10.9

8.7

120.42

122.64

g/l

1.34

393

2303

Pregnancy hypertension

1401

9502

1.35

23.79

6.6

7.7

120.41

119.97

g/l

0.36

1342

9152

Multiple myeloma and malignant plasma cell neoplasms

255

1321

2.10

23.70

7.8

6.7

106.54

121.41

g/l

25.03

246

1273

D07AA Corticosteroids, weak (group I)

621

4065

1.58

23.52

7.5

8.4

121.45

122.69

g/l

0.74

597

3914

Budesonide

576

3718

1.61

23.52

8.3

7.8

119.71

122.11

g/l

1.98

561

3572

Hypothyroidism, other/unspecified

4346

24415

1.19

23.47

8.0

7.9

121.18

121.14

g/l

0.05

4190

23541

Embolic stroke with flimmer

157

675

2.57

23.43

6.9

6.5

117.11

119.30

g/l

0.61

149

650

Other eating disorders

165

712

2.42

23.43

7.7

9.4

122.94

122.76

g/l

0.04

165

685

Hypothyreosis and Thyroxine purchase for inclusion criteria

4483

25248

1.19

23.42

7.9

121.14

121.09

g/l

0.05

4324

24343

Flat foot [pes planus] (acquired)

429

2592

1.73

23.22

7.4

8.5

121.25

120.77

g/l

0.20

410

2492

Multiple myeloma, excluding all cancers (controls excluding all cancers)

255

1332

2.08

23.13

7.9

6.7

106.48

121.47

g/l

25.39

246

1284

Drug-induced neutropenia

360

2089

1.84

23.07

9.4

8.8

111.90

121.43

g/l

14.41

349

2017

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

321

1793

1.89

22.99

8.0

8.2

123.71

122.25

g/l

0.59

310

1717

Excessive, frequent and irregular menstruation

1568

6635

1.34

22.93

7.6

7.4

120.66

118.20

g/l

5.26

1507

6395

Chronic sinusitis

1947

15425

1.29

22.91

8.4

8.2

123.53

121.23

g/l

5.43

1879

14864

Other inflammatory liver diseases

338

1929

1.87

22.86

10.7

8.6

116.72

122.13

g/l

4.61

324

1858

Other disorders of optic [2nd] nerve and visual pathways

317

1775

1.90

22.86

9.9

8.7

120.79

121.68

g/l

0.31

302

1708

Benign neoplasm of ovary

645

4293

1.55

22.80

6.5

6.7

118.16

120.07

g/l

1.88

624

4117

Amenorrhoea

227

1127

2.09

22.67

10.4

8.0

119.54

119.49

g/l

0.01

219

1091

Urticaria and erythema

1492

11460

1.33

22.47

8.0

122.08

121.33

g/l

0.72

1434

11046

Other congenital malformations

348

1999

1.82

22.43

10.7

9.1

119.90

123.01

g/l

1.94

335

1928

Anaemia in chronic diseases classified elsewhere

155

682

2.56

22.32

12.6

9.6

102.56

122.36

g/l

26.94

149

659

Other enthesopathies

1321

9996

1.35

22.29

7.3

8.5

123.66

121.41

g/l

3.70

1266

9641

Benign neoplasm: Pituitary gland, craniopharyngeal duct

263

1402

2.01

22.22

8.1

9.2

126.39

122.03

g/l

3.15

248

1349

Embolic stroke

272

1468

2.00

22.21

8.7

7.1

118.46

119.50

g/l

0.35

260

1405

Car occupant injured in other and unspecified transport accidents

773

5369

1.48

22.03

8.6

8.3

122.59

122.47

g/l

0.05

735

5168

Immunodeficiency with predominantly antibody defects

142

600

2.60

21.98

18.7

9.2

115.79

121.25

g/l

2.04

135

581

Gangrene, not elsewhere classified

190

4.39

21.96

9.7

7.5

108.34

118.63

g/l

3.87

178

Persons with potential health hazards related to communicable diseases

1373

10358

1.34

21.94

11.0

8.5

120.57

123.19

g/l

5.13

1314

9977

Other skin changes

814

5739

1.47

21.90

7.3

7.7

119.38

120.45

g/l

0.75

783

5530

Other infectious diseases

403

2444

1.74

21.86

10.6

7.9

117.16

121.29

g/l

3.41

385

2350

Rheumatism, unspecified

605

4015

1.56

21.86

5.8

7.8

120.90

119.49

g/l

1.07

581

3866

Early lumbar disc prolapse, operated

359

2092

1.78

21.81

8.4

10.4

129.85

125.12

g/l

3.65

333

2025

Left hemicolectomy

162

737

2.49

21.74

12.9

8.5

114.29

120.16

g/l

3.40

157

714

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

1627

7570

1.32

21.71

7.2

9.0

121.48

125.04

g/l

9.33

1549

7320

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

276

1500

1.94

21.67

8.6

8.3

123.88

122.61

g/l

0.44

266

1440

Other coagulation defects

328

1880

1.84

21.65

12.2

8.6

120.86

121.68

g/l

0.28

318

1808

Trigger finger

642

4329

1.54

21.55

8.2

8.6

121.58

120.97

g/l

0.32

621

4157

Paralytic strabismus

367

2183

1.79

21.55

8.9

8.1

120.39

121.08

g/l

0.25

355

2100

Seborrhoeic keratosis

1075

7959

1.40

21.54

6.2

7.5

120.54

120.53

g/l

0.00

1038

7660

Nephrotic syndrome

178

837

2.33

21.52

12.1

9.9

107.81

122.42

g/l

15.18

172

813

Impingement syndrome of shoulder

1185

8890

1.37

21.52

7.9

8.8

124.63

121.74

g/l

4.87

1122

8565

Viral warts

432

2669

1.69

21.42

7.9

8.7

120.30

122.94

g/l

1.76

417

2569

Arthropathies in other diseases classified elsewhere

200

984

2.21

21.40

11.9

10.3

113.17

122.96

g/l

8.51

193

953

Acute appendicitis

3238

25667

1.21

21.37

8.4

8.5

123.77

122.40

g/l

3.26

3126

24732

Sequelae of injuries of lower limb

438

2721

1.69

21.36

10.0

8.7

119.81

123.45

g/l

3.03

419

2620

Dental pulpitis 3, only avohilmo

286

1119

1.91

21.34

7.4

9.4

125.30

124.10

g/l

0.40

274

1079

Nonalcoholic fatty liver disease

429

2656

1.70

21.31

10.9

8.8

122.15

123.43

g/l

0.56

419

2560

Benign neoplasm of middle ear and respiratory system

370

2205

1.77

21.31

8.5

7.9

121.80

123.33

g/l

0.68

361

2120

Haemorrhoids and perianal venous thrombosis

1361

10416

1.34

21.24

6.5

7.3

120.40

121.22

g/l

0.77

1313

10023

Benign neoplasm: Small intestine

236

1242

2.09

21.23

8.0

8.3

116.57

119.93

g/l

1.72

226

1197

Left bundle-branch block

317

1809

1.85

21.22

7.2

6.9

121.79

121.58

g/l

0.06

310

1740

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

586

3903

1.57

21.16

6.8

6.3

116.37

121.25

g/l

6.66

567

3759

Intestinal malabsorption

230

1193

2.07

21.10

11.6

8.7

115.13

122.29

g/l

6.36

221

1151

Hallux valgus (acquired)

1518

8495

1.32

20.96

6.6

8.0

120.48

119.94

g/l

0.48

1463

8180

Other benign neoplasms of connective and other soft tissue

409

2506

1.70

20.94

7.7

8.1

122.08

122.96

g/l

0.37

393

2404

Septal defects

268

1425

1.94

20.93

12.1

9.9

122.19

122.59

g/l

0.11

257

1378

Migraine without aura and triptan purchases

512

3296

1.59

20.84

7.3

8.1

125.67

121.37

g/l

5.64

503

3173

Spondyloarthritis

810

5742

1.45

20.73

7.7

7.9

119.01

121.97

g/l

3.92

783

5523

Papilloedema, unspecified

124

507

2.70

20.65

8.7

9.5

121.67

120.72

g/l

0.19

119

490

Barrett oesophagus

276

1542

1.94

20.49

10.9

8.6

118.53

122.91

g/l

3.29

267

1484

Benign neoplasm of other and unspecified intrathoracic organs

269

3.55

20.49

11.2

6.7

118.53

122.84

g/l

1.10

263

Atrial septal defect

177

835

2.26

20.48

14.2

9.7

121.14

122.50

g/l

0.36

170

813

Cluster headache, wide

181

868

2.23

20.41

8.8

126.48

122.81

g/l

1.38

172

836

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

316

1832

1.84

20.40

9.4

6.6

121.13

121.56

g/l

0.15

304

1761

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

249

1327

1.95

20.39

8.9

8.1

122.56

122.13

g/l

0.12

241

1277

Pruritus

470

3000

1.63

20.38

8.8

7.5

118.73

120.52

g/l

1.13

456

2870

TMD related operations

676

4652

1.50

20.37

8.3

8.7

125.63

122.51

g/l

3.83

640

4487

Cluster headache, strict

166

771

2.30

20.30

9.4

9.1

126.68

122.89

g/l

1.31

157

742

Conduct disorder

339

3.01

20.25

9.7

10.6

128.21

126.57

g/l

0.30

322

Abnormal results of function studies

388

2375

1.71

20.14

10.4

8.3

121.34

122.51

g/l

0.48

376

2288

Unspecified event, undetermined intent

137

593

2.53

20.12

8.9

9.7

122.71

123.46

g/l

0.15

131

574

Pyogenic arthritis

342

2029

1.78

20.12

8.6

8.5

117.13

122.34

g/l

4.48

333

1944

Irritable bowel syndrome

1081

8060

1.37

20.12

7.2

7.4

123.10

121.53

g/l

1.68

1045

7747

Other bursopathies

625

4258

1.53

20.11

8.1

8.4

122.07

121.35

g/l

0.39

603

4096

Diseases of appendix

3472

26877

1.19

20.09

8.5

123.63

122.25

g/l

3.51

3351

25907

Glaucoma

2800

20531

1.22

20.02

6.5

7.6

119.97

120.28

g/l

0.34

2686

19803

Appendicitis, broad definition

3443

26741

1.19

19.95

8.5

123.65

122.26

g/l

3.54

3323

25775

Polyuria

1078

8080

1.38

19.90

7.8

8.0

120.95

121.79

g/l

0.69

1049

7769

Dislocation, sprain and strain of joint and ligaments of hip

199

1007

2.15

19.85

7.7

7.8

118.35

121.23

g/l

1.17

194

972

Other diseases of stomach and duodenum

326

1920

1.80

19.83

10.8

7.6

114.78

121.38

g/l

6.26

315

1854

Gestational [pregnancy-induced] hypertension

784

5540

1.44

19.79

6.3

7.5

121.19

120.35

g/l

0.58

752

5330

Fracture of forearm

2417

18655

1.23

19.74

8.4

7.7

118.67

120.84

g/l

6.11

2329

17985

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

123

516

2.69

19.72

10.1

7.0

117.33

121.37

g/l

1.31

117

502

Non-allergic asthma

431

2725

1.66

19.64

7.6

8.3

123.98

121.63

g/l

1.43

414

2615

Other and unspecified tonsillitis

1267

8192

1.33

19.62

9.3

9.4

126.02

124.95

g/l

0.96

1221

7889

Abnormal findings on examination of urine, without diagnosis

234

1256

2.01

19.53

9.5

8.6

118.40

121.82

g/l

1.57

228

1206

Sequelae of injuries of neck and trunk

167

797

2.29

19.47

13.2

9.5

120.35

123.11

g/l

0.94

161

770

Benign neoplasm: Descending colon

365

2238

1.75

19.40

7.7

8.0

117.94

121.30

g/l

2.44

352

2156

Lesion of radial nerve

200

1020

2.12

19.40

10.2

9.5

119.98

121.60

g/l

0.51

191

980

Voice disturbances

1167

8878

1.35

19.26

8.8

7.6

121.81

120.71

g/l

1.14

1135

8539

Secondary thrombocytopenia

324

3.22

19.22

13.3

8.7

108.88

121.66

g/l

6.99

312

Disorders of optic nerve and visual pathways

409

2567

1.66

19.12

9.1

8.5

121.01

122.28

g/l

0.60

391

2469

Exposure to other and unspecified inanimate mechanical forces

316

1860

1.79

19.08

8.6

9.2

121.40

124.37

g/l

1.59

303

1789

Mucosal proctocolitis

541

3611

1.55

19.07

8.9

8.7

119.88

123.97

g/l

4.64

524

3479

Other follicular disorders

308

1798

1.80

19.05

8.3

9.0

122.76

123.95

g/l

0.45

295

1732

Hidradenitis suppurativa

156

725

2.29

19.04

8.6

10.4

121.41

123.17

g/l

0.47

151

699

Other secondary gonarthrosis

283

1627

1.86

18.96

7.6

9.0

120.13

121.25

g/l

0.40

270

1561

Open wound of forearm

426

2708

1.64

18.95

7.6

8.3

120.74

123.14

g/l

1.56

417

2607

Cardiomyopathy, Hypertrophic obstructive

109

439

2.76

18.87

17.4

7.0

119.26

122.83

g/l

0.92

109

420

Problems related to social environment

143

646

2.39

18.85

6.9

7.9

122.93

120.27

g/l

0.71

135

622

Behavioural disorders

347

2.91

18.85

9.7

9.8

128.24

126.68

g/l

0.28

330

Diabetic retinopathy, strict definition

970

6352

1.40

18.85

13.0

9.4

113.35

122.78

g/l

35.22

933

6156

Inflammatory disease of uterus

476

3091

1.58

18.81

7.0

7.1

121.69

119.65

g/l

1.54

463

2972

Localized swelling, mass and lump of skin and subcutaneous tissue

1406

10996

1.31

18.80

7.8

8.1

121.10

121.27

g/l

0.11

1375

10589

Acute alcohol intoxication ICD-9

209

1100

2.06

18.67

7.7

8.5

123.34

123.00

g/l

0.08

204

1059

Inflammatory diseases of female pelvic organs

2266

14012

1.23

18.63

7.3

7.1

120.75

118.88

g/l

5.10

2191

13497

Hyperplasia of prostate

2117

9836

1.26

18.61

7.9

9.5

123.50

123.34

g/l

0.12

2027

9552

Correction of physiology of bite - demanding therapy visit

286

1645

1.82

18.60

8.0

8.8

124.88

122.20

g/l

1.47

272

1586

2038

15676

1.25

18.57

6.7

7.1

118.85

119.72

g/l

1.20

1962

15113

Disorders of speech understanding and production

169

801

2.19

18.56

11.4

8.4

121.83

122.89

g/l

0.24

158

771

Polyarthritis, unspecified

195

1001

2.10

18.54

8.3

118.25

122.26

g/l

1.93

186

964

Follicular cysts of skin and subcutaneous tissue

825

5997

1.42

18.49

8.4

121.94

122.13

g/l

0.09

797

5792

Other specified/unspecified hearing loss

407

2586

1.66

18.36

7.8

7.7

120.57

120.43

g/l

0.05

397

2485

Fracture at wrist and hand level

1483

11693

1.29

18.33

8.6

8.8

122.35

123.11

g/l

0.71

1416

11252

Impotence

309

1843

1.80

18.30

9.1

9.9

124.39

123.89

g/l

0.14

293

1786

Other disorders of binocular vision

240

3.38

18.28

4.0

9.4

126.06

122.68

g/l

0.76

231

Ptosis of eyelid

540

3661

1.55

18.17

9.0

7.9

120.72

120.06

g/l

0.32

524

3522

Spondylopathies in diseases classified elsewhere

312

3.18

18.06

8.3

8.1

112.27

120.22

g/l

2.90

306

Acute appendicitis, no complications

2433

20200

1.22

18.02

8.1

8.7

124.32

122.71

g/l

3.39

2352

19443

Weight loss

452

2953

1.60

18.00

8.2

7.9

118.48

120.97

g/l

1.80

431

2847

Benign neoplasm: Duodenum

162

796

2.28

17.96

9.2

8.1

116.88

120.36

g/l

1.31

156

768

Conjunctivitis (acute, non atopic)

1134

8636

1.34

17.95

7.8

8.2

122.62

121.98

g/l

0.47

1097

8309

Other disorders of bone

830

6063

1.41

17.87

8.1

8.3

123.25

122.95

g/l

0.15

798

5843

Cauda equina syndrome

319

3.09

17.78

11.5

10.1

121.51

121.56

g/l

0.01

306

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

132

588

2.38

17.74

13.2

10.6

119.86

123.79

g/l

1.13

125

570

Papulosquamous disorders

1794

14543

1.26

17.64

8.4

8.1

121.93

121.67

g/l

0.21

1737

14016

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

764

3524

1.43

17.59

6.8

7.4

121.70

122.07

g/l

0.19

737

3388

Malignant neoplasm of respiratory system and intrathoracic organs

1082

7597

1.35

17.57

8.7

7.1

120.11

120.04

g/l

0.04

1046

7315

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1358

10621

1.30

17.55

8.3

8.6

125.35

123.00

g/l

3.93

1317

10224

Other/unspecified rheumatoid arthritis

601

4181

1.50

17.53

7.7

7.3

115.75

119.80

g/l

5.44

576

4019

Benign neoplasm: Kidney

194

1020

2.08

17.53

6.7

7.8

122.01

120.13

g/l

0.69

187

990

135

616

2.38

17.52

8.7

10.7

126.22

122.39

g/l

1.17

130

597

Collagenous colitis

405

2597

1.63

17.50

9.4

7.9

117.87

121.04

g/l

2.50

394

2494

1454

10209

1.30

17.50

6.0

6.5

117.21

119.26

g/l

3.74

1408

9821

Varicose veins

3077

19776

1.19

17.43

7.1

7.7

120.34

120.66

g/l

0.38

2953

19046

Olecranon bursitis

326

1992

1.74

17.40

10.6

9.5

122.42

123.09

g/l

0.22

321

1917

Thrombocytopenia, unspecified

342

2113

1.71

17.39

11.4

8.5

112.85

121.78

g/l

11.02

330

2032

Benign neoplasm: Skin of eyelid, including canthus

624

4369

1.48

17.37

7.0

7.5

119.99

121.81

g/l

1.38

604

4193

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

223

1228

1.95

17.30

11.8

6.7

110.31

122.49

g/l

13.23

213

1187

Diffuse large B-cell lymphoma, helper endpoint

223

1228

1.95

17.30

11.8

6.7

110.31

122.49

g/l

13.23

213

1187

Vitamin B12 deficiency anaemia

531

3617

1.53

17.28

7.9

7.0

114.30

120.84

g/l

11.32

514

3479

Arthropod-borne viral fevers and viral haemorrhagic fevers

468

3110

1.57

17.26

7.6

8.8

123.50

122.93

g/l

0.22

448

2988

Asthma mixed form (mode), excluding more controls

203

1073

1.97

17.19

5.6

6.1

123.22

122.03

g/l

0.31

198

1025

Preparation and fitting of bite rail to mouth

544

3715

1.51

17.18

7.8

8.8

126.32

122.89

g/l

3.67

513

3586

Coxibs

1454

6068

1.30

17.14

6.9

8.8

123.34

120.13

g/l

6.51

1395

5832

148

715

2.30

17.06

8.3

8.4

121.75

118.81

g/l

0.94

142

695

Emotional disorders and disorders of social functioning with onset specific to childhood

140

636

2.25

17.04

8.9

9.5

125.45

125.10

g/l

0.07

135

612

Other obstetric conditions, not elsewhere classified

788

3679

1.41

17.02

6.9

7.4

121.58

122.12

g/l

0.32

761

3539

Alcoholic gastritis

104

434

2.72

17.00

10.4

9.0

123.36

122.77

g/l

0.08

104

421

Postprocedural disorders of nervous system

264

1521

1.80

16.95

6.0

8.9

125.44

123.12

g/l

1.12

253

1466

Other epidermal thickening

215

1175

1.96

16.95

8.4

8.9

121.23

121.29

g/l

0.01

209

1130

Crohn disease

536

3660

1.51

16.94

9.9

8.4

119.58

123.41

g/l

4.02

519

3529

Enthesopathies of lower limb, excluding foot

901

6721

1.37

16.93

7.7

8.7

123.37

121.31

g/l

2.20

880

6483

Abnormal findings on diagnostic imaging of central nervous system

203

1088

1.98

16.87

9.4

9.2

123.97

122.00

g/l

0.70

198

1050

Disturbance of activity and attention

270

1539

1.78

16.86

8.8

9.9

128.87

125.66

g/l

1.84

261

1482

Leiomyoma of uterus

1583

7081

1.28

16.80

7.2

7.3

119.78

120.97

g/l

1.59

1518

6801

Carbimazole or st.post thyroidectomy, condition for graves disease

826

6094

1.39

16.77

8.1

7.7

122.43

120.90

g/l

1.32

795

5858

Urticaria

1140

8802

1.32

16.68

8.0

123.15

121.62

g/l

1.71

1092

8469

Hyperkinetic disorders

290

1692

1.73

16.66

8.5

10.3

128.56

125.70

g/l

1.63

281

1626

Iridocyclitis

990

7531

1.35

16.42

7.7

7.9

119.92

121.87

g/l

2.24

954

7249

Dislocation, sprain and strain of joints and ligaments at neck level

570

3959

1.48

16.39

6.7

8.5

125.49

123.33

g/l

1.68

550

3811

Right bundle-branch block

172

882

2.09

16.37

13.2

7.3

122.17

121.63

g/l

0.13

167

844

Other disorders starting during childhood or adolecense, excluding more controls

118

495

2.37

16.35

9.6

122.42

124.89

g/l

0.55

112

480

Generalized epilepsy

179

929

2.03

16.24

8.4

9.2

122.88

123.02

g/l

0.03

170

902

Monoamine oxidase A inhibitors

531

3655

1.50

16.24

7.9

8.3

121.80

120.99

g/l

0.41

522

3513

Vitamin deficiency

225

1262

1.89

16.22

11.0

8.6

119.93

120.60

g/l

0.17

217

1211

Vitamin deficiency, wide

225

1262

1.89

16.22

11.0

8.6

119.93

120.60

g/l

0.17

217

1211

Normal-pressure hydrocephalus

274

1638

1.80

16.21

4.0

7.0

124.84

119.68

g/l

4.00

266

1568

Benign neoplasm of other and unspecified intrathoracic organs

308

3.07

16.19

11.2

7.8

118.53

120.67

g/l

0.43

300

Multiple myeloma and malignant plasma cell neoplasms

255

1494

1.84

16.19

7.8

7.4

106.54

120.96

g/l

24.36

246

1437

Other intracranial haemorrhages

179

942

2.07

16.15

9.4

7.6

116.67

120.31

g/l

1.51

174

904

Benign neoplasm of urinary organs

245

1419

1.85

16.09

6.9

8.0

122.43

120.39

g/l

0.89

235

1370

Other hammer toe(s) (acquired)

781

5392

1.40

16.09

7.0

7.5

119.08

119.30

g/l

0.12

745

5197

Specific development disorders of speech and language

210

1108

1.90

15.86

9.8

9.4

122.28

123.51

g/l

0.34

197

1068

Overexertion and strenuous or repetitive movements

441

2942

1.56

15.85

10.6

8.7

121.97

123.29

g/l

0.68

430

2835

Other shoulder lesions

383

2474

1.61

15.84

6.7

9.0

123.64

122.21

g/l

0.62

359

2376

Disorders of vestibular function (Vertigo)

2151

17838

1.22

15.79

6.4

7.7

122.58

120.20

g/l

6.79

2076

17197

Suggestive for eosinophilic asthma

425

2822

1.57

15.73

7.4

8.5

123.92

121.67

g/l

1.41

404

2719

Unknown and unspecified causes of morbidity

298

1816

1.70

15.66

5.8

8.2

124.62

122.52

g/l

0.94

288

1745

Injuries to the wrist and hand

4642

29685

1.14

15.61

8.6

8.3

123.35

121.83

g/l

5.13

4484

28618

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1279

10125

1.29

15.56

8.4

8.7

123.49

122.92

g/l

0.42

1235

9752

Viral haemorrhagic fevers, not elsewhere classified/unspecified

380

2472

1.61

15.54

7.8

9.0

124.30

122.89

g/l

0.59

361

2379

Occupational exposure to risk-factors

185

999

2.01

15.43

5.5

9.6

129.99

122.59

g/l

4.45

175

964

Dronedarone medication

151

760

2.16

15.39

7.6

6.9

126.48

121.01

g/l

2.41

145

729

Complications of other internal prosthetic devices, implants and grafts

188

1018

1.97

15.32

9.2

7.0

117.94

121.47

g/l

1.51

178

973

Trigeminal neuralgia

264

1576

1.76

15.26

6.9

9.0

123.92

119.94

g/l

2.67

251

1516

Other disorders of eye and adnexa

555

3898

1.47

15.20

8.2

8.0

121.84

121.66

g/l

0.07

539

3752

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

1123

7085

1.31

15.19

5.7

6.8

118.25

120.36

g/l

3.65

1079

6803

Actinic keratosis

1857

14591

1.24

15.17

6.7

6.8

118.66

119.60

g/l

1.29

1785

14067

Melanocytic naevi

1186

9331

1.30

15.14

7.4

8.1

120.69

121.58

g/l

0.77

1137

8981

Adult respiratory distress syndrome

335

2.85

15.13

25.0

10.5

113.58

120.36

g/l

1.92

326

Chronic nephritic syndrome

208

1169

1.91

15.12

11.8

9.1

110.65

123.20

g/l

13.23

203

1129

Adhesive capsulitis of shoulder

759

5627

1.39

15.12

7.8

8.5

121.50

121.05

g/l

0.23

731

5423

Other specified/unspecified systemic involvement of connective tissue

264

1581

1.76

15.11

9.1

8.3

118.97

120.36

g/l

0.56

251

1523

Other diseases of jaws

303

1877

1.69

15.09

10.4

7.9

119.57

123.08

g/l

2.18

294

1803

Abnormal weight loss

409

2722

1.57

15.08

8.5

8.0

118.89

120.97

g/l

1.23

390

2625

Sequelae of injuries of head

253

1502

1.78

15.04

13.7

9.4

121.71

123.94

g/l

0.83

238

1448

Skin changes due to chronic exposure to nonionizing radiation

1902

14938

1.23

15.03

6.7

6.9

118.75

119.64

g/l

1.19

1829

14402

Ingrowing nail

241

1410

1.80

14.99

7.1

9.2

118.38

123.63

g/l

3.26

235

1362

Carcinoma in situ of endometrium

123

4.58

14.98

3.1

6.9

123.68

119.42

g/l

0.67

118

Hypoparathyroidism

182

986

1.99

14.92

8.3

6.7

117.54

119.39

g/l

0.59

174

950

Other disorders of gingiva or/and edentulous alveolar ridge

233

1354

1.82

14.92

9.5

8.4

116.77

122.47

g/l

3.95

223

1303

Examination and encounter for administrative purposes

214

1216

1.87

14.88

6.6

7.8

124.99

122.13

g/l

1.18

202

1176

Unspecified nephritic syndrome

127

608

2.29

14.87

9.0

9.7

117.64

122.60

g/l

1.69

121

589

Internal derangement of knee

1660

13547

1.24

14.85

8.2

8.9

122.95

122.39

g/l

0.52

1601

13083

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

181

980

1.98

14.83

7.2

6.2

102.86

121.01

g/l

21.51

176

942

Other interventions on the root canals of the tooth

421

2.56

14.80

13.2

9.7

115.69

121.99

g/l

2.01

403

Metatarsalgia

384

2522

1.58

14.78

7.8

8.5

121.28

120.86

g/l

0.16

369

2423

Gingival hyperplasia

163

853

2.05

14.77

10.7

8.8

115.64

122.81

g/l

4.18

154

819

Fibroblastic disorders

1104

8649

1.31

14.76

8.7

8.2

119.99

121.13

g/l

1.05

1070

8343

Intussusception

114

523

2.38

14.75

7.3

7.8

116.51

119.38

g/l

0.88

103

504

Pleural plaque

514

3603

1.49

14.75

6.6

7.1

125.33

120.10

g/l

6.97

498

3467

IBD patients in KELA-register

928

7096

1.34

14.73

8.9

8.6

121.11

123.41

g/l

2.70

897

6841

Malignant neoplasm of head and neck

417

2806

1.56

14.70

11.1

8.1

115.50

121.51

g/l

7.61

402

2701

Diseases of inner ear

2534

21138

1.19

14.70

6.7

7.8

122.66

120.60

g/l

6.03

2442

20390

Other disorders of central nervous system

257

3.06

14.66

7.0

9.9

121.45

122.84

g/l

0.23

250

Early lumbar disc prolapse operation

372

2425

1.58

14.63

8.4

9.9

130.00

125.95

g/l

2.95

346

2338

Disorders of magnesium metabolism

191

3.63

14.54

12.4

7.3

106.09

120.33

g/l

6.76

183

Pre-eclampsia or eclampsia

699

5131

1.39

14.51

6.4

7.5

119.25

119.93

g/l

0.40

661

4934

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

193

1069

1.91

14.50

6.9

8.6

122.45

123.27

g/l

0.20

184

1033

Polymyalgia rheumatica

636

4638

1.42

14.37

7.1

6.8

116.53

119.59

g/l

3.83

619

4468

Heterophoria

311

1960

1.65

14.35

8.8

8.5

125.21

121.94

g/l

1.99

298

1880

Disorders of tooth development and eruption

177

925

1.93

14.31

15.1

8.5

116.91

125.92

g/l

5.97

170

898

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

246

3.16

14.30

16.3

6.0

111.96

123.70

g/l

4.81

240

Secondary parkinsonism+Parkinsonism in other disease

158

832

2.07

14.29

5.4

8.7

124.50

120.51

g/l

1.50

153

806

Gout due to impairment of renal function

300

2.97

14.26

8.1

8.4

114.13

120.27

g/l

1.46

293

Other ulcerative colitis

254

1530

1.74

14.19

9.6

8.8

120.67

124.07

g/l

1.77

243

1478

Pre-eclampsia

634

4598

1.41

14.19

6.3

7.6

119.26

120.20

g/l

0.57

597

4418

Non-follicular lymphoma

474

3296

1.50

14.17

10.6

7.8

111.78

121.14

g/l

17.96

455

3175

Thyroiditis, ILD-related definition

441

3006

1.51

14.14

9.0

7.7

121.20

120.66

g/l

0.22

432

2886

Other peripheral vascular diseases

337

2177

1.61

14.10

6.2

7.6

119.80

122.03

g/l

1.13

320

2096

Abnormal blood-pressure reading, without diagnosis

188

1042

1.90

14.04

6.8

7.7

121.65

120.78

g/l

0.23

179

994

Benign neoplasm of major salivary glands

403

2711

1.54

13.98

10.4

7.6

120.52

122.86

g/l

1.36

389

2600

Diabetic neuropathy

626

4569

1.43

13.98

10.1

9.9

114.80

121.40

g/l

11.89

609

4425

Acute suppurative otitis media

844

5972

1.34

13.94

9.5

9.0

124.63

124.21

g/l

0.22

819

5742

Benign neoplasm of mouth and pharynx

437

2988

1.51

13.91

8.1

7.9

121.03

123.00

g/l

1.17

427

2867

Other disorders affecting eyelid function

222

3.28

13.91

5.2

7.3

125.64

122.32

g/l

0.67

215

Cluster headache, wide,, including avohilmo

215

1244

1.81

13.90

8.0

9.8

126.92

123.82

g/l

1.23

204

1200

Acute and subacute iridocyclitis

826

6279

1.35

13.88

7.8

8.0

119.76

121.88

g/l

2.19

796

6046

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

170

924

1.98

13.88

8.5

7.2

113.92

121.16

g/l

5.77

162

893

Acquired absence of organs, not elsewhere classified

301

2.85

13.87

10.3

7.0

117.86

121.70

g/l

0.78

291

Mental retardation, wide definition

174

945

1.94

13.84

9.1

10.3

125.04

122.67

g/l

0.67

169

909

Convergence insufficiency and excess

252

2.95

13.81

6.2

7.8

123.44

121.60

g/l

0.28

242

Malignant neoplasm of stomach

266

1642

1.72

13.79

10.5

7.6

113.76

120.97

g/l

7.81

257

1579

Other enthesopathy of foot (+metatarsalgia)

404

2723

1.53

13.76

7.6

8.4

121.07

121.18

g/l

0.04

387

2615

Fitting and adjustment of other devices

1058

12455

0.78

13.76

7.0

6.9

120.56

121.07

g/l

0.35

1018

12014

Assault by other specified means

188

3.35

13.74

14.3

10.9

122.86

124.46

g/l

0.19

178

Benign neoplasm: Bronchus and lung

333

2.74

13.68

10.1

7.0

124.65

123.34

g/l

0.23

324

Cluster headache, strict, including avohilmo

200

1139

1.84

13.66

8.4

10.2

127.11

123.80

g/l

1.25

189

1097

Haemangioma and lymphangioma, any site

329

2127

1.60

13.62

6.3

8.3

121.10

123.20

g/l

1.09

321

2035

Secondary parkinsonism

154

818

2.05

13.61

5.5

8.8

124.12

120.34

g/l

1.35

149

792

Divergent concomitant strabismus

318

2043

1.62

13.60

8.5

8.7

123.29

122.64

g/l

0.21

305

1969

Haemangioma, any site

308

1963

1.63

13.58

6.4

8.3

121.26

123.04

g/l

0.80

300

1886

Emotional disorders starting during childhood or adolescence

127

615

2.11

13.43

9.3

9.6

125.44

125.07

g/l

0.07

122

589

Nail disorders

354

2339

1.57

13.41

9.2

9.0

118.68

122.96

g/l

3.26

342

2251

Inflammatory bowel disease, strict (require KELA)

928

7196

1.32

13.34

8.9

8.7

121.11

123.37

g/l

2.62

897

6937

Anterior Iridocyclitis

869

6693

1.33

13.30

7.8

8.1

119.81

121.85

g/l

2.14

838

6447

Urolithiasis

1559

12853

1.24

13.30

7.8

8.3

122.68

121.80

g/l

0.92

1500

12402

Other (seronegative) rheumatoid arthritis, wide

852

6553

1.33

13.27

8.3

7.4

116.76

120.30

g/l

5.67

821

6307

Dislocation, sprain and strain of joints and ligaments of knee

2529

20146

1.18

13.24

7.7

8.5

125.30

123.00

g/l

6.46

2431

19401

Lichen simplex chronicus and prurigo

296

1890

1.64

13.23

9.2

7.9

119.76

121.46

g/l

0.70

282

1810

Acute nasopharyngitis (common cold)

513

3624

1.45

13.21

8.0

9.8

126.52

126.09

g/l

0.16

493

3500

Other factor of the environment

308

2.76

13.20

8.5

8.2

118.36

122.44

g/l

0.85

297

Melanocytic naevi, other sites/unspecified

290

1836

1.64

13.18

6.6

8.4

120.41

123.69

g/l

1.79

278

1763

Malignant neoplasm of bronchus and lung

904

6558

1.32

13.18

8.4

7.0

120.51

119.79

g/l

0.54

875

6323

Toxic effect of alcohol

119

582

2.22

13.18

11.2

9.9

123.18

122.86

g/l

0.06

119

561

Hyperfunction of pituitary gland

190

1076

1.85

13.17

9.6

9.0

121.43

121.66

g/l

0.05

182

1036

Faecal incontinence

368

2462

1.55

13.13

6.8

6.6

117.97

118.99

g/l

0.48

352

2366

Vitamin D deficiency

367

2.54

13.12

8.9

9.8

123.84

121.34

g/l

0.44

351

Other hearing loss

1303

10379

1.26

13.08

7.2

119.77

119.80

g/l

0.02

1248

9993

Benign paroxysmal vertigo

1261

10188

1.26

13.06

6.6

7.6

122.45

119.94

g/l

4.62

1218

9809

Neovascular glaucoma

203

1183

1.82

13.05

7.8

8.0

115.97

120.90

g/l

2.59

196

1138

Salpingitis and oophoritis

673

5009

1.38

13.02

8.5

7.2

119.57

118.99

g/l

0.36

649

4806

Calculus of kidney and ureter

1437

11780

1.25

13.00

7.8

8.4

122.88

121.81

g/l

1.16

1380

11366

Progressive vascular leukoencephalopathy

178

1005

1.91

12.99

5.0

5.8

118.39

118.11

g/l

0.07

178

964

Femoral hernia

218

1297

1.78

12.98

9.2

7.9

123.16

120.79

g/l

0.91

210

1243

Hemiplegia

236

1430

1.73

12.98

10.9

8.6

123.94

121.14

g/l

1.35

229

1376

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

492

3483

1.45

12.96

7.3

8.2

124.63

123.35

g/l

0.68

473

3346

Alzheimer’s disease (Atypical or mixed)

414

2843

1.51

12.94

3.8

6.0

118.68

117.96

g/l

0.30

399

2736

Dermatitis due to substances taken internally

240

1461

1.72

12.93

9.5

7.9

119.22

121.19

g/l

0.78

232

1401

Paraplegia, diplegia of upper limbs

120

594

2.20

12.91

10.0

8.7

120.42

121.83

g/l

0.27

112

574

Pre-eclampsia or poor fetal growth

897

6921

1.31

12.91

7.8

7.5

119.16

120.49

g/l

1.22

851

6659

Meralgia paraesthetica

163

893

1.95

12.91

7.6

9.6

123.75

120.75

g/l

1.06

155

863

Hypothyroidism, strict autoimmune, 3 medication purchases required

3854

23203

1.14

12.90

7.6

7.8

120.65

120.82

g/l

0.21

3728

22359

Erectile dysfunction

444

3116

1.50

12.87

13.9

8.3

122.63

121.62

g/l

0.47

421

3001

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

146

775

2.03

12.84

6.6

6.4

103.60

121.07

g/l

15.64

141

750

Asthma mixed form (mode)

203

1179

1.79

12.80

5.6

6.4

123.22

121.24

g/l

0.62

198

1131

Panniculitis affecting regions of neck and back

175

982

1.88

12.68

10.0

9.4

122.34

121.77

g/l

0.13

166

946

Mixed connective tissue disease

276

1751

1.65

12.62

9.6

8.3

118.78

120.38

g/l

0.72

264

1690

Liposarcoma, excluding all cancers (controls excluding all cancers)

269

2.91

12.61

8.8

6.8

118.65

124.29

g/l

1.59

262

Personal history of other diseases and conditions

332

2171

1.56

12.59

11.0

7.2

117.82

123.19

g/l

5.27

326

2088

Parodontitis, under 40 years, or operation codes

236

1428

1.69

12.56

8.9

9.3

121.08

126.23

g/l

2.69

225

1362

Schizotypal disorder

105

496

2.26

12.51

6.5

10.8

123.24

124.12

g/l

0.15

100

480

Redundant prepuce, phimosis and paraphimosis

908

7058

1.31

12.48

9.6

10.1

125.87

125.71

g/l

0.07

871

6829

Malignant neoplasm of skin

3090

20338

1.16

12.46

6.7

7.7

119.38

120.39

g/l

2.01

2987

19604

Other/unspecified synovitis and tenosynovitis

476

3377

1.45

12.43

8.0

8.4

120.31

121.36

g/l

0.53

463

3243

Glaucoma secondary to other eye disorders

204

1208

1.79

12.41

7.8

8.6

116.04

120.68

g/l

2.38

197

1161

Parodontitis, under 40 years

235

1425

1.68

12.41

9.0

9.2

121.19

126.23

g/l

2.58

224

1359

Lymphoid leukaemia

245

1522

1.69

12.31

9.0

7.5

113.08

122.14

g/l

8.55

237

1469

Foreign body in alimentary tract

249

1554

1.68

12.28

8.4

8.9

121.72

122.17

g/l

0.12

241

1501

Wet age-related macular degeneration

820

6237

1.33

12.26

6.3

116.81

118.69

g/l

1.96

798

5993

Psoriasis

1239

10057

1.26

12.25

8.9

8.4

122.28

122.07

g/l

0.14

1205

9680

Other specified/unspecified dorsopathies

164

913

1.90

12.24

9.8

9.7

120.04

120.84

g/l

0.20

159

881

Other specified disorders of muscle

144

772

1.99

12.20

10.0

9.1

120.66

122.52

g/l

0.44

137

744

Other abnormal findings in urine

437

2.39

12.07

10.9

7.7

118.10

120.24

g/l

0.47

426

Keratitis

1476

12211

1.23

12.02

8.5

8.2

121.70

122.04

g/l

0.25

1430

11764

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

236

1468

1.71

11.99

8.7

7.4

115.82

120.43

g/l

2.94

225

1416

Seropositive rheumatoid arthritis, strict definition

653

4914

1.37

11.95

8.8

7.8

117.87

120.81

g/l

3.28

632

4728

Benign neoplasm: Parotid gland

323

2149

1.56

11.94

11.1

7.9

120.55

122.96

g/l

1.18

315

2063

Herpesviral [herpes simplex] infections

462

3288

1.45

11.91

8.5

8.1

119.69

121.95

g/l

1.61

451

3165

Superficial injury of forearm

369

2517

1.51

11.90

7.8

8.9

122.91

123.26

g/l

0.12

358

2424

994

7486

1.29

11.87

5.6

6.4

117.61

118.85

g/l

1.23

960

7192

Other neurotic disorders

238

1483

1.69

11.85

6.4

8.5

123.22

122.05

g/l

0.37

226

1425

Anankastic personality disorder

148

804

1.93

11.84

6.8

9.5

126.24

122.34

g/l

1.56

141

776

Colitis, primary sclerosing, strict definition

217

2.97

11.74

17.1

11.9

117.71

125.19

g/l

1.61

206

Non-small cell lung cancer, adenocarcinoma, helper endpoint

316

2111

1.58

11.73

9.4

7.3

121.13

120.39

g/l

0.29

304

2035

Non-small cell lung cancer, adenocarcinoma

316

2111

1.58

11.73

9.4

7.3

121.13

120.39

g/l

0.29

304

2035

Burns and corrosions

552

4056

1.40

11.72

9.0

9.1

123.09

123.67

g/l

0.25

536

3902

Melanocytic naevi of trunk

479

3444

1.43

11.68

7.8

8.4

119.32

122.43

g/l

2.63

462

3312

Other inflammation of eyelid

541

3972

1.40

11.64

7.3

8.1

121.40

120.80

g/l

0.29

523

3818

Other disorders of binocular movement

471

2.24

11.63

7.8

9.1

121.98

121.85

g/l

0.02

455

Embedded teeth, including avohilmo

272

1742

1.60

11.62

8.2

9.0

120.00

124.15

g/l

2.62

254

1684

Hydrocele

590

4399

1.38

11.59

8.5

9.1

121.96

122.80

g/l

0.39

562

4265

Third [oculomotor] nerve palsy

103

504

2.25

11.58

10.9

7.9

120.13

120.07

g/l

0.01

489

Persistent delusional disorders

333

2248

1.54

11.50

6.8

8.3

124.09

121.97

g/l

1.07

321

2157

Biomechanical lesions, not elsewhere classified

225

1396

1.70

11.47

6.8

8.5

122.64

120.84

g/l

0.65

220

1344

Chronic tubulo-interstitial nephritis

170

975

1.84

11.47

7.6

7.0

112.93

120.91

g/l

5.78

160

938

Biological medication for rheuma

567

4195

1.38

11.45

9.4

8.8

120.54

123.57

g/l

2.77

550

4044

Malnutrition

102

498

2.23

11.42

11.4

8.6

116.34

120.72

g/l

1.24

481

Basal cell carcinoma, including avohilmo

2818

19413

1.16

11.40

6.5

7.6

119.43

120.16

g/l

1.14

2720

18715

Basal cell carcinoma

2754

19173

1.16

11.36

6.5

7.5

119.32

120.14

g/l

1.34

2660

18479

Myocardial infarction, unclassifiable

1121

8095

1.26

11.35

8.2

6.9

120.18

119.87

g/l

0.19

1076

7787

Other retinal artery occlusion

133

718

2.02

11.31

7.9

8.3

115.50

120.09

g/l

1.91

127

689

Primary biliary cholangitis (PBC)

107

533

2.17

11.29

14.8

6.6

113.36

119.31

g/l

1.97

100

511

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

135

728

1.98

11.27

10.8

6.5

113.38

120.97

g/l

4.37

130

699

Acute laryngitis and tracheitis

366

2470

1.49

11.26

11.0

8.7

124.89

124.51

g/l

0.12

354

2380

Other and unspecified vascular occlusions

451

3243

1.45

11.26

6.8

7.0

118.81

120.31

g/l

0.81

434

3118

Injury of nerves and spinal cord at neck level

122

640

2.07

11.25

9.7

8.2

121.03

122.44

g/l

0.30

117

617

Speech disturbances, not elsewhere classified

388

2714

1.49

11.23

9.5

7.7

122.51

120.61

g/l

1.20

380

2612

L01XE Protein kinase inhibitors

279

1835

1.60

11.19

8.1

8.0

119.31

121.10

g/l

0.66

269

1769

Benign neoplasm of eye and adnexa

386

2695

1.48

11.16

7.7

118.29

122.42

g/l

3.66

369

2585

Malignant neoplasm of retroperitoneum and peritoneum

198

3.15

11.14

9.6

6.8

109.49

120.46

g/l

4.07

192

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2702

18640

1.16

11.13

6.6

7.5

119.20

120.13

g/l

1.56

2608

17969

Malignant neoplasm of endocrine gland

306

2046

1.56

11.12

7.6

8.7

123.25

121.18

g/l

0.98

292

1974

Fistulae involving female genital tract

417

2.33

11.10

7.9

8.5

112.45

119.03

g/l

2.45

404

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1626

15753

0.83

11.02

7.3

8.0

120.12

120.69

g/l

0.59

1564

15165

248

1578

1.63

10.99

5.9

6.3

121.69

119.48

g/l

1.01

242

1515

Lyme disease

678

8795

0.76

10.99

7.7

8.2

121.18

121.04

g/l

0.07

672

8471

Nontoxic multinodular goitre

852

6722

1.30

10.95

6.1

7.0

120.32

118.96

g/l

1.25

821

6473

Squamous cell neoplasms and carcinomas of the skin

586

4411

1.37

10.92

6.8

116.37

119.52

g/l

3.16

567

4246

Lactose intolerance

121

633

2.01

10.90

12.7

8.2

121.00

121.65

g/l

0.12

114

611

Superficial injury of ankle and foot

411

2907

1.45

10.89

8.3

8.8

123.42

123.66

g/l

0.08

396

2794

Other disorders of bladder

559

4180

1.38

10.85

8.0

8.3

121.38

121.70

g/l

0.14

544

4020

Malignant neoplasm of small intestine

124

665

2.04

10.85

5.6

8.7

117.00

121.21

g/l

1.30

116

646

Correction of physiology of bite - very demanding therapy visit

116

601

2.04

10.82

6.5

8.2

124.29

120.42

g/l

1.39

116

582

Parodontitis, operation under 40 years and operation codes

217

1338

1.65

10.80

9.3

9.0

120.87

126.12

g/l

2.56

206

1279

Thyrotoxicosis

978

7848

1.27

10.76

8.5

7.5

121.35

120.31

g/l

0.85

948

7558

Hypertrophic disorders of skin

216

1343

1.67

10.69

8.5

8.7

121.29

122.10

g/l

0.24

209

1294

Bell's palsy

483

3535

1.41

10.63

8.4

8.5

120.94

121.45

g/l

0.21

471

3400

Other Crohn's disease

271

1779

1.58

10.63

9.1

8.6

118.46

124.61

g/l

4.82

264

1716

Benign neoplasm of middle ear and respiratory system

370

2595

1.48

10.62

8.5

8.4

121.80

122.09

g/l

0.10

361

2498

Tumor necrosis factor alpha inhibitors

501

3683

1.39

10.58

9.4

8.9

120.10

123.79

g/l

3.40

485

3560

Other and unspecified injuries of lower leg

278

1836

1.57

10.58

6.9

8.6

121.02

122.54

g/l

0.58

269

1776

Diffuse brain injury

148

833

1.86

10.58

16.6

8.7

118.11

121.90

g/l

1.30

142

796

Parodontitis, under 40 years and operation codes

216

1338

1.65

10.56

9.3

9.0

121.00

126.12

g/l

2.45

205

1279

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

630

4800

1.34

10.50

8.3

8.9

121.48

123.54

g/l

1.66

607

4627

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

789

5942

1.30

10.47

6.6

6.5

117.39

119.85

g/l

3.45

772

5684

Peritonsillar abscess

801

6300

1.29

10.38

8.2

8.8

123.81

122.78

g/l

0.70

773

6064

Other spirochaetal diseases

692

8885

0.76

10.38

7.7

8.1

121.29

121.07

g/l

0.11

686

8558

Diabetes mellitus in pregnancy

809

4089

1.30

10.37

6.6

8.2

121.35

121.45

g/l

0.05

772

3942

Enteropathic arthropathies

101

507

2.12

10.35

7.0

11.6

120.91

122.31

g/l

0.30

492

Calcific tendinitis of shoulder

243

1569

1.61

10.35

6.4

9.7

122.06

121.97

g/l

0.02

230

1510

Anxious personality disorder

334

2.38

10.34

7.6

9.2

125.90

124.99

g/l

0.14

320

Pain associated with micturition

473

3472

1.40

10.25

7.1

8.0

121.17

121.07

g/l

0.04

449

3333

Parkinson's disease, including avohilmo

746

5856

1.31

10.22

5.6

7.4

121.68

119.94

g/l

1.52

713

5651

Psoriasis vulgaris

795

6277

1.30

10.18

9.0

8.7

122.06

122.19

g/l

0.06

772

6056

Acetic acid derivatives and related substances

1399

6039

1.22

10.18

7.2

8.8

122.64

120.05

g/l

4.49

1358

5803

Recurrent dislocation of patella

152

869

1.80

10.15

9.5

126.08

124.37

g/l

0.45

144

842

Lactose intolerance, other/unspecified

110

572

2.03

10.14

13.2

8.3

120.13

121.58

g/l

0.31

103

553

Oral leukoplakia and related diseases

267

1777

1.58

10.13

9.0

8.5

118.21

120.70

g/l

1.18

262

1715

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

267

1771

1.57

10.11

7.1

8.2

124.95

123.65

g/l

0.45

255

1709

Other noninflammatory disorders of uterus, except cervix

942

5153

1.27

10.02

6.2

7.1

119.55

117.40

g/l

2.86

910

4966

Erosion of teeth, including avohilmo

712

5353

1.31

10.00

11.6

7.8

121.67

123.19

g/l

1.07

689

5150

Thyrotoxicosis, other and/or unspecified

757

5951

1.30

9.96

8.9

7.5

121.39

120.56

g/l

0.51

733

5729

Restless leg syndrome

501

3733

1.38

9.94

6.9

8.1

121.07

120.85

g/l

0.09

487

3591

Benign neoplasm: Bronchus and lung

386

2.33

9.88

10.1

7.4

124.65

120.81

g/l

0.98

375

Nummular dermatitis

366

2598

1.46

9.84

9.8

8.0

119.53

122.17

g/l

1.57

354

2494

Temporomandibular joint disorders, including avohilmo

1433

12023

1.20

9.82

6.4

8.0

122.80

121.27

g/l

2.27

1386

11561

Crohn's disease NAS

256

1692

1.57

9.79

8.1

8.6

119.18

124.07

g/l

3.34

249

1630

Other benign neoplasms of skin

1643

14004

1.19

9.76

6.8

7.6

120.77

120.65

g/l

0.08

1582

13489

Dental caries 2, only avohilmo

2460

22120

0.87

9.76

8.1

8.6

122.65

122.44

g/l

0.20

2389

21301

Diffuse large B-cell lymphoma

223

1443

1.64

9.74

11.8

7.7

110.31

121.03

g/l

10.90

213

1387

Burns and corrosions of external body surface, specified by site

426

3100

1.41

9.73

8.9

9.0

122.17

123.67

g/l

0.72

412

2987

Marasmic kwashiorkor

5.83

9.73

16.9

6.2

116.76

121.85

g/l

0.44

Disorders of vitreous body and globe

2275

19383

1.16

9.71

8.0

7.9

119.57

120.45

g/l

1.29

2202

18702

Hypertrophic scar

197

1228

1.66

9.70

8.3

8.8

121.81

122.00

g/l

0.04

190

1184

Prurigo nodularis

125

694

1.94

9.70

8.7

8.0

115.68

119.56

g/l

1.38

120

670

Entropion and trichiasis of eyelid

404

2929

1.43

9.68

7.0

7.1

117.69

119.48

g/l

1.08

395

2815

Lateral epicondylitis

518

3890

1.36

9.61

6.7

9.0

125.71

122.00

g/l

3.88

491

3740

Covid-19 suspected case

692

5397

1.30

9.60

9.3

7.9

122.44

122.63

g/l

0.09

681

5185

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

208

1322

1.64

9.56

7.3

6.7

120.60

121.37

g/l

0.21

202

1281

Chronic rhinitis, nasopharyngitis and pharyngitis

1267

10572

1.22

9.52

8.9

8.2

124.00

121.08

g/l

5.73

1236

10182

Coeliac disease

462

3418

1.39

9.49

8.0

7.9

119.27

122.27

g/l

2.37

442

3289

Other diseases of peritoneum

200

1264

1.66

9.49

6.2

8.0

121.12

120.26

g/l

0.25

188

1221

Opening and dilatation of root channel of tooth

244

1609

1.57

9.45

11.0

8.8

119.87

124.03

g/l

2.35

239

1548

Acute pharyngitis

492

3643

1.37

9.44

9.4

9.2

125.62

124.47

g/l

0.59

476

3524

Mouth breathing

1803

15510

1.18

9.43

8.0

8.9

125.32

122.82

g/l

5.39

1736

14953

Intermittent heterotropia

189

1173

1.66

9.40

13.1

9.1

123.90

121.99

g/l

0.58

184

1131

Tuberculosis, IBD comorbidity

338

2385

1.47

9.39

8.3

7.1

119.34

120.32

g/l

0.38

325

2299

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

221

2.74

9.34

8.5

9.3

116.93

122.26

g/l

1.32

216

Vascular dementia (mixed)

421

2.21

9.31

5.8

6.6

117.87

118.07

g/l

0.03

403

Injury of muscle and tendon at shoulder and upper arm level

1679

14406

1.18

9.31

7.6

8.6

122.89

122.42

g/l

0.40

1614

13899

Disorders of refraction and accommodation

930

7511

1.25

9.29

9.4

8.3

123.09

122.23

g/l

0.63

901

7217

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

303

2.44

9.24

13.2

6.1

113.61

121.86

g/l

3.11

298

Other disorders of veins

1610

13747

1.19

9.24

8.0

7.7

120.31

120.61

g/l

0.23

1573

13252

Carcinoma in situ of rectum

257

2.67

9.18

9.6

7.9

115.94

120.31

g/l

0.98

250

Acute generalized exanthematous pustulosis

189

1188

1.67

9.16

10.3

8.5

118.46

120.08

g/l

0.51

181

1148

Menorrhagia

1338

6177

1.21

9.15

7.3

7.5

120.36

117.98

g/l

4.38

1286

5952

Sequelae of injuries of upper limb

398

2898

1.41

9.15

8.8

9.0

121.90

123.53

g/l

0.78

369

2788

Crohn's disease of large intestine

205

1311

1.62

9.14

10.6

8.6

117.46

123.81

g/l

4.59

197

1270

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

699

5505

1.29

9.11

8.8

9.0

121.54

123.44

g/l

1.62

675

5306

Memory loss

425

3139

1.40

9.11

6.9

7.5

119.41

119.90

g/l

0.20

409

3022

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

365

2.30

9.10

4.2

6.7

119.75

123.24

g/l

0.70

356

Carcinoma in situ of breast, intraductal

269

1824

1.52

9.08

6.2

7.3

117.95

120.15

g/l

1.20

257

1749

Dissection of cerebral arteries, nonruptured

177

2.93

9.01

8.6

8.4

119.42

122.25

g/l

0.38

170

Retinal detachments and breaks

1618

13878

1.18

9.00

8.1

7.8

119.52

121.28

g/l

2.87

1562

13372

Seronegative rheumatoid arthritis

479

3598

1.37

8.98

8.4

7.7

117.61

120.79

g/l

3.10

465

3463

Melanocytic naevi of other and unspecified parts of face

205

1315

1.61

8.98

6.0

7.8

124.19

123.16

g/l

0.31

195

1262

Meningitis

209

1351

1.61

8.97

9.4

9.6

120.57

122.54

g/l

0.71

200

1302

Schizoid personality disorder

467

2.10

8.95

6.2

9.9

125.60

123.66

g/l

0.44

454

Tuberculosis, wide

347

2485

1.44

8.89

8.2

7.2

119.32

120.15

g/l

0.31

334

2393

Papillary adenocarcinoma of thyroid gland

217

1419

1.60

8.88

8.2

8.3

122.35

120.24

g/l

0.78

210

1373

Other benign neoplasms of connective and other soft tissue

409

3008

1.40

8.87

7.7

8.4

122.08

121.89

g/l

0.07

393

2899

Lifestyle-related condition

283

2.45

8.82

8.8

8.0

117.20

121.93

g/l

0.95

272

Other and unspecified mononeuropathies, also in other diseases

139

817

1.80

8.82

7.8

8.1

119.26

120.61

g/l

0.29

132

790

Pedestrian injured in transport accident

284

1963

1.50

8.81

9.1

8.7

119.81

122.39

g/l

1.31

275

1890

Need for immunization against other single viral diseases

101

541

2.01

8.81

14.5

10.2

109.73

123.76

g/l

10.13

101

528

Disorders of vitreous body

2197

18877

1.15

8.81

8.1

7.9

119.52

120.47

g/l

1.38

2128

18213

Crushed, pushed or stepped on by crowd or human stampede

243

1623

1.54

8.80

8.4

9.5

123.66

125.42

g/l

0.64

233

1565

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

570

4402

1.33

8.79

7.0

7.7

120.28

122.63

g/l

2.02

552

4229

Other and unspecified urticaria

696

5503

1.29

8.76

8.6

8.0

123.14

121.75

g/l

1.01

666

5298

Excessive vomiting in pregnancy

236

1566

1.54

8.74

4.7

7.5

122.62

120.40

g/l

1.11

227

1513

Contact with heat and hot substances

213

1390

1.59

8.74

7.9

9.6

121.23

123.57

g/l

0.84

206

1341

Ehlers-Danlos syndrome

132

3.10

8.74

6.4

8.7

125.16

119.81

g/l

0.86

127

Thyrotoxicosis with toxic multinodular goitre

256

1741

1.53

8.73

6.7

7.1

120.63

118.89

g/l

0.69

249

1684

Malignant neoplasm of thyroid gland

277

1912

1.50

8.70

7.4

8.9

123.86

120.98

g/l

1.49

266

1847

Ulcerative colitis (strict definition, require KELA)

640

5023

1.30

8.61

8.5

9.0

121.48

123.49

g/l

1.62

616

4841

Spondylopathies (FG)

512

3903

1.34

8.57

7.5

8.8

121.37

123.17

g/l

1.17

493

3764

Adenocarcinoma and ductal carcinoma of pancreas

170

1067

1.70

8.54

8.5

8.0

113.92

120.55

g/l

5.12

162

1029

Psoriatic and enteropathic arthropathies

454

3408

1.36

8.54

7.5

8.8

122.41

122.63

g/l

0.08

439

3289

Fissure and fistula of anal and rectal regions

984

8113

1.23

8.48

8.2

8.0

121.83

122.70

g/l

0.66

949

7791

Convalescence

214

1409

1.58

8.45

18.1

7.7

116.60

122.42

g/l

3.96

202

1365

Superficial injury of wrist and hand

689

5469

1.28

8.40

8.7

8.8

125.03

122.61

g/l

2.30

670

5261

Parkinson's disease

703

5621

1.28

8.36

5.4

7.5

121.77

119.92

g/l

1.60

672

5420

Generalized epilepsy, mode (most common among epilepsy diagnosis)

120

684

1.83

8.34

8.0

9.1

122.78

122.28

g/l

0.11

113

666

Other/unspecified enthesopathies of lower limb, excluding foot

257

1759

1.50

8.31

7.2

9.1

120.95

121.53

g/l

0.18

252

1694

Sixth [abducent] nerve palsy

156

963

1.71

8.31

8.1

8.5

119.17

121.00

g/l

0.52

150

929

Benign neoplasm: Skin of other and unspecified parts of face

407

3022

1.38

8.28

5.7

7.4

122.52

121.93

g/l

0.24

387

2901

Contusion of other and unspecified parts of foot

164

1017

1.67

8.28

7.8

10.0

122.33

123.84

g/l

0.43

159

978

Central retinal artery occlusion

117

672

1.87

8.24

9.4

8.5

117.26

119.52

g/l

0.60

112

647

Isolated proteinuria

133

789

1.78

8.21

8.8

9.1

118.31

122.17

g/l

1.14

133

759

Lesion of sciatic nerve

215

1432

1.57

8.18

6.3

7.0

122.88

119.68

g/l

1.44

205

1371

Mental and behavioural disorders due to hallucinogens

3.61

8.18

4.3

14.1

133.86

130.29

g/l

0.51

Nontoxic goitre/thyroid nodule

1220

10306

1.20

8.17

5.9

7.2

120.30

119.07

g/l

1.38

1177

9919

Acne

263

1807

1.48

8.14

10.7

9.4

123.04

125.10

g/l

0.80

254

1737

Generalized skin eruption due to drugs and medicaments

165

1035

1.67

8.13

10.2

8.3

117.91

120.59

g/l

0.94

158

1002

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

143

845

1.71

8.11

9.5

10.8

123.44

125.93

g/l

0.64

137

814

Any dementia, excluding more controls

1626

9733

1.18

8.11

5.0

6.8

119.84

119.17

g/l

0.66

1576

9367

Endometriosis

1268

6346

1.20

8.10

6.2

7.5

120.79

118.13

g/l

5.38

1220

6114

Postmenopausal atrophic vaginitis

699

5263

0.79

8.09

6.3

7.6

119.77

117.73

g/l

2.14

682

5074

Blepharochalasis

1276

10840

1.20

8.08

6.7

7.5

121.51

119.35

g/l

3.43

1222

10438

Tooth eruption problems

356

2561

1.40

8.05

9.5

8.7

120.31

123.74

g/l

2.42

333

2478

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

292

2060

1.45

8.04

7.1

7.5

119.05

119.92

g/l

0.31

281

1983

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

193

1260

1.60

8.02

6.9

9.3

122.45

121.53

g/l

0.23

184

1220

Plantar fascial fibromatosis

367

2696

1.40

7.99

7.0

8.6

121.36

121.11

g/l

0.09

357

2592

Fourth [trochlear] nerve palsy

112

640

1.87

7.99

8.0

7.9

120.54

120.22

g/l

0.06

112

618

Postmenopausal bleeding

1165

5357

1.21

7.96

6.7

7.5

119.54

117.56

g/l

2.99

1121

5161

Intentional self-harm by jumping from a high place

3.45

7.93

22.2

13.7

116.97

124.80

g/l

1.13

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

161

1011

1.67

7.90

9.1

8.3

119.73

122.83

g/l

0.95

154

971

Infective bursitis

145

892

1.72

7.88

10.5

9.6

120.33

123.20

g/l

0.84

139

856

Alzheimer’s disease (Late onset), excluding more controls

648

3418

1.29

7.87

3.8

6.3

121.08

117.80

g/l

3.77

633

3278

Acute lymphadenitis

215

1437

1.54

7.86

9.3

9.1

122.69

123.21

g/l

0.13

209

1387

Supervision of normal pregnancy

323

2564

0.71

7.83

5.6

9.1

123.21

121.27

g/l

1.14

315

2481

Viral infections of the central nervous system

280

1976

1.46

7.79

7.6

8.7

123.49

122.53

g/l

0.32

273

1905

Ocular pain

291

2067

1.45

7.78

8.2

8.6

122.38

121.71

g/l

0.23

284

1987

Adalimumab

313

2250

1.43

7.77

9.2

9.1

121.14

124.33

g/l

1.70

303

2175

Ovarian dysfunction

182

1171

1.59

7.77

6.8

6.9

125.11

120.88

g/l

2.50

175

1133

Other keratitis

419

3156

1.36

7.76

9.2

8.3

121.38

122.97

g/l

0.85

408

3044

Benign neoplasm: Choroid

223

1513

1.53

7.71

7.1

7.2

118.05

122.20

g/l

2.30

213

1455

Otitis externa

854

7017

1.24

7.71

7.7

8.2

123.34

121.80

g/l

1.41

828

6752

Other and specified injuries of hip and thigh

102

573

1.89

7.65

5.5

8.6

120.41

121.41

g/l

0.20

556

Dislocation, sprain and strain of joints and ligaments of thorax

135

819

1.73

7.62

6.9

9.4

126.08

122.63

g/l

1.09

129

791

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1033

8647

1.21

7.59

8.0

8.8

125.11

122.82

g/l

2.98

1006

8328

Acne vulgaris

203

1345

1.54

7.59

10.7

9.2

123.60

125.71

g/l

0.69

195

1293

Adenocarcinoma and papillary adenocarcinoma of stomach

135

823

1.73

7.57

10.8

7.4

113.38

120.25

g/l

3.84

130

791

Lichen simplex chronicus

155

977

1.67

7.57

9.7

8.1

120.88

122.00

g/l

0.26

148

942

Acute bronchiolitis

158

888

1.64

7.53

8.6

9.8

122.72

123.63

g/l

0.20

152

862

Suppurative and unspecified otitis media

1218

9154

1.19

7.53

9.0

8.5

123.81

123.04

g/l

0.60

1173

8809

Other and unspecified intracranial injuries

131

792

1.74

7.52

9.3

9.1

121.97

122.13

g/l

0.03

125

767

Crohn's disease of small intestine

254

1773

1.48

7.50

9.3

8.7

120.35

123.95

g/l

1.87

248

1709

Inguinal or femoral hernia, bilateral

502

3909

1.32

7.48

8.0

8.3

122.74

122.82

g/l

0.03

486

3754

Allergic urticaria

284

2022

1.44

7.47

7.3

8.6

121.16

121.63

g/l

0.14

269

1946

Use of levodopa decarboxylase inhibitor

604

4819

1.29

7.39

5.5

7.3

121.35

119.75

g/l

1.16

581

4643

Acute nephritic syndrome

101

572

1.88

7.39

6.6

9.9

116.59

122.17

g/l

1.68

549

Ulcerative colitis (strict) with PSC

158

2.77

7.38

17.6

8.3

118.37

125.73

g/l

1.11

148

Seborrhoeic dermatitis

403

3049

1.36

7.36

8.9

7.8

123.13

122.68

g/l

0.15

384

2937

Sicca syndrome [Sjögren]

334

2456

1.40

7.34

8.4

7.7

117.26

119.20

g/l

1.12

323

2365

Perforation of tympanic membrane

397

2999

1.36

7.29

9.5

7.9

121.56

122.00

g/l

0.17

377

2891

Hypertension, portal

3.92

7.28

11.0

7.9

105.80

122.60

g/l

2.40

Inguinal hernia, bilateral

493

3845

1.32

7.28

7.9

8.3

122.75

122.89

g/l

0.05

477

3694

199

2.45

7.25

6.6

8.7

121.67

126.51

g/l

0.89

192

Pilonidal cyst

295

2126

1.42

7.21

10.2

9.7

129.18

126.68

g/l

1.09

287

2045

Other and unspecified mononeuropathies of upper limb

125

758

1.73

7.10

7.3

10.2

121.51

121.87

g/l

0.06

118

736

Spontaneous rupture of synovium and tendon

336

2494

1.39

7.00

7.7

8.6

122.30

121.30

g/l

0.38

325

2395

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

128

785

1.71

6.99

8.1

8.0

111.54

123.22

g/l

6.24

121

762

Atopic dermatitis, strict definition with reimbursement

939

7605

1.21

6.98

7.6

8.3

122.89

122.99

g/l

0.05

910

7314

183

2697

0.66

6.97

12.1

8.1

113.80

122.15

g/l

4.74

178

2602

Excessive attrition of teeth

1552

7293

1.17

6.97

8.2

7.6

122.69

122.60

g/l

0.06

1506

7021

Benign neoplasm of ovary

645

5207

1.26

6.97

6.5

6.8

118.16

118.52

g/l

0.20

624

5011

Other disorders of white blood cells

231

1613

1.49

6.97

10.6

8.6

115.50

121.43

g/l

3.94

220

1555

Single delivery by forceps and vacuum extractor

195

1759

0.67

6.96

6.1

9.5

120.01

121.18

g/l

0.35

189

1708

Other disorders starting during childhood or adolescence

119

704

1.71

6.94

9.8

10.4

122.37

125.56

g/l

0.82

113

678

Glucosamine medication

2365

16887

1.13

6.94

6.7

7.5

119.31

119.62

g/l

0.32

2295

16273

Disease of hard tissues of teeth, NOS

232

2.38

6.93

15.9

8.7

115.41

122.82

g/l

1.62

225

Preterm labour and delivery

790

6503

1.23

6.93

6.6

7.9

121.55

119.75

g/l

1.98

765

6247

Special screening examination for other diseases and disorders

299

2175

1.40

6.91

11.1

7.0

117.07

122.01

g/l

4.00

283

2099

Hallux rigidus

575

4592

1.28

6.88

7.6

8.3

120.29

120.10

g/l

0.08

558

4432

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

281

2030

1.42

6.88

6.6

8.6

124.47

122.78

g/l

0.69

266

1944

Superficial injury of shoulder and upper arm

431

3320

1.33

6.88

6.1

7.9

122.74

122.61

g/l

0.04

418

3198

Neuroendocrine tumor and carcinoma of small intestine

407

2.04

6.85

4.2

7.9

119.75

121.44

g/l

0.28

397

Oral leukoplakia and related diseases, including avohilmo

371

2808

1.36

6.84

8.6

8.2

119.88

121.65

g/l

0.90

364

2709

Corneal ulcer

697

5690

1.25

6.77

7.8

8.2

122.19

122.54

g/l

0.17

674

5484

Striking against or struck by other objects

1238

10628

1.18

6.77

9.2

9.0

123.58

123.62

g/l

0.02

1190

10240

Benign neoplasm of bone and articular cartilage

271

1950

1.42

6.75

8.2

8.5

122.18

124.55

g/l

1.13

262

1876

Ulcerative enterocolitis

126

778

1.69

6.67

11.0

8.8

116.57

122.82

g/l

2.51

121

750

Parkinson's disease, strict definition

639

5195

1.26

6.65

5.5

7.2

121.61

119.89

g/l

1.33

610

5007

Lymphoid leukaemia

245

1747

1.46

6.64

9.0

8.0

113.08

121.75

g/l

8.08

237

1683

Epidermolysis bullosa

6.76

6.63

19.9

7.0

116.92

121.41

g/l

0.34

Synovial cyst of popliteal space [Baker]

298

2191

1.40

6.62

8.7

8.3

121.84

120.86

g/l

0.37

293

2102

Thyroiditis

256

1835

1.43

6.59

8.5

8.3

122.94

120.58

g/l

1.23

250

1774

Malignant melanoma, excluding all cancers (controls excluding all cancers)

658

5362

1.25

6.57

7.1

7.7

120.50

122.63

g/l

1.95

637

5157

Nosocomial condition (hospital)

145

2.80

6.55

8.0

6.7

112.53

120.17

g/l

1.58

140

Special screening examination for neoplasms

188

1277

1.53

6.53

9.8

7.7

122.45

122.10

g/l

0.08

181

1237

Liposarcoma

229

2.42

6.50

9.0

7.9

118.61

121.91

g/l

0.60

222

Alzheimer’s disease, wide definition, excluding more controls

669

3698

1.25

6.47

4.3

6.4

121.02

118.06

g/l

3.39

653

3549

Erythema multiforme

100

588

1.79

6.45

8.1

8.6

119.85

121.08

g/l

0.22

570

conjunctival haemorrhage

319

2386

1.38

6.44

9.7

7.9

118.83

120.82

g/l

0.96

307

2298

Pedal cyclist injured in transport accident

831

6938

1.22

6.42

7.8

8.5

122.77

g/l

0.00

793

6688

Chondrocostal junction syndrome [Tietze]

146

944

1.61

6.41

7.3

8.6

124.77

120.04

g/l

2.30

141

911

Exposure to excessive natural heat

4.34

6.36

7.3

7.9

120.42

121.83

g/l

0.10

Carcinoma in situ of skin

320

2399

1.38

6.36

6.6

6.4

117.23

121.09

g/l

2.74

308

2309

Benign lipomatous neoplasm

1245

10770

1.17

6.33

7.4

8.2

123.50

121.07

g/l

4.12

1195

10367

Malignant neoplasm of palate, excluding all cancers (controls excluding all cancers)

148

2.72

6.28

10.9

6.7

117.39

122.82

g/l

0.73

143

Malignant neoplasm of pancreas

275

2020

1.41

6.27

7.7

7.4

114.12

120.31

g/l

6.56

265

1941

Injury of muscle and tendon at wrist and hand level

560

4515

1.27

6.22

8.3

9.2

123.62

123.25

g/l

0.15

541

4351

Background retinopathy and retinal vascular changes

573

1.80

6.22

11.9

9.0

115.98

120.53

g/l

1.11

557

Otitis externa, unspecified

395

3051

1.32

6.21

7.2

8.4

124.85

122.63

g/l

1.47

381

2938

Tuberculosis

280

2063

1.40

6.19

8.3

7.3

119.51

119.94

g/l

0.13

270

1983

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

167

1122

1.55

6.19

10.3

6.5

110.65

122.27

g/l

9.81

156

1079

Other and unspecified disorders of white blood cells

171

1156

1.54

6.17

9.6

9.2

115.45

120.60

g/l

2.27

162

1117

Presbycusis

609

4942

1.25

6.11

6.0

6.4

117.58

118.35

g/l

0.42

573

4769

Other and unspecified psoriasis

276

2038

1.40

6.06

11.4

9.0

121.17

122.07

g/l

0.29

269

1962

Rash and other nonspecific skin eruption

377

2907

1.33

6.06

8.2

8.4

119.31

120.90

g/l

0.80

367

2796

Hypermetropia

241

1735

1.42

6.05

7.5

8.3

122.05

122.16

g/l

0.03

230

1669

UC patients in KELA-register (code 208), prior to 1994

198

1384

1.49

6.04

11.0

9.0

119.99

122.44

g/l

0.85

190

1335

Achilles tendinitis

398

3093

1.31

6.01

8.9

9.4

125.12

121.47

g/l

2.68

390

2978

Maternal care for other conditions predominantly related to pregnancy

505

3970

1.27

6.00

8.8

8.1

121.45

120.74

g/l

0.37

483

3832

Medial epicondylitis

146

958

1.58

5.99

6.1

10.4

127.06

122.69

g/l

1.61

141

917

Use of ropinirole

175

1202

1.53

5.98

5.5

8.9

124.39

121.08

g/l

1.43

166

1159

Dermatographic urticaria

220

1566

1.44

5.91

5.5

8.8

124.34

121.60

g/l

1.21

208

1508

Postzoster neuralgia

419

1.93

5.91

7.4

7.6

114.57

120.19

g/l

1.72

403

Other and/or unspecified nontoxic goitre

322

2442

1.35

5.88

6.1

7.4

119.74

119.15

g/l

0.22

317

2345

Anti-inflammatory and antirheumatic products, non-steroids

1419

6213

1.16

5.84

8.3

8.8

122.39

120.20

g/l

3.23

1366

5975

Bullous disorders

241

1755

1.42

5.81

7.1

8.1

117.13

120.59

g/l

1.82

235

1686

Reactive arthropathies, FINNGEN

260

1911

1.39

5.80

10.7

9.1

119.30

123.47

g/l

2.55

252

1838

Degeneration of nervous system due to alcohol

116

735

1.68

5.78

10.7

9.9

117.91

122.75

g/l

1.58

116

706

Reactive arthropathies

332

2532

1.34

5.77

10.7

9.0

119.47

122.85

g/l

2.21

324

2430

Disorders of conjunctiva

3410

26243

1.09

5.74

8.3

8.1

121.56

121.55

g/l

0.01

3308

25285

Degeneration of the brain due to alcohol

116

737

1.67

5.72

10.7

10.4

117.91

122.46

g/l

1.44

116

706

Benign neoplasm: Anus and anal canal

117

741

1.65

5.71

6.9

6.6

115.93

121.99

g/l

2.69

111

718

Ganglion

749

6264

1.21

5.70

7.0

8.4

122.72

121.33

g/l

1.02

724

6038

Cysts of oral region, not elsewhere classified

179

1241

1.49

5.67

7.1

8.5

122.74

123.89

g/l

0.26

169

1193

Bronchitis, not specified as acute or chronic

328

2506

1.34

5.64

8.6

8.5

122.22

121.42

g/l

0.29

316

2415

Autoimmune hyperthyroidism

208

1481

1.44

5.61

7.9

7.6

122.64

121.17

g/l

0.48

197

1423

Atrophic disorders of skin

510

4119

1.26

5.59

6.2

7.6

120.79

120.42

g/l

0.17

488

3958

Enduring personality changes

3.17

5.56

11.5

13.4

119.96

125.53

g/l

0.66

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

266

1973

1.38

5.55

8.2

9.7

124.97

124.38

g/l

0.17

258

1904

Visual impairment including blindness (binocular or monocular)

261

1937

1.39

5.54

9.6

7.5

118.21

120.14

g/l

0.87

253

1862

Vascular dementia

344

2567

1.32

5.49

5.3

6.1

118.81

117.89

g/l

0.36

331

2474

Infections of genitourinary tract in pregnancy

272

2029

1.36

5.45

6.6

7.7

121.25

119.60

g/l

0.74

264

1962

Atopic conjunctivitis

150

1010

1.53

5.45

5.7

8.5

126.54

122.25

g/l

1.69

145

978

Polycystic ovarian syndrome, broad definition

229

1659

1.40

5.44

7.6

6.6

127.09

120.87

g/l

5.68

222

1596

SLE (Finngen)

127

827

1.59

5.44

7.9

7.2

115.22

120.38

g/l

2.12

122

793

Hepatomegaly and splenomegaly, not elsewhere classified

237

2.19

5.42

16.2

8.7

112.27

121.72

g/l

2.14

228

Other and unspecified injuries of wrist and hand

137

908

1.56

5.41

6.8

8.7

124.84

122.03

g/l

0.77

128

869

Cardiomyopathies, Secondary/extrinsic

127

2.67

5.41

23.3

7.2

125.55

122.19

g/l

0.35

122

Female genital prolapse

1148

5734

1.17

5.40

5.7

7.4

119.39

117.78

g/l

2.18

1095

5526

Carcinoma in situ of cervix uteri

197

1395

1.43

5.38

7.1

7.0

119.72

121.64

g/l

0.73

189

1338

Lichen planus

517

4208

1.25

5.37

6.9

8.0

120.87

120.53

g/l

0.14

495

4041

Atypical facial pain

187

1323

1.46

5.31

7.0

8.6

123.87

120.12

g/l

1.84

181

1276

Noninflammatory disorders of female genital tract

1517

6723

1.14

5.31

6.5

7.4

119.98

118.25

g/l

2.90

1461

6479

Inflammatory disorders of breast

180

1262

1.46

5.27

6.8

7.5

119.99

120.36

g/l

0.09

172

1218

Other specified and unspecified retinal disorders

150

1024

1.53

5.25

6.9

8.5

120.56

121.07

g/l

0.11

145

987

Other acquired deformities of musculoskeletal system and connective tissue

191

1362

1.45

5.24

8.3

9.0

125.05

122.88

g/l

0.74

184

1320

Polypectomy (DHB20)

295

2253

1.35

5.24

8.3

9.0

123.84

123.06

g/l

0.25

278

2170

Orthopaedic devices associated with adverse incidents

539

0.37

5.23

7.2

7.0

117.95

119.78

g/l

0.20

525

Giant cell arteritis

181

1283

1.47

5.22

7.7

7.1

119.22

118.96

g/l

0.07

175

1230

Multiple myeloma

119

777

1.62

5.22

7.6

7.2

104.39

120.06

g/l

14.46

113

753

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

119

777

1.62

5.22

7.6

7.2

104.39

120.06

g/l

14.46

113

753

Medical abortion

2314

11376

1.11

5.21

6.8

7.1

119.54

118.55

g/l

1.67

2246

10949

Other disorders of pigmentation

172

1205

1.48

5.21

5.6

8.3

119.08

120.75

g/l

0.47

165

1160

Injury of eye and orbit

514

4189

1.25

5.19

9.2

8.9

124.66

124.27

g/l

0.15

496

4022

Polyp of the female genital tract

1172

5928

1.16

5.19

6.7

7.4

119.41

117.91

g/l

1.95

1136

5713

Other and unspecified follicular disorders

150

1024

1.52

5.19

7.5

10.2

124.14

123.36

g/l

0.17

142

987

Nonspecific lymphadenitis

215

1564

1.41

5.16

8.2

9.0

122.32

123.37

g/l

0.32

202

1512

Other disorders of penis

412

3288

1.28

5.15

10.7

9.9

124.92

123.98

g/l

0.35

395

3186

Ulcerative colitis (strict definition, all Crohn cases excluded)

520

4247

1.24

5.15

8.0

8.7

121.71

123.65

g/l

1.30

505

4094

Speech therapy

1113

9709

1.16

5.15

9.3

7.9

119.15

120.72

g/l

1.86

1085

9359

Other and unspecified acquired haemolytic anaemias

243

2.15

5.13

14.2

9.9

104.44

120.01

g/l

5.80

234

Respiratory tuberculosis, confirmed and not-confirmed

241

1792

1.38

5.12

8.5

7.6

119.92

119.90

g/l

0.01

232

1725

Respiratory tuberculosis

241

1792

1.38

5.12

8.5

7.6

119.92

119.90

g/l

0.01

232

1725

Otalgia

269

2029

1.36

5.12

7.1

8.3

124.17

120.78

g/l

1.96

260

1958

Secondary and unspecified malignant neoplasm of lymph nodes

345

2699

1.31

5.11

8.2

8.1

114.16

121.82

g/l

8.50

331

2597

Propionic acid derivatives

1405

6212

1.15

5.08

8.8

122.58

120.20

g/l

3.72

1355

5974

Benign neoplasm: Heart

103

2.96

5.06

15.0

7.0

112.08

121.42

g/l

1.56

Etanercept

211

1537

1.41

5.04

10.4

9.4

118.24

123.00

g/l

2.63

204

1484

Congenital malformations of spine and bony thorax

107

2.74

5.02

12.0

13.1

120.48

122.87

g/l

0.25

102

Carcinoma in situ of skin of other and unspecified parts of face

313

2426

1.33

5.01

6.6

6.2

115.15

120.30

g/l

5.50

305

2341

Pedal cyclist injured in other and unspecified transport accidents

406

3241

1.28

5.00

7.6

8.6

122.85

123.11

g/l

0.08

383

3123

Ulcerative proctitis

213

1557

1.40

4.99

7.8

8.9

123.92

123.38

g/l

0.15

207

1500

Hyphaema and other vascular disorders of iris and ciliary body

540

1.72

4.98

8.7

7.5

116.60

121.54

g/l

1.48

520

Diseases of external ear

1359

12038

1.14

4.96

7.4

8.1

122.38

121.60

g/l

0.73

1317

11595

Respiratory tuberculosis, bacteriologically and histologically confirmed

532

1.72

4.95

9.7

8.1

121.17

120.40

g/l

0.11

510

Systemic atrophies primarily affecting the central nervous system

174

1237

1.46

4.93

6.7

8.6

130.72

121.40

g/l

8.38

169

1196

Contact with sharp glass

128

854

1.54

4.91

13.0

9.7

124.11

124.92

g/l

0.17

123

824

Convergent concomitant strabismus

183

1307

1.43

4.89

12.8

9.3

121.47

123.13

g/l

0.48

174

1258

Atopic dermatitis, strict definition

883

7436

1.17

4.88

7.7

8.8

122.78

123.17

g/l

0.21

856

7165

Malignant neoplasm of liver and intrahepatic bile ducts

148

1025

1.51

4.88

9.2

7.9

116.61

120.44

g/l

1.45

141

986

Benign neoplasm of major salivary glands

403

3231

1.28

4.87

10.4

8.1

120.52

121.38

g/l

0.34

389

3112

Melanocytic naevi, other sites/unspecified

290

2231

1.33

4.85

6.6

8.9

120.41

122.22

g/l

0.76

278

2144

Premature rupture of membranes

331

3114

0.77

4.85

8.0

7.9

122.45

121.05

g/l

0.70

318

3000

Caught, crushed, jammed or pinched in or between objects

178

1271

1.44

4.84

9.8

10.0

125.78

124.66

g/l

0.29

167

1227

Diseases of tongue

241

1809

1.37

4.81

6.8

7.5

119.79

121.07

g/l

0.43

231

1740

Other disorders of patella

593

4940

1.22

4.79

7.6

9.2

122.98

122.46

g/l

0.25

572

4760

Benign neoplasm: Skin of eyelid, including canthus

624

5237

1.21

4.78

7.0

7.7

119.99

120.40

g/l

0.19

604

5035

Unspecified/other endometriosis

230

1708

1.37

4.77

5.1

7.5

124.60

119.44

g/l

4.43

223

1645

Toxic effect of organic solvents

2.89

4.76

11.1

15.4

122.29

123.75

g/l

0.17

Other female pelvic inflammatory diseases

537

4438

1.23

4.75

7.3

7.0

121.85

118.86

g/l

3.22

512

4265

Respiratory tuberculosis, confirmed

515

1.71

4.75

10.1

8.1

120.72

120.54

g/l

0.02

495

Sequelae of infectious and parasitic diseases

292

2255

1.32

4.74

8.2

8.1

123.19

122.51

g/l

0.22

287

2169

Other leukaemias of specified cell type

3.76

4.73

9.1

9.2

108.81

122.10

g/l

2.01

Dermatopolymyositis (FG)

350

1.88

4.73

18.3

7.6

120.70

121.25

g/l

0.07

340

Postpartum care and examination

310

1520

1.31

4.71

6.1

8.3

119.85

122.56

g/l

1.58

296

1465

Benign neoplasm: Parotid gland

323

2536

1.31

4.69

11.1

8.4

120.55

121.60

g/l

0.38

315

2444

Haemangioma and lymphangioma, any site

329

2586

1.30

4.67

6.3

8.7

121.10

121.95

g/l

0.33

321

2490

Acute appendicitis, with complications

805

6913

1.18

4.65

9.6

8.4

122.10

122.02

g/l

0.03

774

6671

Ankylosing spondylitis

324

2542

1.30

4.63

7.8

9.4

120.08

122.69

g/l

1.54

314

2450

HSIL lesion of the cervix uteri, vagina or vulva

491

4026

1.23

4.63

7.3

7.1

119.82

120.57

g/l

0.39

478

3868

Aspergillosis

218

2.16

4.63

7.7

7.1

121.00

121.58

g/l

0.07

212

Chromosomal abnormalities, not elsewhere classified

356

1.83

4.63

13.0

11.5

128.71

123.90

g/l

1.00

346

Disorders of optic nerve, not elsewhere classified

591

1.66

4.61

8.4

9.2

118.54

120.66

g/l

0.39

575

Macular hole

238

1803

1.37

4.60

5.7

7.3

119.12

120.54

g/l

0.50

233

1730

Pustular psoriasis

178

1286

1.43

4.58

7.2

9.1

122.88

121.04

g/l

0.58

172

1245

Benign neoplasm: salivary glands, exclude unknown (D119)

357

2846

1.28

4.57

10.9

8.4

120.74

121.74

g/l

0.38

348

2743

Other and unspecified disorders of psychological development

115

2.49

4.56

6.9

15.5

128.32

126.84

g/l

0.13

110

Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)

219

2.13

4.56

11.1

6.8

115.95

123.85

g/l

1.69

214

Iliotibial band syndrome

224

2.07

4.55

8.0

7.3

115.95

121.40

g/l

1.06

218

Simple and mucopurulent chronic bronchitis

164

1168

1.45

4.55

6.5

7.8

121.25

119.38

g/l

0.64

159

1127

Conjunctivitis

2946

23712

1.09

4.54

8.2

8.1

121.79

121.52

g/l

0.31

2858

22840

Benign neoplasm of mouth and pharynx

437

3564

1.25

4.53

8.1

121.03

121.78

g/l

0.32

427

3433

Non-small cell lung cancer, squamous

208

1545

1.39

4.52

7.3

7.2

120.60

120.05

g/l

0.15

202

1492

Non-small cell lung cancer, squamous, helper endpoint

208

1545

1.39

4.52

7.3

7.2

120.60

120.05

g/l

0.15

202

1492

Haemangioma, any site

308

2413

1.30

4.51

6.4

8.6

121.26

121.79

g/l

0.18

300

2321

Polycystic ovarian syndrome

113

745

1.54

4.51

5.8

7.0

128.77

120.82

g/l

4.91

108

719

Endometriosis of pelvic peritoneum

463

3739

1.24

4.48

6.0

8.1

121.66

118.82

g/l

2.75

446

3605

Psoriatic arthropathies

370

2964

1.27

4.47

7.6

9.0

122.71

122.43

g/l

0.09

359

2849

Carcinoma in situ of skin of trunk

124

846

1.53

4.45

8.1

6.2

115.53

121.25

g/l

2.27

119

820

Disorders of vagus nerve

4.81

4.44

9.0

9.2

123.42

121.47

g/l

0.10

Hyperkinetic disorders (excl. ADHD)

236

1.99

4.44

6.3

12.7

125.59

127.29

g/l

0.23

225

Hyperhidrosis

560

1.63

4.44

4.1

7.6

124.58

121.18

g/l

0.82

538

Myopia

376

3016

1.26

4.43

9.2

8.3

123.36

123.21

g/l

0.05

365

2907

False labour

736

3928

1.19

4.43

4.9

8.4

124.83

121.21

g/l

5.78

703

3776

Polyhydramnios

113

751

1.54

4.39

6.5

7.4

122.32

121.97

g/l

0.07

108

724

Outcome of delivery

233

1911

0.75

4.38

6.5

8.8

119.68

122.10

g/l

1.24

226

1842

Other benign neoplasm of uterus: Other parts/unspecified

1343

0.63

4.37

4.6

5.4

117.52

116.97

g/l

0.11

1289

Macular pucker

645

5488

1.20

4.34

7.3

7.4

117.63

120.38

g/l

3.05

628

5271

Deficiency of other B group vitamins

560

1.64

4.31

10.6

8.4

118.47

120.29

g/l

0.35

543

Injury of muscle and tendon at hip and thigh level

354

2837

1.27

4.31

9.7

8.8

120.56

123.65

g/l

2.14

340

2731

Other facial nerve disorders

106

703

1.56

4.29

6.4

10.2

124.97

120.13

g/l

1.67

679

Certolizumab pegol

300

1.87

4.28

9.7

9.2

115.83

122.17

g/l

1.26

288

Bicipital tendinitis

190

1404

1.39

4.28

7.8

8.9

127.19

122.71

g/l

2.05

183

1346

Hypertrichosis

321

1.83

4.28

7.9

7.5

127.33

121.23

g/l

1.51

311

Defects in the complement system

142

2.35

4.26

11.3

7.3

128.39

123.15

g/l

0.69

137

Other hereditary haemolytic anaemias

136

2.40

4.26

6.8

8.1

119.43

122.33

g/l

0.23

130

Nonadministration of surgical and medical care

3.76

4.25

7.7

7.1

127.47

119.54

g/l

0.74

Pustulosis palmaris et plantaris

159

1143

1.43

4.24

6.9

9.2

122.69

121.16

g/l

0.43

154

1107

Other menopausal disorders

754

5059

0.85

4.21

7.0

7.9

120.95

118.20

g/l

3.70

732

4880

Residual foreign body in soft tissue

180

1321

1.40

4.20

8.9

9.8

122.40

123.96

g/l

0.42

173

1267

Injury of nerves at wrist and hand level

145

1029

1.45

4.17

11.2

10.1

119.82

124.26

g/l

1.68

138

990

Rhabdomyosarcoma, excluding all cancers (controls excluding all cancers)

4.27

4.15

5.7

13.8

111.08

123.27

g/l

0.97

Mild or no visual impairment, binocular

106

2.59

4.14

5.9

5.7

124.52

120.62

g/l

0.39

101

Other disorders of bone density and structure

588

1.60

4.14

6.8

9.1

127.52

120.84

g/l

2.44

570

Inflammatory diseases of prostate (prostatitis)

587

4975

1.20

4.13

7.7

9.6

125.75

123.49

g/l

1.68

558

4823

Retinal breaks without detachment

453

5455

0.82

4.11

8.8

8.1

120.10

121.51

g/l

0.77

432

5266

Hordeolum and other deep inflammation of eyelid

197

1472

1.37

4.11

7.5

9.4

125.46

122.08

g/l

1.45

188

1413

Injury of muscle and tendon at lower leg level

598

5072

1.20

4.11

8.7

8.9

125.24

123.13

g/l

1.69

584

4910

Amblyopia ex anopsia

130

905

1.47

4.09

9.3

8.4

124.54

121.85

g/l

0.68

122

874

Effects of heat and light

179

2.17

4.08

11.0

10.4

123.36

121.85

g/l

0.15

170

Cholera

163

1187

1.42

4.05

8.3

7.4

121.09

119.62

g/l

0.43

163

1144

APECED

11.39

4.05

15.3

5.1

116.43

135.38

g/l

—

Melanocytic naevi of lower limb, including hip

134

941

1.46

4.04

6.2

8.8

118.54

122.87

g/l

1.44

129

906

Deviated nasal septum

1461

13162

1.12

4.03

9.0

8.9

124.80

122.62

g/l

3.70

1407

12672

Burn and corrosion of hip and lower limb, except ankle and foot

593

1.60

4.03

11.5

8.5

122.64

123.44

g/l

0.12

570

Palmar fascial fibromatosis [Dupuytren]

689

5925

1.18

4.02

8.8

8.0

120.02

121.26

g/l

0.83

666

5711

Crohn disease (strict definition, require KELA, min 2 HDR)

204

1536

1.36

4.02

11.2

9.0

120.37

123.87

g/l

1.41

197

1479

Other and unspecified rosacea

303

2407

1.28

4.01

7.9

8.4

120.97

121.48

g/l

0.16

293

2326

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

441

3639

1.22

3.99

7.1

7.0

121.39

119.32

g/l

1.62

433

3497

Bacterial, viral and other infectious agents

307

2443

1.28

3.99

10.0

9.6

121.43

124.92

g/l

2.08

300

2363

Astigmatism

198

1485

1.36

3.98

15.4

8.3

121.87

122.58

g/l

0.18

193

1429

Endometriosis diagnosis and infertility diagnosis occurring together

266

2075

1.30

3.98

5.3

7.5

121.49

120.96

g/l

0.18

258

2004

Temporal arteritis

156

1135

1.43

3.98

7.9

7.2

118.90

119.18

g/l

0.07

151

1087

Other abnormal uterine and vaginal bleeding

850

5275

1.16

3.97

6.9

7.1

118.81

117.48

g/l

1.31

823

5084

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

158

1146

1.41

3.97

6.5

9.6

124.78

123.47

g/l

0.36

152

1100

malignant neoplasm of male genital organs

2098

12216

1.10

3.92

7.2

8.7

120.77

122.76

g/l

4.26

2008

11815

Rare circulating lymphoid malignancy

128

901

1.48

3.92

8.1

8.7

111.54

121.53

g/l

4.88

121

867

Use of antiglaucoma preparations and miotics

336

2715

1.27

3.89

6.9

6.5

118.18

118.88

g/l

0.26

320

2613

Hirsutism in women

272

1.86

3.89

8.2

6.9

127.67

121.23

g/l

1.50

263

Hyposplenism

4.44

3.89

8.3

25.3

104.82

126.70

g/l

1.83

Systemic lupus erythematosus

127

893

1.47

3.86

7.9

8.4

115.22

120.48

g/l

2.19

122

864

Leiomyosarcoma

198

2.09

3.86

6.9

9.9

116.50

119.93

g/l

0.60

193

Exposure to other and unspecified man-made environmental factors

380

1.74

3.85

8.3

9.5

121.63

122.30

g/l

0.08

369

Sacroiliitis, not elsewhere classified

129

907

1.45

3.83

7.3

9.7

122.85

123.02

g/l

0.03

124

878

Use of levodopa decarbox-comt-inhibitor

147

1068

1.44

3.83

4.7

7.8

122.40

120.54

g/l

0.52

139

1026

Sacrococcygeal disorders, not elsewhere classified

102

689

1.52

3.79

9.9

9.1

121.91

120.74

g/l

0.26

670

Colonic or urogenital fistula

1085

9661

1.13

3.77

8.9

8.3

121.26

121.85

g/l

0.42

1048

9303

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

267

2111

1.30

3.76

7.1

8.8

124.95

122.26

g/l

1.30

255

2038

Fall on and from ladder

331

2684

1.26

3.76

7.9

8.8

124.44

123.05

g/l

0.58

318

2585

Melanocytic naevi of other and unspecified parts of face

205

1564

1.34

3.74

6.0

8.3

124.19

121.46

g/l

1.18

195

1507

Crohn disease (strict definition, require KELA)

206

1571

1.34

3.74

11.1

9.0

120.53

123.92

g/l

1.36

199

1514

Other and unspecified mental retardation

292

1.82

3.71

7.9

11.2

125.67

124.37

g/l

0.15

278

Pyogenic granuloma

416

1.68

3.68

7.1

8.6

111.64

120.70

g/l

2.58

401

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

217

1672

1.32

3.66

10.8

8.9

120.55

124.06

g/l

1.51

210

1613

Impaction of intestines

166

2.14

3.65

14.9

7.5

113.27

120.85

g/l

1.23

157

Disorders of urea cycle metabolism

9.31

3.65

8.1

115.57

117.60

g/l

—

Giant cell arteritis with polymyalgia rheumatica

156

1153

1.40

3.65

7.9

7.2

118.90

119.20

g/l

0.07

151

1105

Benign neoplasm of eye and adnexa

386

3189

1.23

3.63

7.7

7.8

118.29

120.88

g/l

1.74

369

3070

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

161

1195

1.39

3.62

9.1

9.0

119.73

121.64

g/l

0.50

154

1153

Secondary uncertain malignant neoplasm

515

4371

1.20

3.60

7.5

7.7

114.36

120.74

g/l

9.56

494

4210

Perineal laceration during delivery

217

2498

0.77

3.60

5.8

7.4

121.10

121.98

g/l

0.27

209

2404

Any dementia

1711

11009

1.11

3.59

4.9

6.7

119.81

119.03

g/l

0.86

1655

10595

Prepatellar bursitis

185

1403

1.36

3.59

7.2

9.8

123.85

123.91

g/l

0.01

177

1347

Exposure to uncontrolled fire, not in building or structure

3.15

3.58

14.2

6.2

118.69

126.65

g/l

0.82

Myeloproliferative diseases

335

2737

1.25

3.55

8.4

7.8

118.24

121.16

g/l

1.43

324

2637

All dysplastic lesions of the cervix uteri, vagina or vulva

741

6416

1.16

3.52

7.3

7.4

119.03

120.54

g/l

1.44

719

6168

Vasomotor and allergic rhinitis

1335

11884

1.11

3.51

7.7

8.3

124.31

121.54

g/l

5.24

1293

11452

Haemorrhage in early pregnancy

771

6577

1.15

3.50

5.7

7.8

122.13

119.61

g/l

3.25

739

6338

Status post-ami

296

1950

1.27

3.50

6.9

6.2

119.69

119.65

g/l

0.01

283

1874

Dental caries 2

2668

22511

0.93

3.50

8.7

8.5

121.79

122.55

g/l

1.12

2590

21675

Other disorders of the genitourinary system

473

3996

1.20

3.49

8.5

7.3

119.61

118.98

g/l

0.31

452

3836

Benign lipomatous neoplasm of other sites/unspecified

308

2495

1.26

3.48

7.8

7.3

122.07

122.08

g/l

0.00

302

2390

Effects of foreign body entering through natural orifice

934

8286

1.14

3.48

8.4

9.1

125.06

123.56

g/l

1.39

899

8000

Bacterial meningitis

133

965

1.42

3.45

9.7

10.0

119.57

122.39

g/l

0.82

126

933

Arthropathy in ulcerative colitis

301

1.78

3.42

8.7

10.8

121.43

121.84

g/l

0.05

288

Conductive hearing loss, unspecified

309

2511

1.25

3.42

8.4

8.2

121.65

122.09

g/l

0.14

295

2419

Motorcycle rider injured in other and unspecified transport accidents

187

1429

1.33

3.39

12.5

10.0

125.86

126.48

g/l

0.14

176

1381

Dementia

1893

12021

1.10

3.38

4.8

6.9

120.31

119.25

g/l

1.45

1830

11577

Flatulence and related conditions

235

1.88

3.38

7.9

7.8

116.83

119.79

g/l

0.38

227

Scar conditions and fibrosis of skin

131

950

1.41

3.37

6.8

8.7

122.54

121.15

g/l

0.33

123

913

SLE, strict definition

121

867

1.44

3.37

7.8

8.4

115.70

120.60

g/l

1.88

116

839

SLE, ICD10

121

867

1.44

3.37

7.8

8.4

115.70

120.60

g/l

1.88

116

839

Disorders of synovium and tendon in diseases classified elsewhere

571

1.55

3.36

5.9

9.5

124.09

123.06

g/l

0.18

545

Acute myeloid leukaemia, helper endpoint

229

1.89

3.34

9.4

6.4

99.51

122.96

g/l

9.39

222

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

229

1.89

3.34

9.4

6.4

99.51

122.96

g/l

9.39

222

Other and unspecified iridocyclitis

154

1150

1.37

3.33

6.2

8.8

121.48

121.20

g/l

0.05

149

1110

Pedal cyclist injured in noncollision transport accidents

386

3217

1.22

3.30

8.7

8.9

122.95

123.44

g/l

0.19

373

3098

Other specified/unspecified bacterial intestinal infections

243

1933

1.28

3.29

8.6

8.2

119.22

121.73

g/l

1.13

237

1860

Benign neoplasm: Skin of trunk

135

990

1.40

3.26

7.4

8.4

123.43

122.70

g/l

0.14

129

957

Burns and corrosions of multiple body regions

209

1.93

3.25

10.9

10.3

124.34

122.00

g/l

0.22

202

Contact with other sharp object(s)

206

1605

1.31

3.25

11.0

9.9

124.36

124.77

g/l

0.09

199

1546

Dermatopolymyositis

392

1.66

3.23

18.3

7.5

120.70

121.19

g/l

0.07

381

Other disorders of cornea

350

2900

1.23

3.23

8.6

7.9

120.79

122.03

g/l

0.53

342

2790

Carcinoma in situ of stomach

6.28

3.22

6.5

7.2

121.00

122.94

g/l

—

Rosacea

384

3211

1.21

3.19

8.5

8.3

120.41

121.15

g/l

0.30

372

3094

Mixed conductive and sensorineural hearing loss

499

4274

1.19

3.18

7.1

7.6

120.71

120.31

g/l

0.17

477

4112

Polyglandular dysfunction

2.97

3.15

10.4

16.9

114.13

123.63

g/l

1.24

Other congenital malformations of skin

130

953

1.40

3.15

10.5

9.1

120.76

122.14

g/l

0.28

125

921

Diseases of middle ear and mastoid

2123

16114

1.08

3.14

8.5

8.3

123.14

122.49

g/l

0.71

2039

15521

Nasal polyp

803

7114

1.14

3.14

7.8

8.5

124.85

121.78

g/l

4.07

770

6845

Toxic effect of other gases, fumes and vapours

127

2.20

3.13

9.5

12.4

126.58

125.10

g/l

0.12

122

Bitten or struck by other mammals

333

2752

1.23

3.11

10.3

8.6

123.16

123.00

g/l

0.05

321

2656

Lichen planus, including avohilmo

697

6124

1.15

3.11

7.0

7.8

121.32

120.67

g/l

0.37

668

5898

Pain and other conditions associated with female genital organs and menstrual cycle

518

4259

1.17

3.10

6.9

7.8

122.51

119.13

g/l

3.99

498

4110

Ulcerative rectosigmoiditis

288

2349

1.25

3.10

8.8

8.6

122.16

123.78

g/l

0.66

280

2260

Autoimmune polyglandular failure

3.89

3.08

13.7

25.3

118.10

129.77

g/l

—

Other osteochondrodysplasias

169

1.99

3.08

8.6

11.7

116.59

121.94

g/l

0.92

163

Tarsal tunnel syndrome

235

1.84

3.08

5.0

7.6

120.95

121.17

g/l

0.02

229

Other injuries of spine and trunk, level unspecified

184

1.96

3.07

9.8

7.2

111.62

124.70

g/l

2.60

178

Benign neoplasm: Skin of scalp and neck

598

1.50

3.07

7.3

8.9

119.31

122.94

g/l

0.77

580

L01XX Other antineoplastic agents

227

1814

1.28

3.03

8.2

7.9

113.84

120.42

g/l

4.23

219

1751

Contact with hot air and gases

164

2.03

3.03

14.0

7.4

122.26

122.57

g/l

0.02

159

Endometriosis ASRM stages 1,2

477

4077

1.18

3.03

6.1

7.4

121.59

120.12

g/l

1.01

459

3922

Lesion of plantar nerve

218

1732

1.29

3.01

5.2

7.9

122.90

119.23

g/l

2.03

212

1671

Other and unspecified haemorrhagic conditions

391

1.63

3.01

12.1

7.6

113.52

121.06

g/l

2.07

382

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

492

4228

1.18

3.00

7.3

8.5

124.63

121.90

g/l

2.17

473

4073

Hypersomnia

352

1.66

3.00

9.9

10.7

127.02

121.38

g/l

1.12

342

Dental caries 2 and operation codes

2610

22144

0.93

3.00

8.7

8.5

121.75

122.55

g/l

1.16

2532

21324

Carcinoma in situ of stomach

5.58

2.96

6.5

5.3

121.00

125.42

g/l

—

Malignant neoplasm of prostate

2041

11961

1.09

2.96

6.9

8.7

120.86

122.56

g/l

3.19

1950

11568

Folate deficiency anaemia

232

1.84

2.95

12.5

10.1

107.23

122.39

g/l

3.51

223

Prolonged pregnancy

208

2393

0.79

2.92

5.9

8.1

120.57

121.26

g/l

0.20

200

2309

Other vitreous opacities

150

1142

1.35

2.92

6.2

8.5

121.90

120.74

g/l

0.30

145

1102

Other congenital malformations of kidney

2.45

2.92

8.1

7.4

116.74

119.95

g/l

0.26

L04AC Interleukin inhibitors

157

1200

1.34

2.92

9.5

10.2

120.97

123.88

g/l

0.99

152

1158

Special screening examination for infectious and parasitic diseases

529

4578

0.86

2.91

11.1

8.4

122.47

125.14

g/l

2.43

523

4402

Glaucoma, exfoliation

451

3863

1.19

2.91

5.0

6.4

120.73

118.50

g/l

1.72

432

3727

Albinism

7.64

2.89

2.8

10.1

127.50

122.10

g/l

—

Other disorders of conjunctiva

558

4858

1.16

2.89

9.4

7.8

119.86

120.59

g/l

0.35

539

4669

Other/unspecified reactive arthropathies

229

1842

1.27

2.85

11.3

9.1

119.55

122.79

g/l

1.58

222

1777

Non-seminoma of testis, excluding all cancers (controls excluding all cancers)

111

2.19

2.84

8.6

14.5

119.30

133.13

g/l

1.63

106

181

1.90

2.84

6.6

11.5

126.58

121.82

g/l

0.61

174

Malignant neoplasm of breast

1839

12291

1.09

2.80

6.1

7.0

118.01

118.63

g/l

0.78

1778

11838

Benign neoplasm: Anus and anal canal

117

866

1.40

2.79

6.9

7.4

115.93

120.63

g/l

1.84

111

840

Other lesions of median nerve

109

797

1.41

2.78

6.3

7.9

120.14

119.40

g/l

0.12

101

768

Spermatocele

341

2868

1.21

2.78

7.4

9.5

124.45

122.73

g/l

0.72

331

2774

Follicular lymphoma

148

1134

1.34

2.76

8.3

7.3

117.21

121.82

g/l

1.75

138

1096

Intercostal neuropathy

199

1.87

2.76

6.6

11.6

123.83

120.85

g/l

0.40

192

Chondropathies

532

4628

1.16

2.76

7.7

8.6

123.99

122.80

g/l

0.69

508

4463

Unspecified renal colic

163

1.97

2.74

8.9

7.0

124.87

121.00

g/l

0.55

155

Disorders of puberty, all

197

1.82

2.73

11.8

10.3

123.94

125.71

g/l

0.17

185

Transient synovitis

148

1.98

2.70

7.1

11.7

120.75

124.60

g/l

0.47

143

Congenital absence, atresia and stenosis of large intestine

5.20

2.69

8.7

9.4

119.71

124.47

g/l

—

Benign neoplasm: other/unspecified salivary gland

717

1.42

2.68

7.1

6.4

119.27

121.21

g/l

0.43

696

Nonsuppurative otitis media

675

5154

1.14

2.68

10.2

8.3

123.18

122.92

g/l

0.12

651

4948

Soft tissue disorders in diseases classified elsewhere

5.50

2.68

4.3

12.5

119.43

116.44

g/l

—

Complications of labour and delivery

1785

10744

0.92

2.68

7.2

7.7

119.91

119.36

g/l

0.58

1725

10338

Lichen ruber planus, wide definition including periferal and oral lichen planus

793

7102

1.13

2.65

7.0

7.9

121.57

120.56

g/l

0.74

761

6841

Calculus of lower urinary tract

221

1792

1.26

2.64

8.1

8.7

120.70

121.57

g/l

0.26

215

1729

Contact with machinery

443

3823

1.18

2.64

8.5

9.3

125.54

123.72

g/l

0.94

425

3684

Drug-induced systemic lupus erythematosus

165

1.94

2.64

10.8

5.7

112.63

121.04

g/l

1.31

160

Disorders of orbit

150

1159

1.32

2.63

8.2

8.7

122.91

120.85

g/l

0.63

144

1116

Neurological devices associated with adverse incidents

9.24

2.62

4.0

7.5

126.80

118.13

g/l

—

Supervision of high-risk pregnancy

483

2516

1.17

2.62

6.0

9.1

122.76

121.42

g/l

0.81

463

2434

HSIL lesion of the cervix uteri

410

3508

1.18

2.61

7.9

7.2

119.96

120.87

g/l

0.44

398

3372

Other and unspecified bullous disorders

256

1.73

2.61

7.5

7.1

121.38

120.05

g/l

0.17

248

Other/unspecified enthesopathies, not elsewhere classified

318

2673

1.21

2.58

7.5

8.4

122.93

121.31

g/l

0.73

309

2564

2.58

16.7

17.0

110.07

127.79

g/l

1.66

Carcinoma in situ of skin

320

2699

1.21

2.57

6.6

6.9

117.23

119.66

g/l

1.33

308

2599

Prolapse and hernia of ovary and fallopian tube

163

1267

1.31

2.57

4.8

5.2

116.18

116.92

g/l

0.21

157

1225

Benign neoplasm: Other parts of oropharynx

211

1.79

2.56

8.9

9.9

120.25

124.51

g/l

0.66

204

Other and unspecified types of non-Hodgkin lymphoma, hilmo

167

1317

1.30

2.56

10.3

7.9

110.65

120.94

g/l

8.14

156

1268

Dementia, including avohilmo

2018

12998

1.08

2.55

5.0

7.0

120.32

119.29

g/l

1.49

1954

12523

Foreign body or object entering through skin

218

1769

1.25

2.55

9.6

9.2

122.10

124.64

g/l

1.04

210

1708

Open wound of wrist and hand

1699

15624

1.08

2.54

9.2

8.9

123.85

123.60

g/l

0.19

1646

15037

Juvenile osteochondrosis

688

1.41

2.54

8.9

10.0

123.62

124.65

g/l

0.18

662

Scleritis and episcleritis

199

1600

1.27

2.53

7.8

8.8

121.79

122.29

g/l

0.13

193

1536

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

101

743

1.40

2.53

7.2

114.21

121.29

g/l

3.53

720

Retinal detachment with retinal break

526

4613

1.16

2.52

8.4

7.8

119.89

121.65

g/l

1.12

514

4449

Impacted cerumen

268

3215

0.82

2.52

7.0

7.6

121.08

120.81

g/l

0.08

260

3091

Myeloproliferative diseases (CML excluded)

295

2475

1.21

2.50

7.9

7.8

119.40

121.00

g/l

0.54

285

2383

Chronic laryngitis and laryngotracheitis

527

4621

1.15

2.50

9.3

7.9

123.15

120.38

g/l

2.37

515

4448

Other noninflammatory disorders of vulva and perineum

264

2186

1.22

2.49

6.7

7.2

119.54

118.35

g/l

0.54

258

2106

Torsion of testis

392

1.54

2.49

11.7

11.8

132.94

130.19

g/l

0.42

377

Viral meningitis

111

828

1.37

2.49

8.1

10.1

126.13

123.05

g/l

0.74

106

800

Other benign neoplasm of uterus: Other parts/unspecified

1195

0.71

2.49

4.6

5.3

117.52

118.07

g/l

0.12

1148

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

442

1.52

2.48

12.4

9.9

119.29

128.56

g/l

2.74

424

Poor fetal growth

241

1975

1.23

2.48

11.6

7.3

118.53

121.76

g/l

1.73

229

1894

Spinal instabilities

701

1.40

2.48

8.3

10.4

120.95

121.00

g/l

0.01

676

Vascular dementia (subcortical)

112

842

1.37

2.44

5.1

6.5

118.64

118.28

g/l

0.07

112

813

Other contact dermatitis

270

2248

1.22

2.44

9.0

8.0

122.13

121.95

g/l

0.05

257

2155

Polycythaemia vera

128

982

1.34

2.42

6.4

7.8

127.19

121.40

g/l

1.67

122

950

Periodic paralysis

5.64

2.42

1.3

10.5

121.83

122.38

g/l

—

Non-Hodgkin lymphoma, all

158

1249

1.30

2.39

10.3

7.9

110.48

120.67

g/l

7.70

149

1204

Lichen sclerosus et atrophicus

334

2842

1.19

2.39

5.9

7.2

120.22

119.66

g/l

0.22

320

2720

Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents

3.61

2.38

12.9

9.7

114.56

126.59

g/l

—

Cleft lip, lip and palate or palate

292

1.62

2.38

11.5

10.3

122.34

125.29

g/l

0.35

278

Cellulitis of external ear

270

1.66

2.37

8.3

8.4

122.79

119.23

g/l

0.61

257

Other nonthrombocytopenic purpura

240

1.72

2.37

3.2

9.5

120.90

122.04

g/l

0.15

229

Thyrotoxicosis with diffuse goitre

442

3845

1.16

2.35

8.0

7.8

121.30

120.50

g/l

0.35

421

3688

Drug-induced acute pancreatitis

3.49

2.34

9.0

7.3

128.78

124.28

g/l

—

Cardiovascular devices associated with adverse incidents

4.63

2.34

9.0

6.8

124.86

126.11

g/l

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

233

1.72

2.33

9.5

8.9

118.00

122.62

g/l

0.71

227

Drug phototoxic response

4.50

2.32

8.4

13.4

119.57

115.53

g/l

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1050

6768

0.91

2.28

6.6

8.3

122.32

120.21

g/l

3.08

1014

6515

Muscular dystrophy

196

1.77

2.28

4.0

10.7

124.61

122.97

g/l

0.16

188

Tinnitus

907

8256

1.11

2.27

8.5

8.3

122.32

121.25

g/l

0.91

886

7946

Ectopic pregnancy

489

4293

1.15

2.27

6.5

7.4

121.42

119.27

g/l

1.69

471

4131

Primary open-angle glaucoma

1365

12325

1.09

2.27

6.3

7.0

119.78

119.37

g/l

0.32

1309

11886

Fibrosis and sclerosis of liver

4.95

2.26

15.3

10.0

112.00

121.00

g/l

—

Polyclonal hypergammaglobulinaemia

3.48

2.25

17.4

9.9

119.11

122.45

g/l

—

Failed induction of labour

105

788

1.35

2.24

5.0

7.5

120.02

121.87

g/l

0.46

100

756

Injury of blood vessels at ankle and foot level

3.42

2.24

6.2

23.1

127.22

125.84

g/l

—

Benign neoplasm: Choroid

223

1846

1.23

2.24

7.1

8.0

118.05

120.51

g/l

1.04

213

1774

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

244

1.68

2.22

5.6

6.4

118.59

123.85

g/l

0.91

235

Acute myeloid leukaemia

260

1.65

2.22

9.4

7.1

99.51

119.91

g/l

7.80

254

Malignant neoplasm of breast, HER2-negative

1778

12212

1.08

2.21

6.1

6.9

118.02

118.59

g/l

0.67

1718

11763

Endometriosis of ovary

512

4505

1.14

2.21

7.1

7.5

119.22

118.09

g/l

0.70

484

4334

Medullary carcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

2.83

2.21

4.9

6.1

125.36

127.72

g/l

0.14

Primary angle-closure glaucoma

171

1379

1.27

2.21

5.8

8.0

118.81

118.86

g/l

0.01

163

1316

Benign neoplasm: Skin of other and unspecified parts of face

407

3547

1.16

2.18

5.7

7.7

122.52

120.57

g/l

1.19

387

3408

Unspecified visual impairment (binocular)

349

1.54

2.17

12.7

10.0

117.71

121.52

g/l

0.66

339

Single spontaneous delivery

1266

7300

0.92

2.17

5.9

7.2

119.66

118.12

g/l

2.26

1221

7054

Other maternal disorders predominantly related to pregnancy

1723

10109

1.08

2.17

6.9

7.9

121.76

119.57

g/l

4.91

1650

9759

Profound mental retardation

4.00

2.16

12.6

7.5

116.71

130.55

g/l

—

Other and unspecified trigeminal disorders

382

1.52

2.16

8.3

8.0

121.48

119.19

g/l

0.37

371

Otitis media in diseases classified elsewhere

4.71

2.16

8.3

13.8

124.83

119.93

g/l

—

Female infertility

862

4827

1.11

2.14

7.0

8.2

120.35

118.89

g/l

1.38

827

4657

Cleft palate

168

1.78

2.14

8.9

12.9

123.92

124.12

g/l

0.01

159

Urethral stricture

235

1966

1.22

2.12

6.8

8.7

121.29

122.97

g/l

0.61

224

1890

Dental caries 1 and operation codes, only avohilmo

1119

6115

0.91

2.11

8.8

121.75

119.91

g/l

2.17

1086

5858

Other and unspecified acne

246

1.63

2.11

10.5

8.9

120.46

124.65

g/l

0.52

233

Degenerative diseases of the nervous system

1454

10188

1.08

2.11

4.7

6.7

119.89

118.82

g/l

1.20

1394

9818

Carcinoma in situ of lip, excluding all cancers

3.94

2.10

4.0

3.9

114.29

127.24

g/l

—

Osteomalacia

193

1.73

2.09

6.3

10.5

127.87

121.38

g/l

0.70

186

Stenosis and insufficiency of lacrimal passages

334

2880

1.18

2.08

5.8

7.9

120.12

119.73

g/l

0.13

316

2767

Amputation of ankle

3.16

2.07

7.6

7.0

115.22

121.91

g/l

—

Non-seminoma of testis

126

1.92

2.07

8.6

13.0

119.30

133.23

g/l

1.68

119

105

2.04

2.07

8.4

9.3

125.10

124.65

g/l

0.03

Oral lichen ruber planus wide, hypothyreosis or thyroxin

186

1526

1.24

2.06

7.1

7.2

119.03

119.35

g/l

0.08

179

1476

Chronic suppurative otitis media

233

1952

1.21

2.04

9.0

8.6

121.43

121.64

g/l

0.05

222

1872

Struck by thrown, projected or falling objec

161

1301

1.26

2.03

6.4

9.5

128.00

125.01

g/l

0.99

153

1255

Respiratory tuberculosis, not confirmed

166

1349

1.26

2.02

7.5

7.8

119.52

119.43

g/l

0.02

161

1295

Carcinoma in situ of skin of trunk

124

977

1.31

2.02

8.1

7.1

115.53

120.09

g/l

1.62

119

943

Carcinoma in situ of breast, intraductal

269

2288

1.19

2.00

6.2

7.1

117.95

118.81

g/l

0.34

257

2205

Disorders of puberty

171

1.73

2.00

9.7

11.1

123.48

126.62

g/l

0.31

161

Fracture of spine, level unspecified

2.66

1.97

11.2

5.2

120.73

123.67

g/l

0.15

Carcinoma in situ of skin of other and unspecified parts of face

313

2704

1.18

1.97

6.6

6.3

115.15

118.90

g/l

3.25

305

2601

Episcleritis

163

1325

1.25

1.96

8.1

9.2

122.70

121.93

g/l

0.20

158

1281

Congenital malformations of genital organs

223

1855

1.21

1.95

10.8

8.2

121.87

122.06

g/l

0.05

216

1786

Hypertrophy of tongue papillae

318

1.54

1.93

8.4

9.5

115.94

122.20

g/l

1.09

309

Fenamates

625

3792

1.12

1.92

7.2

8.7

120.25

119.02

g/l

0.82

604

3638

Vasomotor rhinitis (mode)

252

2142

1.19

1.91

5.9

8.7

126.21

121.31

g/l

3.39

243

2058

Tongue abnormality

217

1824

1.21

1.89

6.5

8.2

120.01

120.25

g/l

0.06

207

1761

Long labour

458

4509

0.88

1.88

7.5

8.1

120.35

121.09

g/l

0.34

441

4328

Other disorders of Eustachian tube

728

1.33

1.88

9.6

8.2

122.52

120.98

g/l

0.31

705

Malignant neoplasm of uterus, part unspecified

4.00

1.87

4.3

6.8

105.50

114.56

g/l

—

Diving or jumping into water causing injury other than drowning or submersion

124

1.88

1.86

16.2

13.7

130.82

126.20

g/l

0.43

118

Acute poliomyelitis

380

1.47

1.84

4.8

6.9

124.41

121.19

g/l

0.59

367

Carcinoma in situ of lip

3.42

1.84

4.0

4.3

114.29

124.88

g/l

—

Use of apomorphine

3.56

1.82

16.1

8.6

106.00

128.00

g/l

—

Benign neoplasm: Skin of lip

322

1.51

1.82

5.4

6.8

121.85

122.16

g/l

0.03

314

Tetraplegia

202

1.67

1.82

21.9

10.2

116.63

123.63

g/l

1.27

195

Disorders of optic chiasm

4.41

1.79

9.4

7.0

129.80

126.38

g/l

—

Unspecified urinary incontinence

223

2625

0.84

1.78

10.1

7.2

118.39

119.46

g/l

0.33

218

2520

Female infertility, cervigal, vaginal, other or unspecified origin

769

4697

1.10

1.78

6.8

8.2

119.62

118.84

g/l

0.52

737

4529

Congenital malformations of eye, ear, face and neck

175

1448

1.22

1.77

10.0

9.2

123.36

123.23

g/l

0.03

165

1397

Demyelinating diseases of the central nervous system

247

2109

1.18

1.77

8.6

9.1

123.22

122.83

g/l

0.12

234

2032

Melanocytic naevi of lower limb, including hip

134

1082

1.26

1.75

6.2

9.5

118.54

121.77

g/l

0.95

129

1045

Infections with a predominantly sexual mode of transmission

864

7948

1.09

1.72

9.7

8.2

120.91

122.72

g/l

1.92

836

7646

Other and unspecified hypertrophic disorders of skin

142

1.77

1.72

10.8

11.2

117.42

121.62

g/l

0.45

134

Other deformities of toe(s)

119

951

1.28

1.72

6.4

9.2

121.77

120.22

g/l

0.39

112

919

Other congenital malformations of limb(s)

104

1.88

1.71

30.8

7.7

122.79

123.76

g/l

0.06

Ankylosing spondylitis, ICD10

304

2648

1.16

1.71

7.9

9.1

120.20

123.80

g/l

2.48

295

2555

Normotensive glaucoma

329

2887

1.16

1.71

6.6

7.2

118.75

119.04

g/l

0.10

316

2778

Interstitial emphysema and related conditions originating in the perinatal period

3.39

1.70

14.8

18.8

106.67

123.79

g/l

—

General- and plastic-surgery devices associated with adverse incidents

2.24

1.69

15.1

8.0

115.46

120.44

g/l

0.41

Benign neoplasm: Skin of scalp and neck

671

1.33

1.68

7.3

9.4

119.31

120.69

g/l

0.22

650

Pregnancy with abortive outcome

2314

11495

1.06

1.68

6.7

7.0

119.78

118.54

g/l

2.43

2237

11064

Other and unspecified injuries of forearm

143

1.74

1.67

16.5

13.3

117.58

122.67

g/l

0.61

135

Benign neoplasm: Skin, unspecified

119

954

1.27

1.67

7.3

7.8

121.50

122.78

g/l

0.26

113

928

Injury of muscle and tendon at ankle and foot level

610

1.34

1.67

6.6

10.6

124.03

122.99

g/l

0.16

588

Asphyxiation

3.44

1.67

4.8

3.0

130.67

125.40

g/l

—

Aphakia

378

1.44

1.67

10.0

8.8

117.66

120.14

g/l

0.33

358

Pregnancy examination and test

323

1756

1.15

1.66

7.8

8.6

121.63

122.24

g/l

0.21

311

1695

Benign neoplasm of bone and articular cartilage

271

2348

1.17

1.65

8.2

9.0

122.18

123.15

g/l

0.34

262

2260

Need for immunization against single bacterial diseases

2.67

1.65

31.0

11.9

109.75

123.03

g/l

—

Chronic suppurative otitis media, including avohilmo

264

2284

1.17

1.64

8.5

8.7

121.87

121.76

g/l

0.03

252

2192

All dysplastic lesions of the cervix uteri

588

5322

1.11

1.64

7.5

7.4

119.12

120.76

g/l

1.32

571

5117

Hereditary retinal dystrophy

372

1.44

1.64

5.0

8.0

121.29

122.34

g/l

0.14

358

Carcinoma in situ of bronchus and lung

2.73

1.63

9.6

11.0

113.88

125.24

g/l

—

Alzheimer disease, including avohilmo

1480

10060

1.07

1.61

4.3

6.5

120.10

118.53

g/l

2.28

1422

9690

Endometriosis ASRM stages 3,4

685

6271

1.10

1.60

6.7

6.9

119.50

119.26

g/l

0.12

652

6030

Severe mental retardation

2.44

1.60

3.2

7.4

128.40

126.02

g/l

—

Superficial frostbite

169

1.67

1.60

9.8

12.0

124.41

123.23

g/l

0.11

162

Shoulder region

366

1.44

1.60

7.3

7.5

120.16

122.14

g/l

0.27

354

Hypertrophy of breast in women and men

587

5346

1.10

1.55

8.0

8.1

121.33

120.84

g/l

0.24

571

5139

Allergic rhinitis

920

8456

1.08

1.54

7.8

8.7

124.78

122.63

g/l

2.51

889

8140

Benign neoplasm: Scapula and long bones of upper limb

194

1.59

1.54

4.8

7.1

127.30

125.85

g/l

0.15

186

Benign neoplasm: Other parts of oropharynx

244

1.53

8.9

10.6

120.25

120.95

g/l

0.08

235

Vestibular neuronitis

319

2816

1.15

1.53

6.5

8.3

123.66

121.52

g/l

1.15

307

2708

Traumatic amputation of forearm

3.63

1.51

44.2

10.8

98.80

119.88

g/l

—

Thyroiditis, unspecified

352

1.43

1.51

7.4

120.35

119.67

g/l

0.09

341

Other demyelinating diseases of the central nervous system

787

1.28

1.51

13.2

10.2

122.55

123.13

g/l

0.11

764

Alcohol abuse counselling and surveillance

456

1.37

1.50

10.1

10.2

119.82

124.17

g/l

0.76

440

Other specified/unspecified nutritional deficiencies

164

1.65

1.50

8.0

7.3

117.23

122.70

g/l

0.70

158

Vitiligo

253

1.51

1.49

6.8

9.7

123.70

122.53

g/l

0.13

243

Antenatal screening

423

2662

0.89

1.49

6.0

9.1

121.29

121.18

g/l

0.04

415

2575

Otitis media, unspecified

287

2314

1.15

1.49

10.3

9.0

125.33

123.03

g/l

1.07

272

2237

Injury of blood vessels at wrist and hand level

189

1.61

1.48

10.9

11.7

116.41

122.71

g/l

0.79

181

Erythema annulare centrifugum

2.46

1.48

4.6

7.9

119.11

123.60

g/l

—

L02BA Anti-estrogens

527

4791

1.11

1.47

5.5

7.2

118.49

119.15

g/l

0.39

510

4612

Delivery

1299

7312

0.94

1.47

6.4

7.2

119.27

118.10

g/l

1.49

1256

7066

Primary open-angle glaucoma, strict

1081

10105

1.07

1.47

6.5

7.0

119.58

119.21

g/l

0.25

1037

9735

Crushing injury of ankle and foot

1.88

1.47

8.0

13.1

126.65

122.34

g/l

0.37

Foreign body in respiratory tract

163

1371

1.21

1.47

9.6

9.0

125.14

121.61

g/l

1.58

157

1325

Unspecific neurodegenerative disorder

1773

11607

1.06

1.46

4.4

6.8

120.57

118.94

g/l

2.83

1709

11175

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

133

1.70

1.46

5.5

12.2

118.86

127.14

g/l

1.30

126

Other hypersecretion of intestinal hormones

3.60

1.46

26.6

13.1

101.00

124.18

g/l

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

264

1.50

1.45

9.5

10.1

118.00

120.07

g/l

0.26

256

Chronic iridocyclitis

161

1355

1.21

1.45

7.3

8.4

120.63

121.49

g/l

0.21

153

1300

Gender identity disorders

154

0.45

1.45

11.1

14.1

117.00

125.82

g/l

—

145

Contact with other specified venomous animals

142

1.69

1.45

11.9

127.04

123.19

g/l

0.38

135

Disturbances of smell and taste

140

1166

1.22

1.43

7.0

9.1

119.99

120.71

g/l

0.18

134

1125

Carcinoma in situ of cervix uteri

197

1687

1.18

1.41

7.1

119.72

120.62

g/l

0.28

189

1626

Diastasis of muscle

151

1.65

1.40

5.2

8.5

131.50

120.75

g/l

1.47

146

Additional codes for the location of defect, injury or illness

183

1565

1.19

1.38

7.7

8.8

122.66

121.67

g/l

0.25

172

1505

Other specified transport accidents

113

1.76

1.38

9.5

13.6

123.37

122.69

g/l

0.05

105

Other melanin hyperpigmentation

649

1.30

1.37

6.5

7.1

115.44

119.53

g/l

1.23

627

Abrasion of teeth

958

6579

1.08

1.36

7.4

7.5

120.98

122.17

g/l

1.08

918

6335

Squamous cell neoplasms and carcinoma of rectum, excluding all cancers (controls excluding all cancers)

2.78

1.36

8.3

6.8

112.67

123.83

g/l

—

Use of selegiline

177

1514

1.19

1.36

5.0

7.5

121.75

121.01

g/l

0.20

170

1458

Colorectal squamous cell carcinoma, excluding all cancers (controls excluding all cancers)

2.77

1.36

8.3

6.8

112.67

123.83

g/l

—

Dacryoadenitis

193

1.56

1.36

5.7

7.0

119.72

120.02

g/l

0.03

185

Duodenal ulcer - Chronic or unspecified with haemorrhage, drug-induced

3.20

1.35

7.6

9.6

128.80

121.89

g/l

—

Other histiocytosis syndromes

2.73

1.35

4.7

31.2

122.17

128.50

g/l

—

Medical treatment for female infertility

418

3762

1.11

1.35

6.1

7.5

121.07

121.75

g/l

0.32

400

3616

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

281

2485

1.14

1.35

6.6

8.9

124.47

121.74

g/l

1.42

266

2394

Contact with and exposure to communicable diseases

730

7843

0.92

1.33

8.0

8.6

124.29

123.45

g/l

0.52

681

7551

Scissor bite

367

1.37

1.33

11.3

121.62

123.78

g/l

0.29

354

Use of donepezil

673

6985

0.92

1.30

4.1

6.2

121.59

118.26

g/l

4.61

646

6732

Squamous cell neoplasms and carcinoma of rectum

2.66

1.30

8.3

8.0

112.67

118.96

g/l

—

Colorectal squamous cell carcinoma

2.65

1.30

8.3

8.0

112.67

118.96

g/l

—

Labour and delivery complicated by fetal stress [distress]

387

2867

0.90

1.29

5.3

7.8

121.44

122.36

g/l

0.43

375

2752

Chronic diseases of tonsils and adenoids

3070

20152

0.96

1.28

7.8

8.7

124.82

121.77

g/l

12.69

2954

19415

Benign leiomyoma with endometriosis

444

4036

1.11

1.28

6.7

6.6

118.67

119.69

g/l

0.57

425

3858

Atypical virus infections of central nervous system

254

1.47

1.28

5.0

8.1

124.00

123.06

g/l

0.09

244

Benign neoplasm of thyroid gland

788

1.25

1.28

8.5

6.2

122.24

121.64

g/l

0.12

762

Motor- or nonmotor-vehicle accident in traffic area

139

1.64

1.28

10.1

11.7

126.73

124.59

g/l

0.20

131

Arthropathic psoriasis

385

3479

1.12

1.27

7.6

8.7

122.66

122.51

g/l

0.05

374

3343

Degenerative macular diseases

475

4342

1.10

1.26

6.8

7.0

118.16

119.82

g/l

1.06

463

4181

Malignant neoplasm of testis

444

1.34

1.26

11.8

10.8

121.24

125.79

g/l

0.85

426

Unspecified drowning and submersion

2.59

1.25

2.7

29.7

135.67

122.58

g/l

—

Occupant of special vehicle mainly used on industrial premises injured in transport accident

133

1.66

1.24

6.0

8.4

124.05

123.04

g/l

0.06

128

Endometriosis of intestine

229

1.46

1.24

6.9

9.6

123.06

119.47

g/l

0.50

223

Familial chondrocalcinosis

0.00

1.23

0.0

7.4

—

119.58

—

Benign leiomyoma with endometriosis

444

4861

0.91

1.22

6.7

118.67

118.45

g/l

0.09

425

4678

Biliary cirrhosis, secondary

2.84

1.21

44.2

6.6

106.00

123.55

g/l

—

Use of benzatropine

2.83

1.20

5.0

6.6

131.80

125.40

g/l

—

Unspecified chronic bronchitis

119

995

1.21

1.20

11.0

7.9

123.80

119.11

g/l

1.45

113

959

Benign neoplasm: Trachea

2.72

1.19

10.8

5.8

122.40

126.05

g/l

—

Psoriatic arthropathies, ICD10

356

3223

1.11

1.17

7.5

9.0

122.89

122.61

g/l

0.09

347

3105

Childhood allergy (age < 16)

254

1852

1.13

1.15

9.5

8.8

123.02

125.00

g/l

0.76

249

1777

Secondary malignant neoplasm of respiratory and digestive organs

399

1.34

1.15

4.5

8.1

115.38

120.74

g/l

1.14

390

Dental caries 3 and operation codes, only avohilmo

1293

6847

0.94

1.14

8.5

8.7

122.06

120.13

g/l

2.62

1253

6573

Other appendicitis

284

2544

1.13

1.14

9.4

8.3

122.40

122.85

g/l

0.13

274

2454

Dysplasia of cervi uteri

641

4602

1.08

1.13

7.3

7.9

118.71

118.93

g/l

0.11

622

4433

Carcinoma in situ of skin of eyelid, including canthus

2.09

1.13

3.0

7.0

115.60

121.75

g/l

—

Benign neoplasm: Liver/bile ducts (ICD-9)

2.62

1.13

5.8

10.4

121.20

121.76

g/l

—

Postpartum haemorrhage

478

4523

0.92

1.10

7.0

8.3

116.14

121.11

g/l

6.60

461

4344

Drug-induced aplastic anaemia

2.28

1.10

6.7

3.2

106.57

125.03

g/l

—

Benign neoplasm: other/unspecified salivary gland

824

1.22

1.09

7.1

7.9

119.27

120.31

g/l

0.20

799

Endometriosis of rectovaginal septum and vagina

237

2106

1.13

1.09

6.6

6.9

119.68

118.15

g/l

0.63

231

2028

Hydrocephalus in other diseases

147

0.52

1.09

24.4

11.1

117.75

119.59

g/l

—

140

Traumatic subcutaneous emphysema

2.27

1.09

7.9

5.5

107.86

120.91

g/l

—

Malignant neoplasm of hypopharynx, excluding all cancers (controls excluding all cancers)

197

1.48

1.06

14.0

6.8

108.29

123.44

g/l

3.34

192

Congenital malformations of uterus and cervix

306

1.36

1.06

18.7

9.3

123.63

121.50

g/l

0.33

296

Alzheimer’s disease, wide definition

849

7532

0.94

1.04

4.0

6.2

120.32

118.18

g/l

2.45

825

7259

Complications associated with artificial fertilization

221

1.42

1.04

4.6

10.5

121.61

120.71

g/l

0.09

214

Fat embolism (traumatic)

2.14

1.04

7.0

8.2

110.57

122.91

g/l

—

Disorder of thyroid, unspecified

317

1.36

1.04

16.7

6.4

120.00

119.27

g/l

0.09

310

Migraine, single triptan purchase ok & required. ICD-code if available is included

2687

18814

0.96

1.04

7.9

8.6

124.26

122.02

g/l

6.90

2613

18105

Triptan medication for migraine, single purchase ok

2687

18814

0.96

1.04

7.9

8.6

124.26

122.02

g/l

6.90

2613

18105

Benign neoplasm: Skin of trunk

135

1160

1.18

1.04

7.4

9.3

123.43

121.31

g/l

0.54

129

1126

Other congenital malformations of skull and face bones

1.90

1.01

3.7

26.3

128.78

127.00

g/l

—

Disorders of breast

1573

13964

1.05

1.01

7.5

7.0

119.57

118.95

g/l

0.68

1516

13450

Symptoms and signs involving appearance and behaviour

190

1.46

1.01

4.9

7.3

121.52

120.70

g/l

0.09

183

Vascular dementia (undefined)

120

1014

1.19

1.00

4.2

6.2

120.10

116.94

g/l

0.93

113

977

Other osteochondropathies

226

2017

1.13

1.00

8.4

9.4

122.87

123.87

g/l

0.30

215

1947

Malignant neoplasm of parotid gland

208

1.44

0.99

5.8

7.8

120.38

119.59

g/l

0.08

201

Other bursitis, not elsewhere classified

259

1.39

0.99

3.8

8.4

124.46

121.05

g/l

0.42

247

Embedded and impacted teeth

605

4794

1.08

0.99

7.4

8.7

123.16

124.40

g/l

0.76

580

4621

Other peripheral vertigo

321

2923

1.11

0.99

6.2

7.7

123.55

120.65

g/l

1.92

309

2818

Other psoriatic arthropathies

343

3132

1.10

0.99

7.1

9.0

123.09

122.63

g/l

0.16

335

3016

Delivery, wide proxy

1108

6207

0.95

0.98

6.3

6.9

118.83

117.87

g/l

0.96

1069

5981

Deep endometriosis

266

2398

1.12

0.98

6.3

6.8

119.84

118.94

g/l

0.34

259

2308

Tuberculosis of nervous system

2.03

0.98

17.4

10.6

117.57

118.35

g/l

—

Tic and related disorders

157

1.49

0.98

9.7

7.7

121.52

124.40

g/l

0.29

150

Maternal care for known or suspected fetal abnormality and damage

244

2419

0.89

0.97

7.6

8.4

120.08

121.15

g/l

0.42

238

2332

Carcinoma in situ of prostate

207

0.60

0.97

6.7

9.1

125.85

123.13

g/l

0.26

202

Other disorders of amniotic fluid and membranes

212

2358

0.89

0.97

6.5

8.1

121.87

121.16

g/l

0.22

207

2277

Ovarian hyperstimulation (induction)

216

1.41

0.97

4.7

8.6

121.07

122.53

g/l

0.15

208

Other disorders of thyroid

330

1.33

0.97

16.4

6.5

120.55

120.65

g/l

0.01

322

Alzheimer disease

1235

8885

1.05

0.95

4.1

6.3

119.76

118.40

g/l

1.56

1185

8558

Adenocarcinoma of pancreas

101

857

1.20

0.94

7.2

8.1

114.21

119.75

g/l

2.44

827

Noise effects on inner ear

160

1406

1.15

0.94

8.3

9.6

127.23

124.64

g/l

0.78

147

1348

Other congenital malformations of peripheral vascular system

261

1.37

0.94

19.7

10.5

121.14

121.31

g/l

0.01

251

Carcinoma in situ of bronchus and lung

2.05

0.94

9.6

11.1

113.88

119.21

g/l

—

Persons encountering health services in circumstances related to reproduction

2066

13502

1.04

0.93

9.4

9.5

123.80

123.87

g/l

0.05

1971

13033

Hypertrophy of breast

459

4258

1.08

0.91

7.9

7.6

121.68

119.85

g/l

1.31

444

4100

Seminoma of testis, excluding all cancers (controls excluding all cancers)

229

1.39

0.90

14.1

11.6

118.45

127.88

g/l

1.64

221

Occupant of streetcar injured in transport accident

2.14

0.89

4.0

8.5

115.17

121.29

g/l

—

Postpartum hemorraghe, parous women as controls

478

4500

0.93

0.89

7.0

7.1

116.14

121.79

g/l

8.29

461

4329

Severe bullous disorders, KELA reimbursement

1.82

0.88

4.8

5.5

113.00

119.74

g/l

0.54

Unspecified transport accident

105

1.58

0.85

9.0

9.8

120.63

123.50

g/l

0.20

Chalazion

368

3400

1.09

0.85

7.3

8.5

123.20

122.35

g/l

0.34

354

3271

Kaposi sarcoma, excluding all cancers (controls excluding all cancers)

1.97

0.84

1.8

7.1

108.00

121.19

g/l

—

Disorders of pituitary gland, other and/or unspecified

147

1.48

0.84

28.9

11.0

116.14

122.31

g/l

0.95

142

Other infective (teno)synovitis

106

1.57

0.83

5.4

8.8

120.44

122.78

g/l

0.14

101

Acquired atrophy of ovary and fallopian tube

1.80

0.83

10.6

6.3

119.20

119.93

g/l

—

Routine general health check-up of defined subpopulation

311

1.30

0.82

5.8

6.7

120.15

122.47

g/l

0.29

300

Other and unspecified disease of Bartholin gland

739

1.19

0.82

7.2

7.7

122.90

117.99

g/l

1.71

712

Drug-induced headache, not elsewhere classified

106

1.55

0.82

15.9

6.0

123.56

122.28

g/l

0.11

101

Lymphocyte function antigen-1 [LFA-1] defect

0.00

0.81

0.0

7.3

—

122.04

—

Other or unspecified paralytic strabismus

165

1.43

0.81

11.0

7.8

114.91

121.67

g/l

0.66

156

Use of other anti-dementia drugs

1004

8348

1.05

0.80

3.6

6.2

120.68

118.22

g/l

3.51

957

8039

Use of memantine

1004

8348

1.05

0.80

3.6

6.2

120.68

118.22

g/l

3.51

957

8039

Mandibular prognathia AND surgery (LeFortI or BSSRO)

0.50

0.80

3.8

13.9

128.80

123.78

g/l

—

Pedal cyclist injured in collision with motor vehicle

768

1.19

0.80

7.6

9.0

122.39

122.20

g/l

0.03

740

Allergic colitis

303

1.30

0.80

22.7

8.4

125.74

124.34

g/l

0.15

291

Benign neoplasm: Liver/bile ducts (ICD-9)

2.38

0.80

5.8

6.5

121.20

117.22

g/l

—

Polyglandular dysfunction, other/unspecified

2.36

0.80

10.6

7.5

110.80

119.22

g/l

—

Separation of retinal layers (serosa)

144

1277

1.14

0.78

9.8

9.2

120.07

124.23

g/l

1.45

139

1233

Other and unspecified disorders of sclera

2.24

0.77

2.8

6.5

110.40

117.67

g/l

—

Use of rivastigmine

513

4811

1.07

0.77

3.6

6.1

119.58

118.33

g/l

0.78

493

4638

Adenomyosis (Endometriosis of uterus)

422

3938

1.08

0.77

6.5

7.2

119.77

117.55

g/l

1.65

413

3799

Benign neoplasm: Prostate

230

0.67

0.77

6.6

8.4

126.06

121.86

g/l

0.32

224

MS-disease / Multiple Sclerosis

189

1703

1.12

0.76

6.6

8.9

125.09

122.77

g/l

0.97

179

1640

Cleft lip and cleft lip and palate

150

1.43

0.76

13.2

11.3

121.43

128.06

g/l

0.68

142

Other noninflammatory disorders of vagina

218

1980

1.11

0.75

6.3

7.0

118.57

118.30

g/l

0.09

207

1917

Effects of air pressure and water pressure

100

1.55

0.75

14.3

14.9

122.47

124.12

g/l

0.11

Lichen striatus

2.12

0.75

2.2

8.6

122.20

123.40

g/l

—

Open bite that required surgery (Lefort1 or BSSRO)

133

1.45

0.75

2.8

12.0

124.47

122.39

g/l

0.18

127

Malignant neoplasm of placenta, excluding all cancers (controls excluding all cancers)

2.12

0.75

7.4

3.6

120.80

117.84

g/l

—

Undefined dementia

350

3464

0.92

0.74

3.7

5.7

119.98

118.19

g/l

0.91

334

3331

Varicose veins of other sites

219

1994

1.11

0.74

7.3

9.0

126.08

123.95

g/l

0.78

209

1926

Other otitis externa (chronic)

205

1861

1.11

0.73

8.8

8.9

122.95

121.73

g/l

0.38

197

1785

Other congenital malformations of face and neck

627

1.19

0.73

7.1

9.8

125.57

122.18

g/l

0.71

607

Uterine polyps

286

2638

1.09

0.72

6.8

7.4

119.82

118.09

g/l

0.91

272

2549

Benign neoplasm: Scapula and long bones of upper limb

230

1.33

0.72

4.8

7.5

127.30

122.19

g/l

0.77

219

Transient global amnesia

336

3123

1.08

0.72

5.6

7.5

121.78

119.52

g/l

1.28

324

3010

Malignant neoplasm of gum

136

1.46

0.71

15.9

7.8

114.84

120.36

g/l

0.72

129

Medicines for HER+ breast cancer

1221

11460

1.04

0.69

5.6

7.1

118.36

118.58

g/l

0.17

1176

11052

Foreign body on external eye

463

4915

0.94

0.68

7.9

9.7

127.32

124.96

g/l

1.56

444

4738

Benign neoplasm: Connective and other soft tissue of thorax

120

1.47

0.68

5.8

7.1

123.18

120.97

g/l

0.17

115

Disorders of other and unspecified cranial nerves

120

1.46

0.67

16.3

11.9

116.35

118.51

g/l

0.16

115

Certain conditions originating in the perinatal period

160

1276

1.12

0.67

13.1

10.1

121.52

124.01

g/l

0.80

152

1233

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

155

1.40

0.66

6.9

13.5

129.14

125.35

g/l

0.28

148

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

323

1.26

0.66

6.0

6.8

116.77

122.79

g/l

1.12

313

Allergic conjunctivitis

1924

18400

1.03

0.65

8.3

7.9

121.56

121.20

g/l

0.35

1868

17723

Carcinoma in situ of prostate

187

0.67

0.65

6.7

8.2

125.85

125.46

g/l

0.03

181

Benign neoplasm: Skin of lip

388

1.23

0.65

5.4

7.2

121.85

120.08

g/l

0.23

377

Drowning and submersion while in natural water

139

1.42

0.64

3.3

12.4

137.79

120.04

g/l

2.55

134

Exposure to ignition of highly flammable material

113

1.46

0.64

8.3

13.6

121.31

126.87

g/l

0.42

106

Vascular dementia (other)

156

1.39

0.64

5.5

7.4

119.62

117.06

g/l

0.23

150

Ankyloglossia

198

1.32

0.64

9.7

12.0

126.58

126.33

g/l

0.02

185

Nontoxic single thyroid nodule

188

2058

0.91

0.63

4.8

7.6

121.28

119.91

g/l

0.38

179

1978

Crowding of teeth, including avohilmo

165

1231

1.11

0.63

9.9

8.9

121.11

123.88

g/l

0.94

158

1192

Pemphigus erythematosus

0.00

0.62

0.0

5.8

—

122.52

—

Disorders of glossopharyngeal nerve

1.61

0.62

32.6

10.7

108.75

122.33

g/l

—

Chronic myeloproliferative disease

409

1.22

0.62

7.5

8.9

104.57

120.46

g/l

5.65

398

Unspecified hairloss

1.88

0.61

2.7

10.3

129.50

123.53

g/l

—

Antepartum haemorrhage, not elsewhere classified

161

1461

1.11

0.60

10.2

7.9

120.92

121.36

g/l

0.10

155

1410

Postpartum hemorraghe, all women as controls

478

5024

0.95

0.59

7.0

7.6

116.14

121.54

g/l

7.69

461

4829

Systemic disorders of connective tissue in diseases classified elsewhere

1.53

0.59

4.1

6.3

124.83

123.72

g/l

0.06

Obstructed labour due to malposition and malpresentation of fetus

440

4386

0.94

0.59

6.6

8.6

122.11

121.33

g/l

0.38

429

4205

Other assisted single delivery

253

0.74

0.58

8.3

9.6

123.11

121.22

g/l

0.14

244

Puerperal sepsis

359

3375

1.07

0.58

8.2

7.7

121.46

119.47

g/l

1.20

350

3248

Tonsillectomy and adenotomy

1693

12133

0.97

0.58

7.3

9.0

126.04

123.63

g/l

4.70

1619

11700

Subclinical iodine-deficiency hypothyroidism

1.71

0.58

6.5

7.7

127.00

118.24

g/l

—

Crystalline deposits in vitreous body

276

1.26

0.57

5.5

7.3

116.59

120.85

g/l

0.67

270

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1828

17497

1.03

0.57

8.4

7.9

121.40

121.22

g/l

0.15

1776

16846

Crossbite

146

1227

1.11

0.56

12.2

9.7

123.99

122.69

g/l

0.34

137

1188

Malignant neoplasm of base of tongue

169

1.34

0.56

8.9

9.7

114.68

121.37

g/l

0.82

164

Peroneal tendinitis

330

1.23

0.56

5.1

9.5

128.70

120.45

g/l

1.45

322

Bus occupant injured in other and unspecified transport accidents

151

1.36

0.56

7.5

116.35

122.59

g/l

0.65

145

L02BX Other hormone antagonists and related agents

182

1976

0.91

0.56

5.3

8.1

113.01

122.03

g/l

8.15

176

1902

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1358

10345

1.03

0.55

7.2

7.5

120.30

119.89

g/l

0.35

1309

9958

Palindromic rheumatism

271

0.76

0.54

13.0

8.6

124.33

122.44

g/l

0.14

264

Use of anticholinesterases

1259

10505

0.97

0.54

3.9

6.5

120.87

118.54

g/l

4.14

1213

10113

N06DA Anticholinesterases

1259

10505

0.97

0.54

3.9

6.5

120.87

118.54

g/l

4.14

1213

10113

Contact with blunt object, undetermined intent

117

1.40

0.54

4.6

14.4

126.88

124.46

g/l

0.17

112

Foreign body entering into or through eye or natural orifice

257

2406

1.07

0.50

8.2

9.1

126.13

124.19

g/l

0.77

250

2320

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

157

1709

0.91

0.50

11.2

7.7

119.09

120.85

g/l

0.57

150

1648

Other noninflammatory disorders of cervix uteri

129

1413

0.91

0.49

6.3

7.3

118.50

118.17

g/l

0.07

123

1364

Follicular lymphoma, hilmo

148

1360

1.10

0.48

8.3

8.2

117.21

120.73

g/l

1.19

138

1308

FESS (DNB20)

358

3776

0.94

0.48

6.7

9.0

126.90

122.74

g/l

3.16

336

3643

Other protozoal intestinal diseases

321

0.80

0.48

5.7

9.8

124.23

121.03

g/l

0.28

312

Miliary tuberculosis

1.45

0.47

11.0

6.0

92.86

118.30

g/l

—

Colour vision deficiencies

0.58

0.47

7.8

14.1

113.20

127.86

g/l

—

Infectious mononucleosis

169

1563

1.08

0.46

8.2

9.3

125.77

125.71

g/l

0.01

163

1505

Mandibular hypoplasia

112

1.36

0.46

12.5

7.9

124.93

123.55

g/l

0.09

107

Unattended death

230

0.77

0.45

4.9

7.3

122.78

120.62

g/l

0.17

225

Benign neoplasm: Trachea

1.70

0.45

10.8

4.4

122.40

122.29

g/l

—

Lipodystrophy, not elsewhere classified

1.67

0.44

16.0

5.0

116.40

121.26

g/l

—

Benign neoplasm: Bones of skull and face

239

1.23

0.44

8.5

7.4

119.86

121.09

g/l

0.15

234

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

157

1696

0.92

0.44

11.2

7.1

119.09

121.17

g/l

0.72

150

1634

Plasmodium vivax malaria

0.00

0.42

0.0

10.4

—

114.29

—

Anomalies of dental arch relationship, including avohilmo

512

4412

1.04

0.42

7.8

8.6

124.83

123.24

g/l

0.99

491

4258

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

0.42

0.0

11.4

—

121.59

—

Complications predominantly related to the puerperium

637

6142

1.04

0.42

8.3

7.4

120.55

119.92

g/l

0.37

624

5905

Other and unspecified spinal muscular atrophies

238

0.78

0.42

12.3

9.4

126.53

120.71

g/l

0.48

233

LSIL lesion of the cervix uteri, vagina or vulva

306

2902

1.06

0.42

7.2

7.3

117.79

120.75

g/l

2.25

298

2795

Intentional self-harm by hanging, strangulation and suffocation

150

1.29

0.41

5.3

11.7

130.11

125.27

g/l

0.42

142

Other specified and unspecified disorders of choroid

1.38

0.41

11.0

7.6

119.77

120.59

g/l

0.06

Benign mammary dysplasia

448

4294

1.05

0.41

7.3

6.8

118.13

118.12

g/l

0.00

431

4137

Benign lipomatous neoplasm of other sites/unspecified

308

2927

1.06

0.41

7.8

122.07

120.78

g/l

0.58

302

2813

therapeutic use

855

1.11

0.40

9.3

7.9

117.09

121.08

g/l

1.26

826

Abnormal findings on diagnostic imaging of breast

325

1.18

0.40

8.0

6.8

119.29

118.75

g/l

0.06

317

Cleft lip and palate

115

1.33

0.40

7.7

12.4

120.40

127.19

g/l

0.58

109

Seminoma of testis

262

1.20

0.38

14.1

12.2

118.45

125.49

g/l

1.08

252

Ethmoidectomy

379

3959

0.95

0.38

7.1

9.1

126.92

122.57

g/l

3.56

356

3818

Undescended testicle

197

1.23

0.38

14.3

12.2

125.00

129.23

g/l

0.39

190

Sweet's syndrome

1.49

0.37

11.0

5.8

107.00

122.50

g/l

—

Acrodermatitis chronica atrophicans

1.48

0.37

9.3

7.5

112.00

121.26

g/l

—

Graves disease, strict definition

259

2458

1.06

0.37

6.1

8.3

122.21

121.12

g/l

0.36

246

2370

Febrile neutrophilic dermatosis [Sweet]

1.42

0.36

11.0

5.6

107.00

121.75

g/l

—

Gestational diabetes (for exclusion)

775

5322

1.03

0.36

7.0

8.0

121.91

121.32

g/l

0.38

749

5121

Other porphyria

1.40

0.35

6.3

6.0

135.83

123.80

g/l

—

Respiratory distress of newborn

159

1.23

0.35

12.9

14.6

115.71

123.47

g/l

0.63

154

Otosclerosis

230

2424

0.94

0.35

8.4

8.3

120.45

120.81

g/l

0.10

223

2339

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

155

1.25

0.33

16.3

6.9

118.37

121.40

g/l

0.26

148

Spontaneous abortion

1269

8820

0.98

0.33

6.5

7.6

120.90

119.08

g/l

2.84

1213

8498

Meningococcal infection

155

1.24

0.33

7.8

8.1

131.11

124.95

g/l

0.67

146

Dementia in Alzheimer disease

609

5365

0.97

0.32

3.6

6.2

120.03

118.07

g/l

1.62

593

5178

Cholesteatoma of middle ear

179

1694

1.06

0.31

8.4

8.3

121.01

120.98

g/l

0.01

174

1638

Other obstructed labour

178

1684

1.06

0.31

6.8

7.6

120.30

120.61

g/l

0.08

169

1623

Rheumatic heart disease, other

1.28

0.30

4.6

6.3

124.43

121.16

g/l

—

Whooping cough

1.32

0.30

19.8

6.6

109.73

125.60

g/l

1.45

Pollen allergy

400

4102

0.96

0.30

7.8

8.9

125.22

123.84

g/l

0.66

390

3963

Alzheimer’s disease (Late onset)

790

6939

0.97

0.30

3.7

6.1

120.50

118.04

g/l

2.85

767

6692

Tic and related disorders

194

1.19

0.30

9.7

10.4

121.52

125.69

g/l

0.47

186

Other abnormal products of conception

717

4649

1.03

0.30

6.4

8.0

121.93

120.71

g/l

0.89

683

4465

Ménière disease

326

3136

1.04

0.30

5.4

7.8

123.60

120.31

g/l

2.45

312

3021

Allergic contact dermatitis

355

3683

0.96

0.29

7.8

7.7

121.27

121.41

g/l

0.04

346

3533

Familial erythrocytosis

131

1.24

0.28

15.4

7.4

131.44

121.33

g/l

1.15

124

Other and unspecified atrophic disorders of skin

122

1.25

0.28

3.4

6.0

125.47

119.27

g/l

0.65

117

Infliximab

139

0.78

0.27

2.3

13.1

118.82

125.51

g/l

0.70

130

Tic disorders

187

1.18

0.27

10.0

10.9

123.05

125.16

g/l

0.21

179

Other puerperal infections

111

1184

0.94

0.27

8.1

7.7

121.70

121.44

g/l

0.05

111

1139

Anogenital herpesviral [herpes simplex] infection

132

1247

1.06

0.26

12.1

9.2

120.94

123.41

g/l

0.76

127

1195

Colorectal neuroendocrine tumor and carcinoma

359

1.12

0.25

6.0

7.4

116.78

120.38

g/l

0.55

347

Obstructed labour due to maternal pelvic abnormality

421

4087

1.03

0.25

7.8

7.7

119.67

119.31

g/l

0.15

407

3932

Merkel cell carcinoma of skin

1.40

0.25

5.4

8.1

120.00

121.62

g/l

—

Other benign neoplasm of uterus: Corpus uteri

180

1.18

0.24

7.8

5.5

111.86

121.13

g/l

1.25

174

Merkel cell carcinoma of skin, excluding all cancers (controls excluding all cancers)

1.36

0.24

5.4

5.6

120.00

124.66

g/l

—

Chorioretinal inflammation

755

1.08

0.24

12.7

8.8

121.35

121.14

g/l

0.03

730

Testicular dysfunction, other/unspecified

106

1.25

0.24

8.0

15.9

133.31

126.69

g/l

0.64

100

Leiomyoma of uterus

2169

12178

1.01

0.24

6.9

7.1

119.36

118.84

g/l

0.62

2079

11735

Multiple gestation

162

1697

0.95

0.23

8.2

7.9

119.24

121.00

g/l

0.58

155

1638

Unspecified dementia

348

3234

0.97

0.22

3.8

6.0

119.95

118.07

g/l

0.97

332

3118

Yellow nail syndrome

0.00

0.22

0.0

12.4

—

125.09

—

Other fluke infections

0.00

0.22

0.0

13.4

—

122.17

—

Reduction defects of unspecified limb

0.00

0.22

0.0

5.4

—

126.10

—

Obstetric and gynaecological devices associated with adverse incidents

0.00

0.22

0.0

7.8

—

117.27

—

Enophthalmos

0.00

0.22

0.0

9.6

—

122.33

—

Carcinoma in situ of respiratory system, other/unspecified

0.00

0.22

0.0

6.0

—

123.17

—

Twin gestation

156

1632

0.95

0.21

8.5

7.8

119.03

121.08

g/l

0.70

149

1575

Urticaria due to cold and heat

154

1.18

0.21

8.1

7.6

120.44

123.22

g/l

0.35

148

Benign neoplasm of thyroid gland

916

1.06

0.21

8.5

7.3

122.24

119.96

g/l

0.62

890

Benign neoplasm: Penis

1.27

0.21

11.7

19.5

134.00

132.00

g/l

—

Benign neoplasm: Skin, unspecified

119

1132

1.06

0.20

7.3

8.4

121.50

121.41

g/l

0.01

113

1100

Other disorders of breast

308

3173

0.97

0.20

6.9

7.4

118.45

118.82

g/l

0.14

301

3050

Other and unspecified degenerative diseases of nervous system

694

1.07

0.20

3.7

8.8

123.34

119.56

g/l

0.86

672

Triptan medication for migraine, min. 3 purchases

1666

12981

1.01

0.20

7.5

8.4

123.87

121.65

g/l

4.77

1613

12493

Sudden idiopathic hearing loss

347

3376

1.03

0.20

9.1

8.1

122.09

121.04

g/l

0.39

338

3241

Malignant neoplasm of breast, HER-negative

670

6564

1.02

0.20

6.8

6.7

117.70

117.85

g/l

0.07

654

6322

Oral lichen ruber planus, including avohilmo

175

1682

1.04

0.20

7.0

8.4

123.07

120.79

g/l

0.89

168

1628

Trichomoniasis

213

1.14

0.19

9.1

6.5

117.25

118.91

g/l

0.17

208

Corneal degeneration

386

1.10

0.19

9.9

7.7

119.36

120.05

g/l

0.08

374

Malignant melanoma of skin

401

3915

1.03

0.19

7.2

7.7

120.53

120.98

g/l

0.18

391

3767

Maternal care for known or suspected malpresentation of fetus

330

2394

1.03

0.18

6.6

8.1

121.87

121.62

g/l

0.08

315

2304

Other specified disorders of external ear

118

1234

0.95

0.18

6.8

9.0

121.47

122.04

g/l

0.11

112

1188

Mandibular retrognathia

146

1397

1.04

0.18

6.6

10.0

124.65

123.42

g/l

0.35

135

1352

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

1.16

0.18

7.1

4.9

119.00

122.28

g/l

—

Melanoma in situ of other and unspecified parts of face

320

0.90

0.18

11.0

5.8

116.00

121.28

g/l

0.67

313

Asymptomatic human immunodeficiency virus [HIV] infection status

152

0.85

0.17

10.5

16.5

118.69

125.74

g/l

0.52

145

Villonodular synovitis (pigmented)

186

1.14

0.17

6.2

12.2

122.81

121.36

g/l

0.12

179

L02BG Aromatase inhibitors

927

9405

0.98

0.17

5.7

7.1

118.24

118.29

g/l

0.03

891

9062

Presbyopia

180

1739

1.04

0.17

8.9

124.63

122.88

g/l

0.60

174

1677

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

177

1.14

0.17

4.3

7.2

125.50

123.33

g/l

0.24

172

Other disorders of breast and lactation associated with childbirth

225

0.89

0.16

7.2

7.3

119.15

121.82

g/l

0.25

217

Intrahepatic Cholestasis of Pregnancy (ICP)

114

1190

0.96

0.16

11.7

7.8

122.16

121.69

g/l

0.10

108

1146

Contraceptive management

1332

9256

1.01

0.16

8.6

9.6

123.56

123.85

g/l

0.20

1273

8955

Bullous keratopathy

226

1.12

0.15

5.3

5.8

116.08

121.63

g/l

0.73

218

Injury of nerves at ankle and foot level

159

1.14

0.15

12.1

8.4

126.72

122.66

g/l

0.28

151

Retained placenta and membranes, without haemorrhage

289

2962

0.97

0.15

6.0

7.3

118.14

119.99

g/l

0.93

280

2851

Chronic mastoiditis

830

1.05

0.15

8.3

8.1

123.77

119.91

g/l

1.01

801

Presence of other devices

843

8310

1.01

0.15

7.2

6.7

121.18

120.66

g/l

0.31

801

8000

Unspecified lump in breast

438

4464

0.98

0.15

8.2

7.0

119.50

118.89

g/l

0.29

420

4296

Maternal care for known or suspected abnormality of pelvic organs

541

3668

1.02

0.14

6.5

8.1

121.30

120.94

g/l

0.17

527

3531

Other predominantly sexually transmitted diseases, not elsewhere classified

403

3952

1.02

0.14

10.0

8.2

121.18

123.22

g/l

1.28

387

3803

Gilbert syndrome

170

0.88

0.14

7.8

9.6

132.47

125.29

g/l

0.42

164

Malignant melanoma

515

5231

0.98

0.13

7.5

7.7

120.33

120.59

g/l

0.11

500

5035

Maternal care for other known or suspected fetal problems

431

2814

0.98

0.13

6.7

8.2

120.10

121.67

g/l

0.95

410

2708

Single delivery by caesarean section

397

2254

1.02

0.12

7.1

9.4

118.03

120.28

g/l

1.47

384

2185

Neonatal jaundice from other and unspecified causes

175

1.11

0.12

24.3

14.7

116.45

123.74

g/l

0.80

169

Atopic dermatitis

1785

15108

1.01

0.12

8.2

8.3

122.53

122.42

g/l

0.08

1741

14549

Congenital malformations of breast

249

1.09

0.12

4.1

6.7

120.85

121.26

g/l

0.04

242

L02BB Anti-androgens

345

3390

1.02

0.12

5.7

7.8

114.40

121.07

g/l

7.38

330

3269

Haemorrhagic and haematological disorders of fetus and newborn

210

1.09

0.12

22.6

14.4

113.83

123.17

g/l

1.25

204

Peripheral retinal degeneration

877

1.04

0.11

5.6

8.2

125.45

120.96

g/l

1.19

846

Other congenital malformations of male genital organs

124

1.14

0.11

9.4

14.7

133.07

129.60

g/l

0.22

119

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

114

1175

0.97

0.10

11.7

7.2

122.16

121.92

g/l

0.05

108

1127

Thyrotoxicosis with toxic single thyroid nodule

193

1.09

0.10

3.2

7.1

123.57

120.68

g/l

0.28

187

Neuroendocrine tumor and carcinoma of rectum, excluding all cancers (controls excluding all cancers)

1.16

0.10

5.8

7.5

114.00

122.37

g/l

—

Polymorphous light eruption

155

1.10

0.09

6.0

6.2

116.29

121.57

g/l

0.35

150

Personal history of allergy to analgesic agent

113

0.88

0.08

7.4

123.10

124.01

g/l

—

108

LeFortI or BSSRO operation

844

1.03

0.08

3.3

10.1

128.07

123.29

g/l

1.70

811

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

1.12

0.08

18.9

6.6

110.71

121.59

g/l

—

Pedestrian injured in collision with two- or three-wheeled motor vehicle

1.15

0.08

7.0

14.6

119.80

122.64

g/l

—

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

1.08

0.08

9.4

17.6

141.00

130.32

g/l

—

Other and unspecified cicatricial alopecia

0.81

0.08

7.0

7.9

134.83

119.93

g/l

—

Enterobiasis

0.85

0.08

5.7

8.2

120.83

123.49

g/l

—

Pediculosis and phthiriasis

0.80

0.08

9.2

7.9

130.83

124.62

g/l

—

Carcinoma in situ of breast, lobular

186

1.08

0.07

3.3

6.1

115.00

118.81

g/l

0.42

181

Postpartum haemorrhage due to retained placenta

217

2205

0.98

0.07

7.5

7.1

115.18

122.16

g/l

5.51

210

2109

Lichenoid drug reaction

1.04

0.07

12.8

5.7

123.44

116.79

g/l

—

Benign neoplasm: Floor of mouth

0.85

0.07

24.4

8.6

107.88

120.70

g/l

—

Use of galantamine

232

2288

1.02

0.06

3.4

6.1

121.87

118.16

g/l

1.91

227

2198

Other and unspecified disorders of vitreous body

1581

15665

1.00

0.05

7.3

7.9

121.35

120.20

g/l

1.54

1532

15095

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

191

0.94

0.04

2.3

11.3

126.67

123.82

g/l

0.29

182

Degenerative myopia

170

1.06

0.04

4.7

7.6

125.39

119.41

g/l

0.75

164

Overjet

349

0.97

0.03

11.7

10.6

118.62

122.88

g/l

0.72

337

Malignant neoplasm of breast, HER-positive

1108

10958

1.00

0.03

5.8

7.0

118.21

118.45

g/l

0.18

1064

10570

Contact with nonpowered hand tool

130

1315

0.99

0.03

10.2

9.7

124.98

124.91

g/l

0.01

125

1266

Premenstrual syndrome

181

1.05

0.03

7.5

11.4

120.37

120.02

g/l

0.03

175

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

191

1.05

0.03

4.3

8.6

125.50

120.07

g/l

0.78

184

Defect, injury or illness of neck

108

0.92

0.03

16.7

8.5

130.30

123.62

g/l

—

102

Deep bite

269

2337

1.01

0.03

7.8

9.4

125.23

123.29

g/l

0.82

260

2254

Hereditary motor and sensory neuropathy

221

1.04

0.03

9.2

7.7

120.91

123.17

g/l

0.16

213

Malignant neoplasm of eye and adnexa

229

0.96

0.03

5.4

9.4

129.23

121.86

g/l

1.01

222

Pregnancy, childbirth and the puerperium

1030

5403

1.00

0.02

5.7

6.6

118.48

117.80

g/l

0.58

1004

5191

Early syphilis

341

1.03

0.02

9.4

10.9

126.34

124.59

g/l

0.20

325

Contact with lifting and transmission devices, not elsewhere classified

523

1.01

0.01

9.7

11.3

124.87

123.94

g/l

0.10

504

Impacted teeth

354

3289

1.00

0.00

7.1

8.8

124.49

124.51

g/l

0.01

346

3170

Disorders of parathyroid gland, other and/or unspecified

191

0.99

0.00

8.9

7.4

119.00

119.65

g/l

0.04

185

Other deformity of hallux (acquired)

205

0.97

0.00

4.0

6.8

122.30

119.70

g/l

0.18

197

Other benign neoplasm of uterus: Corpus uteri

214

0.98

0.00

7.8

6.1

111.86

119.79

g/l

1.02

208

Cholinergic urticaria

108

1.02

0.00

2.9

11.8

129.00

124.76

g/l

0.33

103

Occupant of pick-up truck or van injured in other and unspecified transport accidents

125

1.04

0.00

9.0

12.6

127.23

123.62

g/l

0.18

120

Nutritional and metabolic disorders in diseases classified elsewhere

0.00

0.0

3.6

—

132.67

—

Carcinoma in situ of rectosigmoid junction

0.00

0.0

13.4

—

109.20

—

Chlamydia psittaci infection

0.00

0.0

2.6

—

118.40

—

Accident to nonpowered aircraft causing injury to occupant

0.00

0.0

11.0

—

133.60

—

Foreign body granuloma of skin and subcutaneous tissue

0.93

0.00

8.8

4.6

126.78

123.81

g/l

—

Toxic effect of noxious substances eaten as seafood

0.00

0.0

3.4

—

123.60

—

Deficiency of vitamin E

0.00

0.0

10.4

—

114.40

—

Pustulosis subcornealis

0.00

0.0

12.8

—

117.50

—

Ascariasis

0.00

0.0

9.0

—

115.83

—

Other specified disorders of eye and adnexa in diseases classified elsewhere

0.00

0.0

2.4

—

124.86

—

Fetal blood loss

0.00

0.0

10.7

—

123.57

—

Toxic liver disease with acute hepatitis, drug-induced

0.00

0.0

17.0

—

127.33

—

Beau lines

0.00

0.0

19.7

—

113.50

—

Anthrax

0.00

0.0

8.0

—

119.78

—

Congenital malformation of vitreous humour

0.00

0.0

3.2

—

132.50

—

Visual disturbances in diseases classified elsewhere

0.00

0.0

8.0

—

131.88

—

Androgen resistance syndrome

0.00

0.0

11.6

—

112.00

—

Other congenital infectious and parasitic diseases

0.00

0.0

9.6

—

106.80

—

Vascular dementia (sudden onset)

1.01

0.00

2.9

5.7

113.78

114.80

g/l

—

Other protozoal diseases, not elsewhere classified/unspecified

0.00

0.0

20.7

—

117.33

—

Granuloma inguinale

0.00

0.0

4.0

—

107.20

—

Neuropathic heredofamilial amyloidosis

0.00

0.0

6.3

—

126.67

—

Plasmodium malariae malaria

0.00

0.0

2.7

—

119.17

—

Blastomycosis

0.00

0.0

3.0

—

140.29

—

Dietary selenium deficiency

0.00

0.0

14.7

—

117.50

—

Hereditary factor XI deficiency

0.00

0.0

2.5

—

122.50

—

Other specified types of T/NK-cell lymphoma, hilmo, excluding all cancers

0.00

0.0

4.8

—

132.40

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Hemoglobin [Mass/volume] in Arterial blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS